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 Abstract 
 
Cell migration and invasion is a central process in embryonic development, 
wound  healing  and  immune  responses.  Errors  during  this  process  have 
serious consequences, including mental retardation, vascular disease, tumor 
formation and metastasis. An understanding of the mechanism by which cells 
migrate  and  invade  may  lead  to  the  development  of  novel  therapeutic 
strategies for controlling, for example, cancer metastasis. 
 
Fascin is an actin-bundling protein involved in filopodia assembly and cancer 
invasion and metastasis of multiple epithelial cancer types. In this thesis, I 
have  investigated  the  role  of  fascin  in  invadopodia  formation,  which  are 
invasive  finger-like  protrusions  that  cancer  cells  use  to  invade  into  and 
degrade extracellular matrix. I demonstrated that fascin and its actin bundling 
activity are required for the assembly of the actin cytoskeleton at invadopodia 
as well as for the degradation of matrix. Fascin is a very stable component of 
invadopodia  and  its  presence  enhance  the  stability  of  actin  structures  at 
invadopodia.  Furthermore,  fascin  is  required  for  invasive  migration  into 
collagen  I-Matrigel  gels  particularly  in  cell  types  that  use  an  elongated 
mesenchymal type of motility in 3D. These data provide a potential molecular 
mechanism for how fascin increases the invasiveness of cancer cells. 
 
During embryogenesis, melanoblasts proliferate and migrate ventrally through 
the developing dermis and epidermis as single cells. In the second part of this 
thesis, I examined the importance of small Rho GTPase Rac1 on melanoblast 
migration during development. I demonstrate that targeted deletion of Rac1 in 
the melanoblasts of developing mice causes defects in migration, cell cycle 
progression and cytokinesis.  Rac1 null cells migrate markedly less efficiently, 
but  surprisingly  global  steering,  crossing  the  dermal/epidermal  junction 
and homing  to  hair  follicles  are  normal.    Melanoblasts  navigate  in  the 
epidermis using two classes of protrusion: short stubs and long pseudopods.  
Short stubs are driven by actin assembly, but unexpectedly are independent 
of Rac1, Arp2/3 complex, myosin or microtubules.  Rac1 positively regulates the frequency of initiation of long pseudopods, which promote migration speed 
and  directional  flexibility.  Scar/WAVE  and  Arp2/3  complex  drive  actin 
assembly for long pseudopod extension, which is also microtubule dependent.  
Myosin contractility balances the extension of long pseudopods by effecting 
retraction and allowing force generation for movement through the complex 
3D  epidermal  environment.  In  addition,  I  demonstrated  that  expression  of 
activated  N-Ras  did  not  affect  migration  and  proliferation  of  melanoblast 
during embryogensis. However, Rac1 is required for constitutively active N-
Ras induced dermal melanocytes survival in mice.  
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1.1 Actin based cell motility 
1.1.1 2D Cell migration  
The  directional  migration  of  cancer  cells  largely  relies  on  the  actin 
cytoskeleton and its regulatory proteins, and indeed, cell motility genes are 
often  found  to  be  upregulated  at  certain  stages  during  the  metastasis 
progression (Machesky, 2008; Nürnberg et al., 2011). During migration on 2D 
surface, cells in response to an external signal, which leads to the generation 
of protrusions in the direction of migration such as lamellipodia and filopodia. 
In  malignant  cancer  cells,  another  kind  of  actin-based  protrusion  termed 
invadopodia are generated from ventral surface of a cell and have proteolytic 
activity toward extracellular matrix (Figure 1.1). Within these protrusions, the 
actin cytoskeleton is dynamically remodelled into different kinds of protrusive 
structures that lie just beneath the plasma membrane and force generated by 
these  protrusive  structures  pushes  the  plasma  membrane  forward  which 
coupled  with  adhesion  of  this  leading  edge  to  the  substrate  drives  cell 
migration.  
 
1.1.2 Actin polymerization 
The protrusive force of leading edge extension is generated by polymerization 
of globular actin (G-actin) subunits to form a double helical polymer called an 
actin filament (F-actin) (Pollard and Cooper, 2009). Based on the arrowhead-
like appearance created by decoration with the moter domain of myosin, one 
end  is  called  the  barbed  end  and  the  other  the  pointed  end  (Small  et  al., 
1978).  The  initial  stage  of  actin  polymerization  is  called  nucleation.  This 
process  is  a  rate-limiting  step  due  to  the  considerable  instability  of  actin 
oligomers. Once the nucleus (trimer) is formed, actin polymerization proceeds 
quickly  at  the  plus  or  barbed  end  and  dissociation  of  actin  monomers  is 
favored at minus or pointed end (Bugyi and Carlier, 2010; Pollard and Cooper, 
2009).  This  kinetic  asymmetry  between  the  two  ends  is  achieved  by  ATP 
hydrolysis. The ATP in actin filaments is hydrolyzed to ADP. Because the 	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between WAVE isoforms in lamellipodial actin regulation
(Kurisu S, 2005, unpublished observations).
(12,54) This may be
simply due to higher expression levels of WAVE2, compared to
those of WAVE1 and WAVE3. Alternatively, it may be caused
by the higher afﬁnity of WAVE2 for IRSp53, which preferen-
tially localizes and activates WAVE2 at the lamellipodial tips
(Fig. 3a). Therefore, inhibiting WAVE2 activity can discourage
cancer cells from showing a motile phenotype. Drugs that inter-
fere with WAVE2 activation may be promising therapy against
invasion and metastasis in cancer patients. Indeed, we have
shown that invasion and metastasis are effectively suppressed
when WAVE2 activity is inhibited in highly metastatic B16F10
cells.
(12)
WASPs and WAVEs in 3D cancer cell invasion
Plasticity of cancer cell motility within the 3D ECM. Recently,
researchers have examined cancer motility in the 3D environ-
ment, which more closely mimics the in vivo cancer microenvi-
ronment than the 2D environment. One 3D observation strategy
is to implant cancer cells in live animals and directly observe
the cells under a microscope, which is sometimes called ‘‘intra-
vital imaging’’. Another technique is organotypic culture, in
which cancer cells are usually embedded in type I collagen gel
or in Matrigel, a mixture of ECM with similar constituents to
those of the basement membrane. Using these techniques, com-
bined with time-lapse ﬂuorescent confocal microscopy, it has
been revealed that cancer cells show multiple ‘‘modes’’ of cell
migration in 3D.
(56,57) There are at least three different modes
of migration: collective motility; elongated motility; and round-
shape motility (Fig. 2a,c,d). Collective motility, which refers to
cells moving in a group, is reported in organotypic cultures of
breast cancer, ﬁbrosarcoma, melanoma, and squamous cell car-
cinoma cells.
(58,59) From the histopathological resemblance
between human tumor samples and cultured cancer cells in 3D,
it is speculated that collective motility mimics the invasive
front of human tumors, although direct evidence of this is miss-
ing. The elongated and round-shape modes of motility describe
solitary cells that have departed from the primary tumor mass
through EMT or as a result of spontaneous cell–cell dissocia-
tion. Elongated motility is characterized by a bipolar spindle-
shaped morphology and dependence on protease activity for
migration. This type of motility is usually seen in cancers of
mesenchymal origin, such as glioma, ﬁbrosarcoma, and mela-
noma, and in some aggressive carcinomas.
(57,60,61) Round-
shape motility, which is in contrast characterized by a short
ellipsoid shape during cell movement and a relatively compro-
mised dependence on protease activity for migration, is
reported in some colon carcinoma and melanoma cells as well
as in non-neoplastic hematopoietic cells like lymphocytes and
neutrophils.
(9,60,62) Importantly, some cancer cells can switch
their migration mode, and this plasticity is proposed to explain
why cancer cells continue to move even when one mode of
motility has been suppressed by pharmacological intervention.
Wolf et al.
(57) ﬁrst reported that a cocktail of protease inhibi-
tors triggers mode-shift from elongated to round-shape motility
in ﬁbrosarcoma cells and in breast cancer cells, and they
assumed this switching mechanism might underlie the escape
pathway for cancers refractory to protease inhibitor-based
therapies.
Elongated motility versus round-shape motility from an actin
perspective. The actin morphology of migrating cells in 3D dif-
fers strikingly from that in 2D. Cells that have resumed elon-
gated motility no longer form broad lamellipodia at the leading
edge. Instead, they usually extend long ﬁnger-like protrusions
rich in F-actin, which here we call ‘‘pseudopodia’’ (Figs 2c).
(a) (b)
(c) (d)
Fig. 2. Multiple modes of cancer cell motility in 3D. (a) Cancer progression is illustrated from the standpoint of cell motility mode. A primary
tumor initially invades in a mode called collective migration. If cancer cells are released from a primary tumor mass and move as single cells, the
cells can adopt two modes of invasion, round-shape motility or elongated motility. EMT, epithelial-to-mesenchymal transition. (b) The actin
cytoskeleton of a two-dimensionally migrating cell. In 2D circumstances, characteristic actin structures (colored in red) are commonly seen in
many cell types. They generally form lamellipodia, ﬁlopodia, and stress ﬁbers. In malignant cancer cells, invadopodia are sometimes evident as
large actin dots that show proteolytic activity around them. (c) The actin cytoskeleton in cells migrating in the elongated motility mode. The tip
contains dense actin networks and its biogenesis is dependent on Wiskott–Aldrich syndrome protein family verprolin-homologous protein and
actin-related protein 2⁄3 activities. (d) The actin cytoskeleton in cells migrating in the round-shape motility mode. Protrusions used for
migration are, in this case, membrane blebs. Both the formation and retraction of membrane blebs rely on actomyosin contractility.
Kurisu and Takenawa Cancer Sci | October 2010 | vol. 101 | no. 10 | 2097
ª ª 2010 Japanese Cancer Association
Figure 1.1 Actin-based structures in metazoan cells. 
A metazoan cell migrate on a 2D surface. Characteristic actin structures are commonly 
seen in many cell types. They generally form lamellipodia, filopodia, and stress fibers. 
whereas invadopodia are recognised as large actin dots. (B) side view of a cell, 
emphasizing that invadopodia are ventral. Figure adapted from (Kurisu and Takenawa, 
2010).
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 ADP-actin has lower binding affinity to the filaments end than ATP-actin and 
hydrolysis of ATP in the F-actin is irreversible, consequently, depolymerization 
is favoured at pointed end. Subsequently, ADP-actin monomers released from 
old  filaments  then  undergo  nucleotide  exchange  for  next  round  of 
polymerization. Furthermore, because the barbed end of actin filaments face 
toward  the  cell  plasma  membrane,  thus  under  cellular  conditions, 
incorporation of new actin subunits at the barbed end provides mechanical 
force for the generation of membrane protrusions in migrating cells. In vivo, 
spontaneous formation of actin nuclei is disfavored due to the strong kinetic 
barrier  and  the  large  concentrations  of  monomer  binding/sequestering 
proteins  in  cells  (e.g.  thymosin  beta  4  and  profilin).  Therefore,  F-actin 
polymerization  is  regulated  by  several  actin  nucleators  from  a  number  of 
different  families  and  is  assisted  by  various  proteins  that  bind  to  actin 
monomers or to filament ends. 
 
1.1.3 Lamellipodia 
Actin powers protrusions by polymerizing just under the plasma membrane. 
One of the filament geometries is the formation of branched actin filaments, 
which lead to generation of sheet-like protrusions consist of highly branched 
short  actin  filaments  at  cell  leading  edge,  termed  lamellipodia,  which  are 
important in cell motility and cell spreading (Figure 1.2) (Nobes et al., 1995; 
Ridley et al., 1992). The major actin nucleator within lamellipodia is Arp2/3, an 
assembly of 7 subunits that include two actin related proteins Arp2 and Arp3 
and  five  non-Arp  components,  p41/ARPC1,  p34/ARPC2,  p21/ARPC3, 
p20/ARPC4 and p16/ARPC5, which was the first actin nucleation factor to be 
identified (Machesky et al., 1994). Arp2/3 complex binds to the preexisting 
‘mother’  filaments  and  promotes  the  formation  of  new  ‘daughter’  filaments 
branching at a 70
o angle from preexisting filaments.  Other regulators of actin 
dynamics at leading edge of lamellipodia include ADF/cofilin, which bind G-
actin  monomers  and  depolymerize  actin  filaments  through  severing  and 
increasing off-rate for actin monomers from the pointed end, thus maintain the 
G-actin monomer pool for polymerization at the plus end (McGough et al.,  	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Figure 1.2 The regulation of lamellipodia formation.
Simple schematic diagram of the regulation of actin polymerisation leading to lamellipodia 
formation. Scar/WAVE complex is recruited to the plasma membrane, possibly via the 
small GTPase Rac1 in response to a variety of signals. where it activates Arp2/3 complex 
to polymerize actin filaments at the free barbed ends off the sides of actin filaments near 
the plasma membrane. Branches grow and push against the plasma membrane. ADP 
bound actin filaments were depolymerized by binding of ADF/cofilin and actin monomers 
undergo a rapid cycling from ADP to ATP bound forms that is promoted by profilin. Rac or 
Cdc42 acts via group I Paks to stimulate LIMK, which inhibit cofilin-induced actin 
depolymerization, allowing increased accumulation of polymerized actin at the leading 
edge of cells.
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1997). Other proteins include profilin, which binds and incorporates G-actin 
from the cytoplasmic pool to the growing barbed ends of the actin filaments. 
Capping protein, which binds to the barbed end of actin filaments. Capping 
protein  restricts  actin  polymerization  and  affects  the  balance  between 
branched and unbranched networks. Therefore, it optmizes the rate of motility 
by promoting more frequent filament nucleation by the Arp2/3 complex (Akin 
and Mullins, 2008; Dos Remedios et al., 2003; Le Clainche and Carlier, 2008). 
As  Arp2/3  complex  itself  has  little  nucleation  activity,  nucleation-promoting 
factors (NPFs) are thus required to initiate a new actin filament via activation 
of Arp2/3 complex (Campellone and Welch, 2010). The main NPFs to activate 
Arp2/3 complex are the WASP family proteins, of which the best known are N-
WASP and SCAR/WAVE complex. SCAR/WAVE complex, which consists of 
five  subunits  (SCAR/WAVE,  HSPC300,  Abi,  Nap1,  and  Cyfip)  has  been 
shown  to  be  the  major  NPF  to  activate  Arp2/3  complex  in  lamellipodia. 
SCAR/WAVE  complex  interacts  with  Arp2/3  complex  and  G-actin  via 
Scar/WAVE verprolin central acidic domain (VCA) domain and this facilitates 
Arp2/3 catalytic activity (Insall and Machesky, 2009). SCAR/WAVE complex 
also acts as a scaffold that directly or indirectly link Arp2/3 complex activity to 
various  regulatory  proteins  such  as  the  Rho  family  of  small  GTPases. 
SCAR/WAVE  complex  interacts  with  the  small  GTPase  Rac1  (described 
below)  via  Cyfip  and  it  has  been  proposed  to  be  recruited  to  the  plasma 
membrane at sites of lamellipodial assembly by Rac1, thus allow signaling to 
catalyze rapid filament growth (Innocenti et al., 2004; Kunda et al., 2003). 
However, this dendritic branched network model of actin filament organization 
in the protruding lamellipodia is recurrently being challenged. Victor Small and 
colleagues  used  cryo-electron  tomograms  and  negatively  stained 
cytoskeletons  to  visulaise  actin  networks  in  the  lamellipodia  in  frozen  'live' 
cells (Urban et al., 2010). They demonstrate that actin filaments at the leading 
edge diverge at various angles and are unbranched. The authors propose a 
new  model  for  lamellipodial  protrusion  and  suggest  that  Arp2/3  nucleates 
actin filaments on the membrane and rides on the filament pointed end after 
nucleation initiated by WAVE complex until being released and recycled at the 
lamellipodium tip. They propose that tetramers of VASP, a barbed end binding 	 ﾠ 28	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protein that can compete with capping protein, mediates elongation of long 
unbranched filaments adjacent to the plasma membrane (Urban et al., 2010). 
 
1.1.4 Filopodia 
In addition to lamellipodia, filopodia are slender cytoplasmic projections that 
extend beyond the leading edge of lamellipodia in migrating cells. They are 
made  up  of  bundles  of  parallel  actin  filaments,  which  grow  at  the  tip  end 
(Oldenbourg et al., 2000). They can form focal adhesions with the substratum 
and  are  believed  to  function  as  directional  sensors  (Zheng  et  al.,  1996). 
Earlier work suggested that N-WASP localizes to filopodia and that activation 
of  N-WASP  by  the  small  Rho  GTPase  Cdc42  leads  to  filopodia  formation 
(Nobes et al., 1995; Stradal et al., 2004). Thus, it has been proposed that 
filopodia are generated by the reorganization of an Arp2/3 complex generated 
actin network (Figure 1.3). Proteins that mediate filament elongation such as 
VASP and formins bind to actin filaments in lamellipodia and come together to 
form a filopodial tip complex that elongates a group of actin filaments (Figure 
1.3) (Gupton and Gertler, 2007). The filopodial tip complex initiates filament 
cross-linking by recruiting and activating fascin (described below), which then 
allows  the  bundling  process  to  keep  pace  with  elongation  and  guarantees 
efficient  pushing  which  then  forming  a  filopodium.  However, deletion  of  N-
WASP  does  not  inhibit  filopodia  formation  (Snapper  et  al.,  2001). 
Furthermore,  inhibition  of  Arp2/3  or  WAVE  complex  only  minimally  affects 
filopodial protrusion (Steffen et al., 2006) . In addition, a recent study reported 
filopodia formation in Cdc42
-/- fibroblastoid cells (Czuchra et al., 2005), but 
another  paper  disputes  this  and  demonstrates  a  crtitical  role  for  Cdc42  in 
filopodia  formation  in  mouse  embryonic  fibroblast  (Yang  et  al.,  2006). 
Alternatively, it is proposed that filopodia are initiated by de novo nucleation of 
actin  filaments  presumably  close  to  the  plasma  membrane,  driven  by  the 
action of formins, which have been localised to filopodia tips for generating 
unbranched actin filaments (Gupton and Gertler, 2007). These assemblies of 
parallel nascent filopodial actin filaments are cross-linked by actin-bundling  	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Figure 1.3 The regulation of filopodia formation.
Simple schematic diagram of the regulation of actin polymerisation leading to filopodia 
formation. (A) A subset actin filaments of the ARP2/3 ceomplex nucleated dendritic network 
are targeted for continued elongation by the formin and/or by ENA/VASP proteins. Formin also 
nucleates the formation of new, unbranched actin filaments. ENA/VASP proteins can also 
function as initial F-actin-crosslinking proteins in the tip of an elongating filopodium. (B) The 
incorporation of the actin crosslinking protein fascin in the shaft of the filopodium generates a 
stiff actin filament bundle. Formins and/or by ENA/VASP are localized in the 'tip complex' and 
controls the barbed-end elongation of the filaments.	 ﾠ 30	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proteins for force generation.  
 
1.1.5 Invadopodia 
1.1.5.1 Introduction to Invadopodia 
Invadopodia are finger like protrusions especially formed in invasive, tumoral, 
or transformed cells when they are grown on a thin layer of ECM (eg. gelatin 
or fibronectin). Invadopodia are observed as proteolytcally active protrusions 
that extend from the ventral surface of the cell, into the surrounding matrix, 
cause the focal pericellular degradation of ECM (Figure 1.4A). Invadopodia 
have  highly  dynamic  actin  that  resembles  actin  comets  when  viewed  with 
GFP-actin in time lapse (Baldassarre et al., 2006). Invadopodia are normally 
close to the nucleus and proximal to the Golgi complex (Baldassarre et al., 
2003). At ultrastructural level, invadopodia have been suggested to be large 
convolutions  of  cell  membrane  with  long  membrane  extensions  into  the 
matrix,  and  these  protrusions  originate  from  the  larger  invagination  at  the 
ventral surface of cell with diameters range from hundreds of nm to a few µm 
(Baldassarre  et  al.,  2003;  Bowden  et  al.,  1999).  Under  the  fluoresce 
microscope,  invadopodia  appear  as  actin-rich  formations  with  underlying 
holes  of  ECM  degradation,  and  by  using  this  kind  of  assay,  several  actin 
associated proteins, some special proteases and other cellular components 
are identified to be important for the formation of invadopodia over the past 
decade.  
 
1.1.5.2 Regulation of invadopodia formation 
Previous  studies  have  implicated  the  N-WASP-Arp2/3-cortactin-dynamin2 
complex as a key player in invadopodia formation (Figure 1.4B) (Artym et al., 
2006;  Ayala  et  al.,  2008;  Baldassarre  et  al.,  2003;  Buccione  et  al.,  2004; 
Gimona  and  Buccione,  2006).  Interestingly,  only  N-WASP,  but  not  WAVE 
proteins were identified within invadopodia (Lorenz et al., 2004; Yamaguchi 
and Condeelis, 2007; Yamaguchi et al., 2005). In addition, expression of  	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Figure 1.4 The regulation of invadopodia formation. 
(A) MDA-MB-231 human breast adenocarcinoma cells cultured on Alexa594-gelatin coated 
glass coverslips were stained with Alexa488-phalloidin. Bottom images are XZ sections 
showing a cell with an invadopodium collected with a confocal microscope. Invadopodia and 
gelatin degradation were white arrowed. (B) Schematic diagram showing tumour cell with 
formation of invadopodia on a film of crosslinked gelatin. Degradation of gelatin by 
invadopodia-associated MT1-MMP results in the formation of fluorescence negative cavities 
beneath cells that can be visualised by confocal fluorescence microscopy.  Invadopodia are 
enriched with actin branches regulated by N-WASP, Arp2/3 complex and cortactin. Figure B 
adapted from (Stylli et al., 2008).
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dominant-active  mutant  of  Cdc42  or  Rac  enhanced  dot-like  and  diffused 
fibronectin degradation respectively in RPMI17951 melanoma cells (Nakahara 
et  al.,  2003).  N-WASP  drives  formation  of  branched  actin  assembly  via 
activation  of  the  Arp2/3  complex.  Expression  of  a  truncated  “dominant-
negative” N-WASP strongly inhibited formation of invadopodia as well as ECM 
degradation (Mizutani et al., 2002). Cortactin and dynamin-2 may function as 
scaffolds to bring together a multifunctional protein complex, such as Arp2/3 
complex and N-WASP, to coordinate cortical actin assembly/disassembly and 
protease secretion in a highly polarized manner (Artym et al., 2006; Clark and 
Weaver, 2008; Clark et al., 2007). Cortactin is a Src substrate that interacts 
with F-actin and can stimulate actin polymerization by direct interaction with 
the Arp2/3 complex. Cortactin is frequently used as a marker of invadopodia, 
due to its strong localization to these structures. Furthermore, research using 
live cell imaging to study the dynamics of invadopodia formation suggested 
that  cortactin  localization  marks  the  early  stage  of  invadopodia  assembly 
(Artym  et  al.,  2006).  Furthermore,  invadopodia  are  sites  of  tyrosine 
phosphorylation  and  require  Src  kinase  signaling  (Bowden  et  al.,  2006). 
Adhesion  receptors  including  many  kinds  of  integrins  and  CD44,  are  also 
found enriched at invadopodia (Mueller et al., 1999). However, proteins that 
are important in focal adhesion complexes, such as vinculin, are not localized 
at  invadopodia,  indicating  the  specialized  role  of  integrins  at  invadopodia 
compared with their function in focal adhesion complexes (Machesky, 2008). 
Notably,  consistent  with  their  matrix  degradation  activity,  invadopodia  are 
enriched in soluble proteases, such as MMP2, MMP9 and transmembrane 
metalloproteinases  MT1-MMP  (Clark  and  Weaver,  2008).  Live-cell  imaging 
showed that the ECM degradation happened almost simultaneously with the 
recruitment  of  MT1-MMP  to  the  sites  of  invadopodia  (Artym  et  al.,  2006). 
There also must be a mechanism for the trafficking of proteases to the cell 
surface at invadopodia. Indeed, a potential mechanism for MMP delivery to 
invadopodia  has  emerged  recently  with  the  discovery  of  the  role  of  the 
exocyst  complex  and  SNARE  proteins  in  MT1-MMP  trafficking  and 
invadopodia formation (Liu et al., 2009; Poincloux et al., 2009; Sakurai-Yageta 
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It has become now accepted that invadopodia initiation is due to engagement 
of cell surface integrins by substrate components. This was shown first for 
α5β1  and  α3β1  integrins  (Mueller  et  al.,  1999),  despite  the  specific  integrin 
combination  might  be  cell-type  dependent.  α3β1  integrin  activation  can 
promote Src dependent tyrosine phosphorylation of p190RhoGAP (Nakahara 
et al., 1998), which in turn affected the actin cytoskeleton, through the Rho 
family GTPases, thus activating membrane-protrusive and proteolytic activity, 
leading to invadopodia formation and cell invasion.  
The actin filament organization during the formation of invadopodia, however, 
is still not clear, it may be possible that a precursor structure containing the N-
WASP-Arp2/3-cortactin-dynamin2 complex results on the formation of a small 
branched  actin  network  (Artym  et  al.,  2006).  The  later  development  of 
invadopodia may involve both the insertion of new membrane material into the 
plasma membrane as suggested by the close spatial relationship between the 
Golgi complex and invadopodia, and also actin polymerization (Baldassarre et 
al., 2003). There are two possibilities regarding to the growth of actin-rich core 
in the invadopodia (Linder, 2007; Vignjevic and Montagnac, 2008). The first 
possibility is the continued growth of branched actin network initiated by the 
N-WASP  and  Arp2/3  complex  though  the  whole  invadopodia.  The  second 
possibility could be a process resembling the convergent growth of filopodia. 
This may involve the recruitment of actin bundling proteins, such as fascin, to 
crosslink the actin filaments that extend from the branched actin networks into 
bundles to push the plasma membrane. The latter possibility is supported by 
the  observation  that  N-WASP  was  only  active  at  the  base  of  invadopodia 
(Lorenz et al., 2004), and Ena/VASP and diaphanous related formins mDia2 
are required for invadopodia formation (Lizárraga et al., 2009; Philippar et al., 
2008). 
The correlation between invadopodia and structures found when cancer cells 
invade in a 3D matrix is not yet well understood. Recent studies showed that 
during  initial  step  of  metastasis,  invasive  cancer  cells  use  invadopodia 
degrade  a  holes  as  they  force  through  the  basement  membrane  using  a 
machinery based on Arp2/3 nucleated actin assembly and N-WASP-cortactin 
in a 3D experimental setting (Hotary et al., 2006; Schoumacher et al., 2010).  	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1.1.6 Podosomes 
Podosomes were first identified within monocytic cells such as macrophages, 
dendritic  cells  and  osteoclasts  (Marchisio  et  al.,  1984).    Similar  to 
invadopodia, podosomes also present as dot-like structures at the ventral cell 
surface,  which  are  enriched  in  F-actin,  (N-)WASP,  Arp2/3  complex  and 
cortactin  (Buccione  et  al.,  2004).  The  presence  of  actin  polymerization 
proteins such as Arp2/3 complex and WASP differentiate podosomes from 
focal  adhesions  (Marchisio  et  al.,  1988).  Podosomes  also  show  a  ring 
consisting  of  adhesion  plaque  proteins  such  as  paxillin,  vinculin,  talin,  α-
actinin, Src, and tyrosine-phosphorylated proteins surrounding the actin cores. 
The  ultrastructure  of  dentritic  cell  podosome  is  recently  been  solved  by 
transmission electron microscopy (Gawden-Bone et al., 2010), which contain 
actin  foci  surrounded  by  a  specialised  ring  region  that  is  rich  in  material 
containing  paxillin,  thus  confirm  the  light  microscopy  data.  In  contrast, 
invadopodia  seem  to  lack  these  ring  structures  (Gimona  et  al.,  2008). 
Typically, cells form numerous (20-100) podosomes of roughly uniform size 
(1-2  µm  diameter),  but  only  few  (1-10)  invadopodia  of  varying  size.  In 
addition, podosomes are rapidly turned over, as fast as 2-4 mins whereas 
invadapodia are thought to be longer lived, can extend up to over 1 h (Linder, 
2007). Podosomes are able to form widespread but only shallow zones of 
degradation,  probably  through  their  high  number  and  fast  turnover.  In 
contrast, the longer-lived invadopodia form more aggressive, deeper matrix 
degradation.  Little  is  known  about  the  precise  function  of  podosomes.  In 
myeloid cells, podosomes are necessary for directional movement and trans-
cellular diapedesis at sites of inflammation (Calle et al., 2006). In osteoclasts, 
podosomes are thought to aid in the creation of sealing rings associated with 
the  area  of  bone  resorption.  A  role  in  adhesion  is  considered  due  to  the 
similarities between podosomes and focal adhesions. The dynamic nature of 
podosomes suggested that they might transfer membrane tension along the 
substrate, as the lamellipodium extends forwards (Buccione et al., 2004).  	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1.1.7 3D Cell migration: Mesenchymal vs Amoeboid 
1.1.7.1 Introduction to 3D cell migration 
Tumour cell invasion occurs in 3 dimensions. The behavior of cells in 3D has 
been studied within reconstituted extracellular matrices such as collagen and 
matrigel. Tumour cells can migrate using both actin-based protrusions and 
myosin-based contractile activities in 3D (Sahai, 2005; Wolf et al., 2003a), 
which have been described as mesenchymal type motility and amoeboid type 
motility (Figure 1.5). 
 
1.1.7.2 Mesenchymal type motility 
Mesenchymal  cell  migration  as  used  by  MDA-MB-231  carcinoma  cells  or 
HT1080 fibrosarcoma cells (Wolf et al., 2007), involves a long and narrow 
morphology aligned with the direction of migration. Mesenchymal cells move 
by the formation of actin-rich pseudopodia at the leading edge, driven by Rho 
GTPases  Rac  and  Cdc42.  Rac  activity  is  required  for  protrusive  actin 
polymerization and Cdc42 is important in defining polarity, largely through its 
positioning of the microtubule-organising centre between the nucleus and the 
leading  edge.  In  addition,  integrin  clusters  attach  to  the  ECM  and  matrix 
metalloprotease activity is required for ECM degradation and navigating the 
cell through dense matrix (Friedl and Wolf, 2003). 
  
1.1.7.3 Ameoboid type motility 
Cells  moving  in  an  amoeboid  mode,  such  as  MTLn3  rat  mammary 
adenocarcinoma and A375MM human melanoma cells (Sanz-Moreno et al., 
2008; Wyckoff et al., 2006), are more rounded and more reliant on Rho and 
ROCK activity and acto-myosin contraction to remodel the cytoskeleton and 
propel them through gaps between matrix fibres. Cell using ameoboid type of 
migration  normally  squeeze  through  existing  gaps  in  the  ECM  without 
clustering integrins or concentrating proteinases to sites of adhesion (Wolf et  	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Rac 
GTP
WAVE
Rho 
GTP
ROCK
1. Integrin engagement
2. MMP activation
3. Path generating
4. Low acto-myosin contractility
5. Dense/stiff ECM
1. Integrin inhibition
2. MMP inhibiton
3. Path ﬁnding
4. High acto-myosin contractility
5. Soft/loose ECM
ARHGAP22
Figure 1.5 Reciprocal regulation between Rho and Rac during mesenchymal or 
amoeboid motility styles. 
Rac, which drives oriented mesenchymal motility, leading edge protrusion and lamellipodia 
formation. Mesenchymal cells also use integrins to actively contact the ECM and use MMP to 
proteolytically degrade ECM to generate path for migration. Rho activation is responsible for 
amoeboid motility, a non-oriented movement which enables the cell to squeeze between gaps 
of ECM, which is integrin and MMP independent. mesenchymal or amoeboid motility are 
interchangable. Activated RhoA is able to inhibit Rac through the ARHGAP2, while Rac1 
activates WAVE2 which in turn inhibits RhoA. Figure adapted from (Wolf et al., 2003).	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al.,  2003a),  indicating  that  amoeboid  type  migration  is  ECM  degradation 
independent (Sahai and Marshall, 2003; Wolf et al., 2003a). This is similar to 
the mechanism used by lymphocyte (Wolf et al., 2003b). In addition, The low 
levels of attachments to ECM made by amoeboid cells is believed to allow 
them  to  move  faster  through  3D  environments  than  their  mesenchymal 
counterparts (Paňková et al., 2010)  
 
1.1.7.4 Regulation of mesenchymal and ameoboid type motility 
It  has  been  shown  that  tumour  cells  can  invade  using  either  amoeboid  or 
mesenchymal type of movement, interchanging between the two depending 
on the up or down regulation of specific molecular pathways governing the 
mode of motility (Figure 1.5). For instance, activation of the Rac through a 
complex  containing  adaptor  molecule  NEDD9  and  a  Rac  GEF  DOCK3  is 
required for mesenchymal migration in A375MM cells. Rac signals through 
WAVE2  to  direct  mesenchymal  movement  and  suppress  amoeboid 
movement  through  decreasing  myosin  light  chain  phosphorylaton  (Sanz-
Moreno et al., 2008). It has also recently been proposed that Rab5 may play a 
role in the process of amoeboid to mesenchymal transition of cancer cells by 
influence  the  trafficking  of  Rac  (Palamidessi  et  al.,  2008).  Conversely,  in 
amoeboid  movement,  Rho-kinase  signaling  activates  a  Rac  GAP, 
ARHGAP22,  which  inactivate  Rac  and  suppress  mesenchymal  movement 
(Sanz-Moreno  et  al.,  2008).  In  addition,  a  Cdc42  GEF  DOCK10  and 
expression of dominant active Cdc42 can enhance the amoeboid migration 
and cell invasion by suppress Rac activity. Furthermore, the Cdc42 effectors 
N-WASP  and  Pak2  are  required  for  the  maintenance  of  the  rounded-
amoeboid  phenotype  in  melanoma  cells  (Gadea  et  al.,  2008).  However, 
blocking Cdc42 also results in loss of mesenchymal morphology, suggest that 
Cdc42 is also involved in mesenchymal morphology.  
 
When  mesenchymal  HT1080  and  MDA-MB-231  cells  were  subject  to 
protease inhibitors in 3D collagen matrix, they changed from mesenchymal 
morphology  to  amoeboid  morphology  (Wolf  et  al.,  2003a).  It  is  likely  that 	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tumour cells can compensate to environmental factors by change the style of 
migration through different activation and effectors pathways.  
 
1.2 Cancer metastasis  
1.2.1 Metastasis is a multifaceted process 
Metastasis is the ability of cancer cells to spread from their tissue of origin to 
other parts of the body via the bloodstream or the lymphatic system. It is a 
critical  step  in  cancer  progression  and  is  a  major  cause  of  human  cancer 
death (Sporn, 1997). Metastatic development is a multi-step process involving 
the  acquisition  of  invasive  behaviour,  escape  from  the  primary  tumour, 
invasion  into  the  surrounding  tissue,  transit  in  the  circulatory  system,  and 
finally  the  establishment  of  secondary  tumours  at  new  sites  (Figure  1.6) 
(Chambers  et  al.,  2002).  A  primary  step  in  the  metastatic  cascade  is  the 
detachment of cancer cells from a solid tumour mass, which is mediated by 
their  decreased  adhesive  potential  and  dedifferentiation  of  epithelial  cells 
toward a mesenchymal state. This process is termed epithelial-mesenchymal 
transition (EMT) (Thiery et al., 2009).  One of the most important changes 
during this process is the down-regulation of E-cadherin, which under normal 
circumstances provides a bridge between adjacent epithelial cells and serves 
as a scaffold for anti-growth signalling to its downstream effectors such as β-
catenin and TCF transcription factor (Christofori and Semb, 1999). As cell-cell 
junction  proteins  are  suppressed,  individual  epithelial  cancer  cells  start  to 
separate from other cells that normally form a sheet-like structure. These cells 
become more elongated fibroblast-like and gain invasive features such as the 
up regulation of N-cadherin, fibronectin, metalloproteinases, and decrease in 
the abundance of protease inhibitors and altered expression of intergrins that 
preferentially  bind  the  degraded  stromal  components  produced  by 
extracellular  proteases  (Lozano  et  al.,  2003).  Therefore,  cells  become 
differently polarised and rearrange their actin cytoskeleton with the formation 
of specific membrane protrusions. Matrix-degrading proteases are secreted at 
cell at leading edge to allow the cell to degrade and navigate through the 
basement membrane and extracellular matrix. Cancer cells get into the blood 	 ﾠ 39	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Figure 1.6 The main steps in the formation of a metastasis. Formation of 
metastases is a multistep process, involving loss of differentiation, enhanced 
proliferation and angiogensis. The active invasion of a subset of cancer cells then 
escape the primary tumour through the surrounding matrix, enter the circulation which 
they travel to the distant sites of the body, where they extravasate to populate new 
niches and form secondary lesions. Figure adapted from (Bacac and Stamenkovic, 
2008).
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Basement membrane
degradation
Basement membrane
Migration
Growing metastases
Proliferation, angiogenesis,
microenvironment activation
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Figure 1
Principal steps in metastasis. Transformation of normal epithelial cells leads to carcinoma in situ, which,
as a result of loss of adherens junctions, evolves toward the invasive carcinoma stage. Following basement
membrane degradation, tumor cells invade the surrounding stroma, migrate and intravasate into blood or
lymph vessels, and become transported until they arrest in the capillaries of a distant organ.
their microenvironment to metastasize and
that they even rely on host tissue stromal cells
to provide functions, such as a diversity of
proteolytic activity, that they themselves may
lack. Understanding tumor-host interactions
may therefore provide a key to understanding
metastasis. A more recently emerging view,
based on gene expression proﬁle analysis of
diverse primary and metastatic tumors, is
that metastatic cells may constitute part of
the early makeup of a malignant tumor. This
review highlights our current understanding
of tumor cell properties and host tissue
responses whose combination culminates in
cancer metastasis and discusses the origin of
metastaticcellsinlightofrecentobservations.
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 vessel via process called intravasation. Once trapped in the vessel, cancer 
cells must be able to avoid anoikis (A form of programmed cell death which is 
induced by anchorage-dependent cells detaching from the surrounding ECM), 
oppose hydrostatic shear forces that could lead to physical damage and they 
also  need  to  evade  being  targeted  by  immune  surveillance  probably  via 
interaction with platelets, lymphocytes and other blood cells. As only a few 
cancer cells can finally survive and be able to escape from the vasculature via 
process called extravasation. This process requires adherence and invasion 
through endothelium and basement membrane into the new tissue. Surviving 
cancer cells can either undergo proliferation within the blood vessel to form a 
small tumour that can then physically disrupt the endothelium or, probably 
following  leukocytes  in  a  process  similar  to  diapedesis  (a  process  that 
leukocytes  secrete  proteases  to  degrade  the  basement  membrane  and 
allowing them to escape from the blood vessel) to eventually invade into the 
new  tissue  to  establish  growth  as  a  metastasis.  Within  the  new  tissue, 
metastatic tumor cells will frequently undergo reversion from a mesenchymal 
phenotype back to something that is more similar to the original tumor.  
 
1.2.2 Cell migration and invasion in cancer metastasis 
Cell  migration  and  invasion  are  required  at  multiple  steps  of  metastasis  – 
during  invasion  through  the  basement  membrane  and  extracellular  matrix 
toward blood or lymphatic vessels, into and out of a vascular or lymphatic 
vessel, and invading into the new tissue in distant organs. In addition, they are 
also  important  in  many  physiological  events  such  as  embryogenesis, 
morphogenesis,  neurogenesis,  angiogenesis,  wound  healing  and 
inflammation. For instance, during embryogenesis, the directed migration of 
highly motile neural crest cells involves modulation of expression of the cell-
cell adhesion molecule cadherin (Kuriyama and Mayor, 2008). Such change is 
commonly seen in invasive cancer cells undergo EMT and a lack of cadherins 
correlates with cancer cells that start to migrate. In addition, invasion is critical 
for  leukocytes  transmigrate  through  the  endothelial  cell  layer  from  the 
bloodstream to invade to the sites of infection during inflammation (Madri and 	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Graesser, 2000). Moreover, the cellular similarities between wound healing 
and  tumor  cell  invasion  have  been  noted  for  some  time  and  recent 
comparison of gene expression between these two cellular process further 
confirm these similarities at genetic level (Chang et al., 2004; Pedersen et al., 
2003).  Therefore,  tumor  cell  migration  and  invasion  are  believed  to  be 
processes where normal cellular behaviors occur in a mis-regulated manner 
and in an inappropriate context.  
 
1.3 Fascin: the actin bundling protein 
1.3.1 Introduction to fascin  
Fascin was originally characterized as a 55kDa actin-binding and bundling 
protein purified from extracts of sea urchin oocytes and coelomocytes and is 
later found to be highly conserved throughout evolution with the identification 
of orthologues in a number of other species, including the related Drosophila 
singed  protein  (Bryan  et  al.,  1993;  Kane,  1975).  Fascin  is  an  actin  cross-
linking protein, which bundles adjacent actin filaments using two actin-binding 
sites  located  at  N-  and  C-terminus  of  the  proteins.  Fascin  is  found  in 
membrane  ruffles,  microspikes,  and  stress  fibers  and  is  important  for  the 
assembly of filopodia.  It localises along the length of filopodia and regulates 
the formation and dynamics of actin bundles (Vignjevic et al., 2006; Vignjevic 
et al., 2003). 
 
1.3.2 Strcuture of fascin 
The mammalian genome encodes 3 isoforms of fascin. Fascin 1 (The isoform 
studied  in  this  thesis)  is  widely  expressed  in  mesenchymal  and  nervous 
tissues  (De  Arcangelis  et  al.,  2004).  Fascin  2  is  specifically  expressed  in 
retina and ear hair cell stereocilia (Chou et al., 2011; Shin et al., 1999; Wada 
et al., 2003; Wada et al., 2001), whereas fascin 3 is expressed only in testis 
(Tubb  et  al.,  2002).  The  structure  of  fascin  is  unique  among  actin  binding 
proteins.  Fascin has four β-trefoil folds, with each β-trefoil comprising six two-	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stranded  β-hairpins.  Previous  mutagenesis  studies  indicate  that  the  actin-
binding sites are located at the amino terminus in the first beta-trefil domain 
between aa33–47, and the other lies between aa277–493 (Figure 1.7) (Cant 
and Cooley, 1996; Ono et al., 1997). The recent structural analysis, however, 
implicated that the N and C termini constitute one of the actin-binding sites 
with both termini located in the same cleft. A stretch of residues (29–42) at the 
N-terminus has similarity to an actin-binding site of MARCKS and also faces 
the  trefoil  1–4  cleft  suggesting  that  this  cleft  represents  one  of  the  actin-
binding  sites  (Chen  et  al.,  2010).  It  has  also  been  proposed  that  F-actin 
binding in this cleft between trefoils 1 and 4 could induce a conformational 
change at the opposite end of fascin, between trefoils 2 and 3, that might alter 
the actin-binding activity and result in cooperative binding to F-actin (Sedeh et 
al., 2010). 
 
1.3.3 Expression and regulation of fascin 
Fascin is principally expressed in nervous system, somites and mesenchyme 
during mammalian embryonic development (De Arcangelis et al., 2004). In 
adult  human  tissues,  fascin  is  expressed  in  vascular  endothelial  cells, 
neuronal cells, and fibroblasts as well as dendritic cells but is not expressed in 
most  normal  epithelia  (Zhang  et  al.,  2008).  Fascin  is  upregulated  both  at 
mRNA and protein level in many different types of cancers, including colon, 
prostate, breast, stomach and oral squamous cell carcinoma (Machesky and 
Li, 2010).  In colon cancer, fascin is identified as a downstream target of β-
catenin-TCF signaling and is preferentially expressed at the invasive fronts of 
tumors  and  is  thought  to  be  upregulated  only  during  the  active  phase  of 
metastasis  and  then  downregulated  again  when  a  new  metastasis  is 
established as a tumor (Vignjevic et al., 2007).  However, a recent detailed 
promoter analysis has revealed that fascin expression levels are regulated by 
the CREB and AhR transcription factors, but did not support a specific role for 
β-catenin  regulation  of  expression  in  fascin  positive  carcinoma  cells 
(Hashimoto et al., 2009). How this may be related to increased expression in 
cancers is not yet understood. Interestingly, recent studies demonstrate that 	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Figure 1.7 Fascin strcuture. 
Schematic representation of fascin: !-trefoil domains 1–4 and binding partners and the 
domains involved on interactions. Mutantions on residues marked with star lead to the loss of 
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 fascin  mRNA  is  negatively  regulated  by  miRNA  145  both  in  normal 
(Quintavalle et al., 2010) and cancer cells (Chiyomaru et al., 2010; Kano et 
al.,  2010),  suggesting  a  new  source  of  regulation  of  fascin  at  the 
transcriptional level.  
In  addition  to  actin,  fascin  also  binds  to  several  other  proteins  that  can 
regulate its activity. Fascin binds directly to PKC and is a substrate for PKC 
phosphorylation on serine 39 (S39), this turns off the actin bundling activity via 
the actin binding site at the N-terminus (Figure 1.7 and 1.8) (Ono et al., 1997). 
FRET/FLIM  revealed  the  interaction  of  fascin  and  active  PKC  within 
protrusions and filopodia of migrating cells and this complex is regulated by 
the activity of the small GTPase Rac via Pak (Parsons and Adams, 2008). 
Interestingly, recent studies indicated that phosphorylation of fascin negatively 
correlated with the poor survival in patients with esophageal squamous cell 
carcinoma;  this  suggests  the  importance  of  fascin  S39  phosphorylation  in 
cancer  progression  (Zhao  et  al.,  2010).  Extracellular  signals  and  ECM 
components can also regulate the phosphorylation status of fascin in cells and 
thus affect its actin bundling propensity (Figure 1.8) (Adams, 2004a; Kureishy 
et al., 2002) . In Drosophila, fascin homologue singed binds directly to the 
small  GTPase  Rab35  that  is  known  to  be  involved  in  intracellular  vesicle 
trafficking. Rab35 is postulated to recruit and activate fascin to sites of actin 
assembly, and this is dependent upon both GTP-bound Rab35 and fascin S39 
phosphorylation  status  (Figure  1.8)  (Zhang  et  al.,  2009).  A  recent  study 
showed  that  the  bacterial  macrolide  compound  migrastatin,  which  is  an 
organic  compound  which  naturally  occurs  in  the  Streptomyces  platensis 
bacteria, have shown to have potential in treating cancer, as it inhibits the 
metastasis of cancer cells (Shan et al., 2005). More recently, macroketone, 
the synthetic substance based on the fourteen-membered lactone ring found 
in the bacterial antibiotic migrastatin, have been shown bind to one of the 
actin-binding sites on fascin and therefore inhibit fascin activity and tumour 
cell metastasis in vivo (Chen et al., 2010a).  
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Figure 1.8 Regulation of fascin. 
Schematic representation of regulation of fascin activity and its role in cytoskeletal 
reorganization and cell motility.  ECM components control fascin-based protrusions. TSP and 
laminin acts through syndecan-1 and !3"1 integrins to promote the bundling of F-actin by 
fascin. Fascin interaction with GTP bound Rab35 is required for trafficking and localization of 
fascin. In contrast, ligation of !5"1 integrins by fibronectin disfavors fascin protrusions by 
activating Rac which acts via Pak1 to increase the content of S39- phosphorylated fascin as a 
result of PKC activity, and modulates the assembly of focal adhesions as a result of the 
interaction of S39-phosphorylated fascin-1 with the regulatory domain of PKC. How 
dephosphorylation of S39 is regulated is unknown. 
P
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1.3.4 Biological function of fascin 
Fascin has an important role in filopodia formation and dynamics (Jayo and 
Parsons,  2010)  and  in  biochemical  experiments  it  forms  very  stable  actin 
bundles and displays slow dissociation kinetics (Aratyn et al., 2007).  Fascin 
forms both polarized parallel bundles and side-branched actin structures in 
vitro, which agrees with its localization in both lamellipodia and filopodia of 
cells  (Tseng  et  al.,  2001).    Depletion  of  fascin  in  B16  melanoma  cells  or 
human colon carcinoma cells led to a loss of filopodial protrusions (Vignjevic 
et al., 2006; Vignjevic et al., 2007).  Depletion of fascin in colon carcinoma 
SW480  cells  also  led  to  a  decrease  in  migration  and  a  reduction  in  focal 
adhesion  dynamics  (Hashimoto  et  al.,  2007).    In  glioma  cells,  fascin 
knockdown  decreased  migration  and  transwell  invasion  of  cells  and 
decreased  invasion  into  brain  slices  ex-vivo  (Hwang  et  al.,  2008).  Fascin 
expression has been shown to correlate with tumor growth and metastasis in 
a  few  studies.  Hashimoto  et  al.  found  that  fascin  knockdown  significantly 
reduced  tumour  growth  and  metastasis  in  sub-cutaneous  xenografts  of 
SW480 colon cancer cells (Hashimoto et al., 2007).  Another recent study 
showed that fascin knockdown reduced the metastasis and tumor growth of 
DU145 cells implanted in the prostate of Severe comined immunodenficient 
(SCID) mice and high fascin expression correlated with a low probability of 
disease-free survival (Darnel et al., 2009).  Expression of fascin in HT29 colon 
cancer cells also increased the formation of lung tumours following tail vein 
injection of SCID mice (Vignjevic et al., 2007). Fascin localises to the actin-
rich core of podosomes in smooth muscle cells where it promotes adhesion 
stability  and  migration  (Quintavalle  et  al.,  2010).  Conversely,  more  recent 
study using fascin1-null mature dendritic cells showed that fascin is required 
for podosomes disassembly, suggesting a cell type specific role of fascin in 
regulating podosome formation (Yamakita et al., 2011).  
Surprisingly, fascin deficient mice were recently shown to be viable and fertile 
with  no  gross  developmental  abnormalities  other  than  minor  defects  in 
neuronal  cell  behaviour  (Yamakita  et  al.,  2009).  In  addition,  Fascin-1  null 	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fibroblasts protruded filopodia about half as often as normal fibroblasts and 
those  filopodia  were  shorter  and  had  a  shorter  lifespan  (Yamakita  et  al., 
2009), suggest that fascin is not essential for filopodia formation, but may be 
more important for filopodia stabilization.  
Conversely,  the  Drosophila  singed  mutant  animals  are  female  sterile  and 
display aberrant assembly of F-actin-rich structures during bristle extension, 
which also depend on Rab35 to localize fascin to specific subcellular sites for 
F-actin  bundling  (Zhang  et  al.,  2009).  In  addition,  fascin  is  required  for 
polarization  and  migration  of  the  Drosophila  macrophage  equivalent  cells, 
hemocytes  (Zanet  et  al.,  2009).  Fascin  localised  to  and  stabilize  dynamic 
actin-rich  microspikes  within  hemocytes  during  migration.  Interestingly,  the 
highly  conserved  PKC  substrate  serine  site  in  the  N-terminus  (S52  in 
drosophila)  was  not  required  for  motility  in  vivo,  suggest  other  regulatory 
mechanisms upstream of fascin may exist in different organisms. 
 
1.4 Rac and Rho family GTPase 
1.4.1 Introduction to Rho GTPase 
The Rho family GTPase comprises a subset of the larger Ras superfamily of 
small  GTPases.  Small  GTPases  are  generally  20-25  kDa  signalling 
molecules, which act as molecular switches and involved in multiple signaling 
pathways leading to cell adhesion, migration proliferation and transformation 
(Wennerberg et al., 2005). There are approximately 20 members of the Rho 
family  that  can  be  divided  into  6  subgroups  base  on  their  amino  acid 
sequence  identity,  structural  motifs  and  biological  functions  (Figure  1.9) 
(Heasman  and  Ridley,  2008;  Wherlock  and  Mellor,  2002).  The  most 
extensively characterized members of Rho family GTPas are Cdc42, Rac1 
and  RhoA.  Their  roles  on  actin  cytoskeleton  have  been  demostrated  via 
microinjection of active forms (Hall, 1998). This has led to the identification 
that Rho GTPases play an important role in filopodia, lamellipodia, and stress 
fibre formation respectively in different type of cells.  
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growth24. How the loss of CDC42 in mouse neurons 
leads to increased cofilin phosphorylation remains 
unknown. It is unlikely that CDC42 affects cofilin 
through changes in RAC1 or Rho signalling, as RAC1 
activity is not affected in CDC42-null neurons and the 
addition of Rho inhibitors did not rescue their pheno-
type13. It is possible that it occurs through an indirect 
upregulation of another Rho GTPase, such as RhoQ or 
RhoJ (FIG. 1), or deregulation of a cofilin phosphatase. 
Together, these data point to a new link between CDC42 
and cofilin in axon extension.
Axon myelination. A novel function for CDC42 has 
been suggested by studies of glial cells, which wrap mul-
tiple layers of their plasma membrane around axons to 
form myelin25. In oligodendrocytes — the glial cells of the 
central nervous system — myelin sheaths are thinner in 
the absence of CDC42, which seems to be the result of 
a defect in removing cytoplasm as the oligodendrocyte 
plasma membranes wrap around the axon26. Although 
the mechanistic basis for this phenotype is unknown, it 
is possible that CDC42-driven cortical actomyosin con-
traction could push cytoplasm out as the membranes 
extend around the axon. Schwann cells — the glial cells 
of the peripheral nervous system — that lack CDC42 are 
also defective in axon myelination. However, CDC42 is 
required for Schwann-cell proliferation, which precludes 
analysis of the role of CDC42 during myelination27.
Migration and chemotaxis. CDC42 has been implicated 
in chemotaxis and directed migration of several cell types 
both in vitro and in vivo, including macrophages, T cells, 
fibroblasts and D. melanogaster haemocytes28–32. Studies 
on CDC42-deficient MEFs and haematopoietic stem 
cells (HSCs) support a central role for CDC42 in chemo-
taxis14,33. By contrast, directed migration of CDC42-null 
fibroblastoid cells was reported to be normal15, which 
indicates that the contribution of CDC42 could be cell-
type-specific. CDC42 could affect chemotaxis by decres-
ing Rac localization and activation to the leading edge, 
thereby reducing the stability of lamellipodia so that cells 
cannot move persistently in one direction32,34. Indeed, a 
common observation in CDC42-null cells is a reduction 
of RAC1 activity15,35. Conversely, an increase in CDC42 
activity can stimulate migration speed, for example in 
neutrophils isolated from Cdc42GAP-knockout mice36 
and RAC2-null HSCs/progenitor cells (HSC/P cells)37. 
This could be due to the ability of overactivated CDC42 
to stimulate Rac-dependent lamellipodial protrusion.
CDC42-null or CDC42GAP-null leukocytes show 
alterations in recruitment to inflammatory sites and/or   
homing in vivo33,36, but it is unknown whether these 
defects reflect changes to adhesion, migration or chemo-
taxis. Loss of CDC42 strongly affects haematopoietic cell 
differentiation and cell-cycle progression33, both of which 
could indirectly affect the migratory capacity of cells.
Regulating polarity through the PAR complex. Cell 
polarization is the process by which a cell responds to 
an extracellular stimulus by redistributing and maintain-
ing proteins and organelles in an asymmetrical layout. 
Polarity is fundamental to many cellular processes, 
including migration, differentiation and morphogen-
esis. CDC42 seems to function primarily through the 
polarity protein partitioning-defective-6 (PAR6) and 
thereby with PAR3 and/or atypical protein kinase C 
(aPKC) isoforms to induce polarity in several different 
animal models5,38. For example, CDC42 and the PAR 
complex (PAR6–PAR3–aPKC) have been proposed to 
mediate the capture and stabilization of microtubules 
at the front of the cell and to orientate the Golgi and 
microtubule-organizing centre (MTOC) during the 
establishment of migratory polarity39,40. CDC42 can also 
Figure 1 | Rho GTPase family. An unrooted phylogentic tree that is based on the ClustlW 
alignment of the amino-acid sequences of the 20 Rho GTPase proteins. The tree 
demonstrates the relationship between the different family members. The Rho GTPases 
form 8 subfamilies; subfamily one comprises RAC1, RAC2, RAC3 and RhoG; subfamily 
two comprises CDC42, TC10 (also known as RhoQ) and TC10-like protein (TCL; also 
known as RhoJ); subfamily three comprises CHP (also known as RhoV) and 
WNT1-responsive CDC42 homologue-1 (WRCH1; also known as RhoU); subfamily  
four comprises RhoH; subfamily five comprises RhoBTB1 and RhoBTB2; subfamily six 
comprises RhoA, RhoB and RhoC; subfamily seven comprises RND1, RND2 and RND3 
(also known as RhoE); and subfamily eight comprises RAP1-interacting factor-1  
(RIF; also known as RhoF) and RhoD. EMBOSS pairwise alignment was used to calculate 
the percentage of amino-acid-sequence identity within subfamilies. High sequence 
similarity is found between proteins within the Rac and Rho subfamilies, whereas the 
other subfamilies are much less similar. The classical Rho GTPases include the Rho, Rac, 
CDC42 and RhoF and RhoD subfamilies and these all cycle between active GTP-bound 
forms and inactive GDP-bound forms. The atypical Rho GTPases comprise the RhoBTB, 
Rnd, RhoU and RhoV subfamilies and RhoH. These proteins are all effectively GTP-bound 
and are thought to be regulated by other mechanisms, including phosphorylation and 
protein levels.
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Figure 1.9 Mamalian Rho GTPase family. 
On the basis of primary amino acid sequence identity, closely related proteins can be further 
grouped within the family (colour patches). Sequences were aligned using the ClustalW 
algorithm and sequence distances displayed as unrooted dendrograms in TreeView.  
EMBOSS pairwise alignment was used to calculate the percentage of amino-acid-sequence 
identity within subfamilies. The classical Rho GTPases include the Rho, Rac, CDC42 and 
RhoF and RhoD subfamilies and these all cycle between active GTP-bound forms and inactive 
GDP-bound forms. The atypical Rho GTPases comprise the RhoBTB, Rnd, RhoU and RhoV 
subfamilies and RhoH. These proteins are all effectively GTP-bound and are thought to be 
regulated by other mechanisms, including phosphorylation and protein levels. Figure adapted 
from sarah mammalian Rho GTpase. Figure adapted from (Heasman and Ridley, 2008).	 ﾠ 49	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1.4.2 Regulation of Rho GTPase 
Most  Rho  GTPases  shuttle  between  an  inactive  GDP-bound  state  and  an 
active  GTP-bound  state  while  some  others  thought  to  be  regulated  by 
expression level, localization and posttranslational modification (Figure 1.10). 
This exchange cycle between GDP and GTP cycle is control by 3 types of 
regulating protein: GEFs, GAPs and GDIs. In response to diverse extracellular 
stimuli, GEFs activate GTPases by stabilising their nucleotide free form and 
stimulating the exchange of GDP to GTP (Rossman et al., 2005). Binding of 
GTP to Rho GTPases induces a conformational change that allows GTPases 
to interact with and activate downstream effectors. GAPs, on the other hand, 
act  as  negative  regulators  of  Rho  GTPases  by  enhacing  the  intrinsic 
hydrolytic  activity  of  GTP-bound  GTPases  and  thereby  promoting  the 
transition  into  GDP-bound  form,  which  results  in  termination  of  signaling 
(Tcherkezian  and  Lamarche-vane,  2007).  GDIs  is  able  to  form  cytosolic 
complexes with most members of the Rho family thus block the spontaneous 
dissociation of GDP and prevent the interaction with GEFs, which in turn limit 
the function of GTPases by sequestering them from the active pool (Dovas 
and Couchman, 2005). 
 
1.4.3 Introduction to Rac  
Based on sequence similarity, the Rac1 subfamily comprises four proteins: 
Rac1,  Rac2,  Rac3  and  RhoG.  All  Rac  proteins  are  able  to  stimulate  the 
formation of lamellipodia and membrane ruffles, RhoG promotes formation of 
lamellipodia via activating Rac GEF: DOCKs (Dovas and Couchman, 2005; 
Wennerberg  and  Der,  2004).  The  three  Rac  isoforms  have  different 
expression  patterns  despite  their  high  sequence  similarity.  Rac1  is 
ubiquitously expressed, whereas Rac2 expression is mostly restricted to cells 
of  haematopoietic  origin  and  Rac3  mRNA  is  most  abundant  in  the  brain 
(Didsbury et al., 1989; Haataja et al., 1997; Heasman and Ridley, 2008).  
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different changes in the RHO-family proteins are advan-
tageous to growth in different cellular or genetic back-
grounds,so are selected for in the individual tumour.
This could account for the differences in RHO-protein
activity that are found among transformed cells.
RHO proteins in invasion and metastasis
In addition to deregulated proliferation,tumour cells
have altered morphological characteristics and,in the
case of metastasis,acquire the ability to traverse tissue
boundaries.It is clear that RHO-family GTPases are
involved in the control of cell morphology and motil-
ity in untransformed cells.CDC42 is important for
the extension of actin-rich spikes — called filopodia
— which are thought to sense tactic signals and,sub-
sequently,establish the directionality of movement.
Actin-rich ruffles — called lamellipodia — are then
assembled at the leading edge of the cell in a RAC-
dependent manner.RHOA is involved in the genera-
tion of contractile force,and in moving the body and
tail of the cell behind the leading edge (reviewed in
REF.39).All three of these proteins are also involved 
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Table 1 | RHO proteins, their effectors and functions
RHO protein Effectors Effector protein type Function
RHOA, C ROCK I, II Kinase Actomyosin contraction, transformation,
transcription (SRF)2–4
Scaffold Actin polymerization, transcription (SRF)2–4,
microtubules132
PRK1/PKN Kinase Endocytosis, p38  MAPK activation75, 
transcription (MEF2C)2–4
Citron Kinase Cytokinesis2–4
RHOB PRK1/PKN Kinase EGFR trafficking103, motility and cell adhesion27
RHOD Unknown – Vesicle transport104
RND1, 2, 3/RHOE Unknown – Antagonist of RHOA43,44
RHOG Kinectin Scaffold Microtubule binding109
Unknown Unknown RAC1 and CDC42 activation8
RHOH Unknown – Implicated in tumours of myeloid origin15,16
RIF Unknown – Actin organization133
CHP PAK Kinase JNK activation134
WRCH1 PAK Kinase JNK activation, morphological transformation30
RAC1, 2, 3 PAK1, 2, 3 Kinase JNK activation, transformation2–4
MLK2, 3 Kinase JNK activation2–4
PAR6 Kinase Cell polarity, transformation2–4
p67PHOX Enzyme NADPH oxidation, transcription (NF B)2–4
IQGAP1, 2 Scaffold/GAP Adherens junctions2–4
POSH Scaffold JNK activation, transcription (NF B)2–4
IRSp53  Scaffold Actin polymerization2–4
CDC42 PAK1, 2, 3, 4 Kinase JNK activation, transformation2–4
MLK2, 3 Kinase JNK activation2–4
PAR6 Scaffold Cell polarity, transformation2–4
N-WASP, WASP Scaffold Actin polymerization2–4
MRCK1, 2 Kinase Actin organization2–4
TC10 (TCL) PAK Kinase JNK activation9,135
WASP Scaffold Actin polymerization9,135
PIST136 Scaffold ?
?? G L U T 4   t r a n s l o c a t i o n ,   g l u c o s e   u p t a k e 137
CHP, CDC42 homologue protein; EGFR, epidermal growth-factor receptor; GLUT4, glucose transporter 4; IQGAP, IQ-motif-containing
GTPase-activating protein; IRS, insulin-receptor substrate; JNK, JUN N-terminal kinase; MAPK, mitogen-activated protein kinase;
MEF2C, myocyte-enhancer factor 2C; MLK, mixed-lineage kinase; NF- B, nuclear factor of  B; PAK, p21-activated kinase; 
PAR, partitioning defective; PIST, PD2 domain protein interacting specifically with TC10; PKN, protein kinase N; POSH, plenty of SH3
domains; PRK, protein-kinase-C-related kinase; RIF, RHO in filopodia; ROCK, RHO-associated coiled-coil-forming kinase; SRF, serum
response factor; WASP, Wiskott–Aldrich syndrome protein; WRCH, WNT-responsive CDC42 homologue.
Figure 2 | Model of RHO-protein regulation. RHO proteins can bind either GTP or GDP. When
bound to GDP, they can be sequestered in the cytoplasm by RHO–GDP dissociation inhibitors
(RHO–GDIs). The exchange of GDP for GTP is promoted by RHO guanine nucleotide exchange
factors (RHO–GEFs), and is often associated with translocation of RHO proteins to cell membranes.
GTP-bound RHO proteins interact with a range of effector proteins and modulate their ability to
regulate cell behaviour. Most RHO proteins have an intrinsic ability to hydrolyse GTP to GDP and
inorganic phosphate (P), which can be promoted by RHO–GTPase-activating proteins (RHO–GAPs).
RND1, RND2 , RND3/RHOE and RHOH are unable to hydrolyse GTP, and their regulation is likely to
be through changes in protein level or localization, not through GDP/GTP binding.
Figure 1.10 Regulation of Rho GTPase.  
Rho proteins can bind either GTP or GDP. When bound to GDP, they can be sequestered in 
the cytoplasm by binding to GDIs. The exchange of GDP for GTP is stimulated by GEFs, and 
is often associated with translocation of Rho proteins to plasma membranes. Where GTP-
bound Rho proteins interact with a variety of effecters alter their ability to regulate cell 
behaviour. GAPs act as negative regulators of Rho GTPases by enhacing the intrinsic 
hydrolytic activity of GTP-bound GTPases and thereby promoting the transition into GDP-
bound form, which results in termination of signalling. Figure adapted from (Sahai and 
Marshall, 2002).	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1.4.4 Biological function of Rac   
It  has  been  shown  in  multiple  cell  types  including  macrophages,  T  cells, 
epithelial  cells  and  fibroblasts  that  expression  dominant-negative  RAC1 
inhibits  lamellipodia  extension  and  migration  (Heasman  and  Ridley,  2008; 
Ridley,  2001).  Similarly,  RAC1-null  fibroblasts,  schwann  cells,  endothelial 
cells  and  platelets  have  impaired  lamellipodia  formation  (McCarty  et  al., 
2005b; Nodari et al., 2007; Tan et al., 2008; Vidali et al., 2006). Surprisingly, 
RAC1-null  macrophages  can  still  form  membrane  ruffles  and  migrate  at  a 
similar speed to wild-type cells. However, they have an elongated morphology 
and  fail  to  spread,  which  implies  that  they  are  defective  in  lamellipodia 
extension (Wells et al., 2004; Wheeler et al., 2006).	 ﾠ
Rac  regulates  formation  of  lamellipodia  through  several  signaling  ways 
(Figure 1.11). First, Rac can activate Arp2/3 complex through WAVE complex 
(Kunda  et  al.,  2003).  Second,  Rac  can  increase  the  availability  of  actin 
monomers for incorporation into actin filaments by regulating cofilin via Pak 
and LIM kinase (Edwards et al., 1999). 
 
In  addition  to  the  involvement  in  the  regulation  of  the  actin  cytoskeleton 
organization, Rac1 also plays a role in the cell-cycle progression in both G1/S 
(Olson et al., 1995; Vidali et al., 2006) and G2/M phase (Michaelson et al., 
2008; Moore et al., 1997) in different cell types. Rac activity is also required 
for the activation of the JNK/SAPK, and p38 MAP kinase and TNF induced 
p42/44  MAP  kinase  cascades  (Coso  et  al.,  1995;  Minden  et  al.,  1994; 
Williams  et  al.,  2008).  Rac  can  regulate  the  activity  of  NADPH  oxidase 
resulting in the production of superoxide radicals (Diekmann et al., 1994) and 
the activation of NF-κB (Perona et al., 1997; Williams et al., 2008). In addition, 
Rac1 activity is involved in tight junction biogenesis (Jou and Nelson, 1998; 
Mertens  et  al.,  2005),  cadherin-mediated  cell-cell  adhesion  (Braga  et  al., 
2000;  Braga  et  al.,  1999;  Braga  et  al.,  1997;  Takaishi  et  al.,  1997)  and 
integrin-mediated cell-matrix adhesion (Hotchin and Hall, 1995; Nobes and 
Hall, 1995; Price et al., 1998). In cancer, Rac1 is essential for H-Ras-induced  	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Figure 1.11 Rac regulate formation of lamellipodia
Left: Rac promote actin polymerization by activating Arp2/3 complex through WAVE complex. 
Right: Rac-mediated activation of PAK phosphorylates LIM kinase, which phosphorylates and 
inhibits cofilin, thereby regulating actin-filament turnover and actin filament severing. 	 ﾠ 53	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transformation of NIH3T3 fibroblasts in vitro (Qiu et al., 1995), and expression 
of  constitutively  activated  mutants  of  Rac1  is  sufficient  for  their  malignant 
transformation. Interestingly, Rac induced activation of Pak, JNK or induction 
of  lamellipodia,  was  neither  necessary  nor  sufficient  for  Rac1  transforming 
activity, suggest multiple pathways may contribute to Rac1-induced cellular 
transformation (Westwick et al., 1997).  
 
In vivo, expression of dominant negative Rac inhibits protrusion formation and 
collective migration of oocyte border cells in Drosophila egg chamber (Bianco 
et al., 2007; Duchek et al., 2001; Geisbrecht and Montell, 2004; Murphy and 
Montell, 1996; Wang et al., 2010). Likewise, sequestration of Rac activity in 
zebrafish germ cells inhibits actin brush formation, cell polarity and migration 
(Kardash et al., 2010). In mouse, global Rac1 knockout was embryonic lethal 
and developing embryos do not progress past E9.5, with a high incidence of 
apoptotic  cell  death  in  the  mesoderm  during  gastrulation  (Sugihara  et  al., 
1998), therefore tissue specific knockout of Rac have been widely used to 
study Rac1 function.  Deletion of Rac1 induced by wnt-1 Cre in murine neural 
crest cells showed non-requirement of Rac1 for migration of neural crest cells 
to initial target structures, but strong proliferation defect (Fuchs et al., 2009). 
Deletion of Rac1 in developing nervous with nestin Cre showed increased 
apoptosis  and  Rac1-deficient  cerebellar  granule  neurons  showed  impaired 
migration  and  axon  formation.  In  addition,  Rac1  is  required  for  protrusion 
formation and collective migration of anterior visceral endoderm cells to the 
developing anterior side of the embryo between days E5.5-6.0 during body 
axis  specification.  However,  Rac1  is  dispensable  for  proliferation  in  this 
system  (Migeotte  et  al.,  2010).  Epidermal  deletion  of  Rac1  in  keratinocyte 
revealed an important role of Rac in maintaining the adult epidermal stem cell 
compartment (Benitah et al., 2005).  
 
In contrast to Rac1, Rac2 knockout mice revealed normal development but 
neutrophilic, phagocytic and lymphocytic defects (Croker et al., 2002; Li et al., 
2000;  Roberts  et  al.,  1999).  Comparison  of  defects  in  hematopoietic  cell 
function,  observed  after  single  and  double  deletion  of  Rac1  and  Rac2, 
demonstrated  both  overlapping  and  distinct  roles  of  these  two  related 	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GTPases  in  hematopoietic  cells  (Benvenuti  et  al.,  2004;  Gu  et  al.,  2003; 
Walmsley et al., 2003). Similarly, The Rac3 protein is specifically expressed in 
the nervous system and Rac3-deficient mice have no obvious anatomical or 
physiological  defects  (Corbetta  et  al.,  2005).  However,  more  recent  study 
using Rac1 and Rac3 double knockout mice revealed Rac1 and Rac3 play 
complementary roles during late stages of neuronal and brain development 
(Corbetta et al., 2009). 
 
 
1.5 Melanoblast migration 
1.5.1 Introduction to melanoblast migration 
Mammalian  melanoblasts  are  the  precursor  cells  of  melanin  producing 
melanocytes;  they  arise  from  the  neural  crest.  During  embryogenesis, 
melanoblasts  migrate  away  from  the  neuroepithelium  in  an  extraordinary 
journey with cycles of migration and proliferation to eventually populate the 
skin and hair follicles (Figure 1.12) (Kelsh et al., 2009).  
 
In  mouse,  neural  crest  cells  undergo  two  migration  pathways.  Those  that 
migrate  in  the  space  between  the  somites  and  the  neural  tube  (ventral 
pathway)  give  rise  to  neuronal  and  glial  cells,  whereas  those  that  migrate 
between  the  somite  and  the  non-neural  ectoderm  (dorsolateral  pathway) 
differentiate into melanoblasts (Serbedzija et al., 1990). Studies indicated that 
this melanogentic fate is detemined by expression of Kit (The major tyrosine 
kinase  receptor  in  melanocytes)  in  neural  crest  cells  before  the  migration 
(Wilson et al., 2004).  Melanoblasts reside in an area just near the neural 
tube, called the migration staging area, where they receive proliferation and 
survival signals from Kit-ligand (KitL), the ligand of Kit.  Between E8.5 and 
E10.5, their migration is dorsolateral and induced by transient expression of 
KitL in dermatome (Figure 1.12).  After E10.5 they begin to progress ventrally 
toward  the  face,  ventral  abdomen  and  the  developing  limbs  (Figure  1.12).  
They also undergo a migration in the z-plane, as they emerge upward through 
the developing dermis and into the epidermis at around E13.5 (Figure 1.12) 	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Figure 1.12 Melanoblast dorsolateral migration pathway.
(1) Melanoblasts emerge from the dorsal neural tube at around embryonic day 8.5. 
Melanoblasts migrate along the dorsolateral pathway between the dermatome and the 
overlying ectoderm, and from E10.5 migrate ventrally through the developing dermis 
(2-3). At E14.5, they begin to invade the overlying epidermis (4) and then migrate into the 
developing hair follicles at E15.5 (5). NT: Neural tube, S: Somite. Figure adapted from
(Silver et al., 2006).	 ﾠ 56	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 (Mayer, 1973).  Over the next few days they enter developing hair follicles 
(Figure 1.12). At birth, melanocytes are observed in both the epidermis and 
hair follicles, but within a few days, epidermal melanoblasts disappear, leaving 
only  those  in  the  hair  follicles,  which  differentiate  and  produce  melanin  by 
around P4 (Jordan and Jackson, 2000; Mayer, 1973). As a consequence, the 
skin  in  the  adult  mouse  is  mostly  unpigmented.  In  contrast,  human 
melanocytes  normally  located  in  the  bottom  layer  of  the  skinʼs 
epidermis, which comprise from 5% to 10% of the cells in the basal 
layer of epidermis. 
 
1.5.2 Regulaton of melanoblast migration 
To date several genes have been identified which are associated with coat-
color  abnormalities  in  mice,  indicating  defects  in  melanoblast  migration, 
proliferation and survival (Baxter et al., 2004; Bennett and Lamoreux, 2003; 
Kelsh et al., 2009). Some of these genes are also associated with neural crest 
and  melanocyte  disorders  in  humans.  These  genes  include  transcription 
factors: Mitf (Grüneberg, 1953; Hodgkinson et al., 1993; Hughes et al., 1993), 
SNAI2  (Perez-Losada  et  al.,  2002),  Sox10  (Britsch  et  al.,  2001);  Receptor 
tyrosine kinase Kit and its ligand KitL (Cable et al., 1995; Geissler et al., 1988; 
Mackenzie et al., 1997; Wehrle-Haller and Weston, 1995); G-protein coupled 
endothelin-3 receptor/ligand pair (Baynash et al., 1994; Hosoda et al., 1994) 
and secreted protease of the ADAM family of metalloproteinase ADAMTS20 
(Silver et al., 2008).  
For  instance,  signaling  to  Kit  via  KitL  is  known  to  trigger  proliferation  and 
survival  via  activation  of  Ras  and  downstream  MAPK/ERK  signaling 
(Mackenzie et al., 1997; Smalley, 2009; Steel et al., 1992; Yoshida et al., 
2001),  and  has  been  speculated  to  be  involved  in  motility  (Jordan  and 
Jackson,  2000;  Peters  et  al.,  2002).  Application  of  Kit  function  blocking 
antibody to mouse embryo was able to block proper melanoblast development 
(Nishimura  et  al.,  2002;  Yoshida  et  al.,  1996).  Furthermore,  ectopic 
expression of Kitl in the basal layer of the skin promotes dermal melanoblasts 
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 ﾠ 57	 ﾠ
Endothelin-3  signaling  functions  are  necessary  for  the  development  of 
melanoblasts. Endothelin-3 is not required for melanogentic fate specification, 
but is needed for migration and survival of melanoblasts between E10.5 and 
E12.5 (Shin et al., 1999), and is also required for melanoblast development in 
the epidermis beyond E12.5 (Yoshida et al., 1996). Similar to KitL, ectopic 
expression of endothelin-3 in keratinocytes driven by keratin 5 promoter also 
result  increased  melanoblast  proliferation  and  pigmented  skin  harboring 
dermal  melanocytes,  suggest  a  important  role  of  endothelin-3  in  Kit 
independent survival of melanocytes (Garcia et al., 2007).  
In addition to signaling molecules, melanoblast migration at different stages is 
tightly  regulated  by  expression  of  cell-cell  adhesion  molecules  (Pla  et  al., 
2001).  For  example,  E-cadherin  and  P-cadherin  are  expressed  in 
complementary regions of the developing skin and are required to maintain 
the correct organization of the epidermis, dermis and hair follicle. In general, 
E-cadherin  is  expressed  by  keratinocytes  of  the  epidermis;  P-cadherin  is 
expressed by keratinocytes of the hair matrix, but not in the dermis. Similarly, 
Melanoblasts  that  migrate  in  dermis  neither  express  E-cadherin  nor  P-
cadherin (Nishimura et al., 1999). Expression of E-cadherin is required for 
melanoblasts invading the epidermis, and localization of melanoblasts to the 
hair matrix requires P-cadherin expression (Nishimura et al., 1999). 
 
1.6 Thesis aim 
I aimed to investigate the role of two important cytoskeletal proteins, fascin-1, 
an  actin  bundling  protein  and  Rac1,  a  signalling  small  GTPase  in  cell 
migration  and  cancer.    The  actin  cytoskeleton  and  cytoskeletal  control  are 
crucial in development and cancer invasion/metastasis and understanding the 
function of these key proteins in both normal and cancer cells will aid future 
development of diagnostic and therapeutic cancer research.   
The aims of my project are: 
1.  To investigate the potential role of fascin on invadopodia formation.  
2.  To investigate the potential role of fascin in cancer cell invasion. 	 ﾠ 58	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3.  To investigate the potential role of Rho GTPase Rac1 on melanoblast 
proliferation and migration during mouse embryogensis. 
4.  To investigate the potential role of Rho GTPase Rac1 in activated N-Ras 
Q61K induced melanocyte hyperproliferation.  
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Chapter II 
Materials and Methods 
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2.1 Materials 
2.1.1 Reagents and Solutions 
Compound/Reagents  Type  Source 
Y-27632  Rho kinase inhibitor  Dr. M, Olson, Beatson 
institute. 
Latrunculin A  Actin polymerization 
inhibitor 
Sigma 
IPA-3  Pak1/2/3 inhibitor  Dr. J. Chernoof, Fox 
Chase Cancer Centre 
LIMKi  LIM kinase inhibitor  Dr. M. Olson, Beatson 
institute. 
U0126  MEK1/2 inhibitor   Cell signalling 
Blebbistatin  Myosin II inhibitor  Sigma 
GM6001  Metalloprotease inhibitor  Merck chemicals 
CK312  Arp2/3 complex inhibitor 
(Negative Control) 
Merck chemicals 
CK869  Arp2/3 complex inhibitor  Merck chemicals 
Nocodazole  Tubulin polymerization 
inhibitor 
Sigma 
Taxol  Microtubules stabilizer  Sigma 
EGF  Growth factor  Sigma 
Complete matrigel   ECM  BD biosciences 
Growth factor reduced 
matrigel 
ECM  BD biosciences 
Rat Tail Collagen I (High 
concentration) 
ECM  BD biosciences 
PureCol Bovine 
Collagen 
ECM  Advanced Biomatrix 
Human Fibronectin  ECM  BD biosciences 
Mouse laminin   ECM  BD biosciences 
Ampicillin    Sigma 	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Kanamycin    Sigma 
DNA Ladders  1kb  Invitrogen 
6xDNA loading dye    New Englend Biolabs 
Ethidium bromide    Invitrogen 
Fetal Bovine Serum    Autogen Bioclear 
Hybond-P PVDF 
membrane 
  GE Healthcare 
DMEM    Gibco 
F-12K Nutrient Mixture, 
Kaighn’s Modification 
  Gibco 
Luria Broth Agar  LB + 1.5% agar  Beatson Institute 
Central Services 
Luria Broth   1% w/v bacto-tryptone, 
86nM NaCl, 0.5% yeast 
extract 
Beatson Institute 
Central Services 
L-Glutamine (200mM)    Gibco 
NuPAGE Novex Bis-Tris 
Mini Gels 
10%, 12% and 4-12% 
gel percentage 
Invitrogen 
NuPAGE Sample 
Reducing Agent (10X)  
  Invitrogen 
NuPAGE Sample Buffer 
(4X) 
  Invitrogen 
NuPAGE MOPS SDS 
Running Buffer  
  Invitrogen 
NuPAGE Transfer 
Buffer 
  Invitrogen 
PE  PBS + 1mM EDTA  Beatson Institute 
Central Services 
Penicillin-Streptomycin    Gibco 
Primocin    InvivoGen 
PBS  170mM NaCl, 3.3mM 
KCl, 1.8mM Na2HPO4, 
10.6mM H2PO4 
Beatson Institute 
Central Services 
TBST  10mM Tris-HCl, pH 7.4, 
150mM NaCl 
Beatson Institute 
Central Services 	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TAE  40mM Tris, 0.1% glacial 
acetic acid, 1mM EDTA 
Beatson Institute 
Central Services 
TE  10mM Tris-HCl, pH 8.0, 
1mM EDT A 
Beatson Institute 
Central Services 
Trypsin    Gibco 
X-gal  5’-bromo-4-chloro-3-
indolyl-D- 
galactopyranoside 
Promega 
Collagenase type I    Gibco 
Collagenase type IV    Gibco 
Cell dissociation buffer    Gibco 
Sulfo-NHS-SS-biotin     Pierce Chemical 
NeutrAvidin agarose 
resin  
  Thermo Scientific 
RNase free water    Qiagen 
Medium 254    Cascade Biologics 
Human melanocyte 
growth supplement-2, 
TPA free 
  Cascade Biologics 
TPA    Sigma 
Geneticin     Gibco 
10XDMEM    Gibco 
OptiMEM    Gibco 
Annealing buffer   100 mM NaCl and 50 
mM HEPES pH 7.4 
In house 
QIAprep Maxiprep Kit     Qiagen 
2x HBS  50 mM HEPES, 250 mM 
NaCl, 1.5 mM NaHPO4, 
pH 7.1 
In house 
RIPA buffer   50 mM Tris-HCl, 150 
mM NaCl, 1% NP-40 
and 0.25% Na-
deoxycholate 
In house 
7.5% bicarbonate     GIBCO 	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BSA    Sigma 
Melanin bleach kit     Polyscience Inc. 
Brdu    Sigma 
Puromycin     Invivogen 
Protease inhibitor 
cocktail  
  Pierce 
Halt phosphatase 
inhibitor cocktail  
  Pierce 
SeeBlue Plus2 Pre-
Stained Standard  
  Invitrogen 
4-Hydroxytamoxifen    Sigma 
Image-iT FX Signal 
Enhancer  
  Invitrogen 
Citrate buffer, ph 6.4     Dako 
Peroxidase block    Dako 
X-Gal buffer   2 mM MgCl2, 0.02% 
NP-40, 2 mM 
K3Fe(CN)6 and 2 mM 
K4Fe(CN)6) containing 
2 mg/ml X-Gal 
In house 
Detergent buffer  2 mM MgCl2, 0.02% 
NP-40 and 0.01% 
sodium deoxycholate in 
PBS, pH 7.5 
In house 
HBSS    Gibco 
Prolong Gold Antifade 
reagent  
  Invitrogen 
Antibody Diluent    Dako 
Polybrene     Sigma 
NeutrAvidin Agarose 
Resin 
  Thermo Scientific 
TNE buffer  50mM  Tris  HCl  pH7.5, 
150mM NaCl, 1% Triton 
X-100 and 1mM EDTA 
In house 
Table 1 – Reagents and Solution 	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2.1.2 Antibodies and Dyes 
Antibody  Dilution  Source 
Mouse anti-Fascin 
(55K2) 
WB – 1:500; IF – 1:100  Dako 
Mouse anti-Fascin 
(SPM133) 
IF – 1:100  Abcam 
Rabbit anti-Fascin  IHC– 1:200  ATLAS antibodies 
Mouse anti-Cortactin 
(4F11) 
IF – 1:200  Millipore 
Mouse anti-Rac1 
(ARC03) 
WB – 1:500; IF – 1:100  Cytoskeleton Inc. 
Mouse anti-Myc (9E10)  IF – 1:200  Dr. L. Machesky 
Rabbit anti-Pak1/2/3  WB – 1:500  Cell Signalling 
Rabbit anti-Pak1  WB – 1:500  Cell Signalling 
Rabbit anti-Pak2  WB – 1:500  Cell Signalling 
Rabbit anti-Phospho 
Pak1 
(Ser199/204)/Pak2 (Ser 
192/197) 
WB – 1:500  Cell Signalling 
Rabbit anti-p34-Arc  WB – 1:500; IF – 1:200  Millipore 
Rabbit anti-actin  WB – 1:500  Sigma 
Mouse anti-Cdc42   WB – 1:500  Santa Cruz 
Mouse anti-E-cadherin   WB – 1:500; IF – 1:100  BD bioscience 
Mouse anti-ZO-1  WB – 1:500; IF – 1:100  Invitrogen 
Rabbit anti-Collagen IV  IF – 1:100  Abcam 
Rabbit anti-Phospho-
Cofilin (Ser3) 
WB – 1:500  Cell Signalling 
Rabbit anti-Phospho-
Myosin Light Chain 2 
(Ser19), 
WB – 1:500  Cell Signalling 
Rabbit anti-GAPDH  WB – 1:500  Cell Signalling 	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Rabbit PhosphoHistone 
H3 (Ser10) 
IF – 1:100  Cell Signalling 
Rabbit anti-phospho-
Erk1/2 (Thr202/Tyr204) 
WB – 1:500  Cell Signalling 
Rabbit anti-ERK1/2   WB – 1:500  Cell Signalling 
Mouse anti-β1 integrin  WB – 1:500  Millipore 
Mouse anti-active Rac1-
GTP 
IF – 1:100  NewEast Bioscience 
Goat anti-DCT (D-18)  WB – 1:500; IF – 1:100; 
IHC – 1:5000 
Santa Cruz 
Goat anti-WAVE1  WB – 1:500  Santa Cruz 
Rabbit anti-WAVE2  WB – 1:500  Santa Cruz  
Mouse anti-BrdU  IF – 1:100  BD Bioscience 
Rabbit anti-cleaved 
Caspase-3 (Asp175) 
IF – 1:100  Cell Signalling 
Mouse anti-vinculin  WB – 1:500  Millipore 
Rabbit anti-Ki67 (SP6)  WB – 1:500; IF – 1:100  Neomarkers 
Mouse anti-tubulin  WB – 1:500; IF – 1:100  Sigma 
Mouse anti-Paxillin  WB – 1:500; IF – 1:100  Sigma 
Rabbit anti-N-WASP  WB – 1:500  ATLAS antibodies 
Mouse Anti-Abi1  IF – 1:100  Caltag medsystems 
Rabbit anti-Nap1  WB – 1:500  Millipore 
Mouse anti-MT1-MMP 
(3G4.2) 
WB – 1:500  Millipore 
Mouse anti-BrdU  FC-1:50  Dako 
Anti-mouse IgG HRP 
linked 
WB – 1:5000  Cell Signalling 
Anti-Rabbit IgG HRP 
linked 
WB – 1:5000  Cell Signalling 
Anti-Goat IgG HRP 
linked 
WB – 1:5000  Cell Signalling 
Alexa Fluor 594 donkey 
anti-mouse IgG 
IF – 1:500  Molecular Probes 	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Alexa Fluor 594 donkey 
anti-rabbit IgG 
IF – 1:500  Molecular Probes 
Alexa Fluor 488 donkey 
anti-goat IgG 
IF – 1:500  Molecular Probes 
Alexa Fluor 488 donkey 
anti-rabbit IgG 
IF – 1:500  Molecular Probes 
Alexa Fluor 488 donkey 
anti-mouse IgG 
IF – 1:500  Molecular Probes 
Alexa Fluor 488 goat 
anti-mouse IgG 
IF – 1:500; FC – 1:50  Molecular Probes  
Alexa Fluor 488 goat 
anti-rabbit IgG 
IF – 1:500  Molecular Probes 
Alexa Fluor 594 goat 
anti-mouse IgG 
IF – 1:500  Molecular Probes 
Alexa Fluor 594 goat 
anti-rabbit IgG 
IF – 1:500  Molecular Probes 
Alexa Fluor 647 goat 
anti-mouse IgG 
IF – 1:500  Molecular Probes 
Alexa Fluor 647 goat 
anti-rabbit IgG 
IF – 1:500  Molecular Probes 
Alexa Fluor 350 goat 
anti-mouse IgG 
IF – 1:500  Molecular Probes 
Rhodamine Phalloidin  IF – 1:200  Molecular Probes 
Calcein AM  5µM  Molecular Probes 
WB: Western Blot   IF: Immunofluorescence  
IHC; Immunohistochemistry    FC: Flow cytometry    
Table 2 – Antibodies and Dyes 
 
2.1.3 DNA Constructs 
Construct  Type  Source 
LMP  Retroviral shRNA vector  Dr. J. Norman 
eCFP-C1- H. sapiens 
fascin 
Transient expression 
vector 
Dr. J. Adams 	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eGFP-C1- H. sapiens 
fascin S39A 
Transient expression 
vector 
Dr. J. Adams 
eGFP-C1- H. sapiens 
fascin S39E 
Transient expression 
vector 
Dr. J. Adams 
eGFP-C2- X. tropicalis 
fascin 
Transient expression 
vector 
Dr. J. Adams 
eGFP-C2- X. tropicalis 
fascin S33A 
Transient expression 
vector 
Dr. J. Adams 
eGFP-C2- X. tropicalis 
fascin S33D 
Transient expression 
vector 
Dr. J. Adams 
mCherry-C2- X. 
tropicalis fascin 
Transient expression 
vector 
This study 
mCherry-C2- X. 
tropicalis fascin S33A 
Transient expression 
vector 
This study 
mCherry-C2- X. 
tropicalis fascin S33D 
Transient expression 
vector 
This study 
mCherry-C2  Transient expression 
vector 
Dr. J. Norman 
eGFP-C1  Transient expression 
vector 
Dr. L. Machesky 
GFP-mDia2  Transient expression 
vector 
Dr. S. Narumiya 
GFP-mDia2  Transient expression 
vector 
Dr. S. Narumiya 
IRSP53-myc  Transient expression 
vector 
Dr. L. Machesky 
IRTKS-myc  Transient expression 
vector 
Dr. L. Machesky 
GFP-N-WASP  Transient expression 
vector 
Dr. T. Takenawa 
GFP-Cortactin  Transient expression 
vector 
Dr. R. Buccinone 
GFP-p21-ARC  Transient expression 
vector 
Dr. L. Machesky 
GFP-actin  Transient expression 
vector 
Dr. M. Parsons 	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RFP-actin  Transient expression 
vector 
Dr. M. Parsons 
GFP-Lifeact  Transient expression 
vector 
Dr. R. Wedlich-Soldner 
RFP-Lifeact  Transient expression 
vector 
Dr. R. Wedlich-Soldner 
Table 3 – DNA Constructs 
 
2.1.4 Enzymes and kits 
Kit  Supplier 
Amaxa Nucleofection Kit  Lonza 
Glutathione sepharose beads  Thermo Scientific 
Hyperfect  Qiagen 
Lipofectamine 2000   Invitrogen 
QIAquick Gel Extraction Kit  Qiagen 
Restriction enzymes and reaction 
buffers 
New England Biolabs 
SimplyBlue SafeStain  Invitrogen 
Rapid DNA Ligation Kit   Roche 
SuperSignal West Pico 
Chemiluminescent Substrate 
Thermo Scientific 
Phusion High-Fidelity DNA 
Polymerase 
New England Biolabs 
Precision Red Advanced Protein 
Assay 
Cytoskeleton Inc. 
QIAquick PCR purification kit  Qiagen 
QIAprep Spin Miniprep Kit   Qiagen 
Melanin bleach kit   Polyscience Inc. 
Vectastain ABC kit   Vector laboratories, Inc. 
Alkaline phosphatase substrate kit  Vector laboratories, Inc. 	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EnVision Detection 
Systems Peroxidase/DAB, 
Rabbit/Mouse 
Dako 
Table 4 – Enzymes and Kits 
 
2.2 Methods 
2.2.1 Cell Culture 
2.2.1.1 Origin of cell lines 
A375MM human melanoma cells were obtained from R. Buccione (Consorzio 
Mario Negri Sud, Chieti, Italy). CHL-1 and WM266.4 human melanoma cells 
and  Phonenix-Ampho  retroviral  packaging  cells  were  obtained  from  B. 
Ozanne (Beatson Institute, Glasgow, UK). MV3 human melanoma cells were 
obtained  from  G.  van  Muijen  (University  of  Nijmegen,  Nijmegen,  The 
Netherlands).  SCC-9  human  oral  cancer  cells  and  MDA-MB-231  human 
breast  adenocarcinoma  cells  were  obtained  from  ATCC.  Adult  epidermal 
melanocyte (A melanocytes) and neonatal melanocyte (N melanocytes) were 
obtained  from  (Cascade  Biologics)  and  cultured  according  to  the 
manufacturer’s instructions. Primary mouse melanocytes were established as 
described below. 
 
2.2.1.2 Maintenance of cell lines 
All cell lines were routinely grown in tissue culture treated 100 mm dishes 
(Falcon)  at  37°C  in  a  humidified  atmosphere  containing  5%  CO2.  All 
techniques were performed in sterile conditions. All cell lines were cultured in 
DMEM containing 2mM glutamine and 10% FBS, except SCC9 cells were 
cultured in DMEM/F-12 medium (1:1) containing 2mM glutamine, 400 ng/ml 
hydrocortisone and 10% FBS. Fresh media was added every 3-4 days. Cells 
were passaged when subconfluent, typically every 3 days with a 1:10 split 
ratio.  After  aspirating  the  medium  and  washing  with  PE  buffer,  0.1  ml  PE 
buffer with 0.25% trypsin was added and after approximately 3 min cells were 	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resuspended in 10 ml fresh medium, 1 ml of which was added to 19 ml fresh 
medium in a new 10 mm dish. Human primary melanocytes were cultured in 
medium  254  with  human  melanocyte  growth  supplement-2,  PMA  free  and 
split when subconfluent and the medium was changed every 3 days. Cells 
were passaged as described above.  
 
2.2.1.3 Storage of cell lines 
Cells were stored in liquid nitrogen. Cells were trypsinised as described above 
and  pelleted  by  centrifugation.  Cells  were  resuspended  in  medium 
supplemented  as  described  but  with  20  %  FCS  and  10  %  DMSO. 
Resuspended  cells  were  placed  in  cryotubes,  wrapped  in  cotton  wool  and 
frozen  at  -70°C  overnight  before  transferring  to  liquid  nitrogen.  Cells  were 
thawed by placing cryotubes in a 37°C water bath. Cells were diluted in 10 ml 
fresh medium, pelleted by centrifugation, resuspended in 10 ml fresh medium 
and placed in a new 10 mm dish. Medium was changed once the next day.  
 
2.2.1.4 Establishment of primary mouse melanocyte cell lines 
Method  for  obtaining  primary  mouse  melanocytes  was  previously  reported 
(Larue et al., 1992). Briefly, 1 day old Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- 
(#3 and #4) or Rac1 f/f Tyr::CreERT2o/o Ink4a-Arf-/- (#2) littermate mice were 
stunned and decapitated and briefly sterilized by rinsing twice in ice-cold 70 % 
ethanol for 5 s and twice in ice-cold PBS for 5 s. The skin, typically 1 cm
2, was 
removed and cut into small pieces with scissors and forceps and incubated in 
2 ml of collagenase type 1 and 4 at 37°C, 5 % CO2 for 40 min. The epidermis 
and dermis were separated and transferred to 10 ml wash buffer, centrifuged 
at 1100 rpm at room temperature for 5 min and resuspended in 2 ml cell 
dissociation buffer. After incubating at 37 °C 5 % CO2 for 10 mins, the tissue 
was repeatedly put through 18 g and then 20 g needles to further dissociate 
and then resuspended and left to settle in 10 ml wash buffer for 10 mins. The 
supernatant was centrifuged at 1100 rpm for 5 min and resuspended in 2 ml 
PBS and the cells counted. Cells were centrifuged as before and plated at a 
density of 1 x 10
6 per well of a 6-well tissue culture plate in melanocyte growth 	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medium F-12 containing 200 nM TPA and 100 µg/ml primocin. After 2 days in 
culture, G418 was added to the culture medium at 50 µg/ml for 3 d every 
week in order to selectively impair the growth of fibroblasts and keratinocytes. 
Melanocytes were passaged at around 50% confluence. All experiments were 
done  with  melanocytes  that  were  spontaneously  immortalized  (Ink4a-Arf
-/- 
background (Sviderskaya et al., 2002)) and kept in culture for between 3 and 
4  months.  Controls  were  done  to  ensure  that  OHT  did  not  affect  the 
morphology  of  cells  not  carrying  inducible  Rac1  deletion  e.g.  Tyr::CreER 
negative cell lines.   Pure populations of melanocytes were normally achieved 
after 1.5 months culture of N-Ras
Q61K positive cells and after 4 months culture 
of N-Ras
Q61K negative cells.  
 
2.2.2 Molecular Cloning 
2.2.2.1 Agarose gel electrophoresis 
Agarose was added to 1xTAE buffer at between 1 and 2 % depending on the 
size of the DNA to be visualized. Agarose in 1xTAE buffer was heated and 
Ethidium Bromide added at 0.5 µg/ml prior to solidification in a gel tray. DNA 
samples and 1 kb ladder in 1xDNA loading buffer were loaded on to the gel 
and  electrophoresis  performed  at  100V  in  1xTAE  buffer.  DNA  bands  were 
visualized using a UV transilluminator. The DNA bands of interest were cut 
and  purified  using  QIAquick  PCR  purification  kit  according  to  the 
Manufacture’s instructions.  
 
2.2.2.2 Restriction enzyme digests 
 
Restriction  enzyme  digests  contained  1x  appropriate  enzyme  buffer, 
approximately 10 µg DNA and 5-10 U of restriction enzyme were used per 
microgram DNA, made up to volume of 20 µl with distilled water. Reactions 
were incubated for 2 hour at 37°C.  
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2.2.2.3 Ligations 
 
Ligations were performed using the Rapid DNA Ligation Kit. An approximate 2 
fold molar excess of insert DNA to vector DNA was diluted in DNA Dilution 
Buffer to a final volume of 9 µl. This was combined with 1xT4 DNA Ligation 
Buffer was to a final volume of 10 µl and 5 U T4 DNA ligase was added. The 
ligation  reaction  was  incubated  at  room  temperature  for  1.5  h  before 
transforming competent bacteria.  
 
2.2.2.4 Generation of mCherry-C2- X. tropicalis fascin constructs  
mCherry-X. tropicalis fascin, X. tropicalis fascin S33A and X. tropicalis fascin 
S33D  constructs  was  generated  by  subcloning  X.  tropicalis  fascin,  X. 
tropicalis fascin S33A and X. tropicalis fascin S33D from EGFP-C2 vector to 
mCherry-C2 vector using BamHI /XhoI restriction sites.  
 
 
2.2.2.5 Transformation of competent cells 
Competent  E.  Coli  DH5a  cells  were  stored  at  –70°C  and  thawed  on  ice. 
Plasmid  DNA,  typically  20  ng,  was  gently  mixed  with  100  µl  of  cells  and 
incubated for 15 minutes on ice. Cells were then heat-shocked at 42°C for 45 
seconds and placed back on ice for 1 min. 1ml L-broth was added and cells 
were  incubated  with  shaking  at  37°C  for  1  h,  250  rpm.  200  µl  of  the 
transformation  mixture  was  spread  over  pre-warmed  LB  agar  plates 
containing  50  µg/ml  ampicillin  or  kanamycin  depend  on  the  vector  and 
incubated overnight at 37°C. 
 
 
2.2.2.6 Design of shRNA constructs  
Oligos siRNA sequences were designed based on siRNA sequence (see 
below). The resulting sequences were entered into an online shRNA oligo 
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(http//katahdin.cshl.org:9331/homepage/sirna/rnai.cgi?type=shrna) to design 
complimentary 110 nucleotide oligos suitable for ligation into the vector LMP. 
 
2.2.2.7 Oligos for shRNA constructs  
Primer  Sequence 
Fascin 
SEQ1 F 
TCGAGAAGGTATATTGCTGTTGACAGTGAGCGCAACTG
GAAATAGCGAAATAAATAGTGAAGCCACAGATGTATTTA
TTTCGCTATTTCCAGTTTTGCCTACTGCCTCGG 
 
Fascin 
SEQ1 R 
AATTCCGAGGCAGTAGGCAAAACTGGAAATAGCGAAAT
AAATACATCTGTGGCTTCACTATTTATTTCGCTATTTCCA
GTTGCGCTCACTGTCAACAGCAATATACCTTC 
 
Fascin 
SEQ2 F 
TCGAGAAGGTATATTGCTGTTGACAGTGAGCGCCACGG
GCACCCTGGACGCCAATAGTGAAGCCACAGATGTATTG
GCGTCCAGGGTGCCCGTGATGCCTACTGCCTCGG 
 
Fascin 
SEQ2 R 
AATTCCGAGGCAGTAGGCATCACGGGCACCCTGGACG
CCAATACATCTGTGGCTTCACTATTGGCGTCCAGGGTG
CCCGTGGCGCTCACTGTCAACAGCAATATACCTTC 
 
Fascin 
SEQ3 F 
TCGAGAAGGTATATTGCTGTTGACAGTGAGCGACAGCT
GCTACTTTGACATCGATAGTGAAGCCACAGATGTATCGA
TGTCAAAGTAGCAGCTGGTGCCTACTGCCTCGG 
 
Fascin 
SEQ3 R 
AATTCCGAGGCAGTAGGCACCAGCTGCTACTTTGACAT
CGATACATCTGTGGCTTCACTATCGATGTCAAAGTAGCA
GCTGTCGCTCACTGTCAACAGCAATATACCTTC 
 
Fascin 
SEQ4 F 
TCGAGAAGGTATATTGCTGTTGACAGTGAGCGCCTGAG
CCTTATTTCTCTGGAATAGTGAAGCCACAGATGTATTCC
AGAGAAATAAGGCTCAGATGCCTACTGCCTCGG 
 
Fascin 
SEQ4 R 
AATTCCGAGGCAGTAGGCATCTGAGCCTTATTTCTCTGG
AATACATCTGTGGCTTCACTATTCCAGAGAAATAAGGCT
CAGGCGCTCACTGTCAACAGCAATATACCTTC 
 
Table 5 – Oligo sequences for shRNA constructs 
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2.2.2.8 Annealing shRNA oligos 
 
Oligos were dissolved in sterile, nuclease-free water to a concentration of 3 
mg/ml. The annealing reaction consisted of 1 µl each oligo in 48 µl annealing 
buffer. The mixture was incubated for 4 min at 90°C and then for 10 minutes 
at 72°C. The samples were cooled to 4°C and stored until ligation into vector 
LMP, which was digested with XhoI/EcoR1 restriction enzymes. 
 
 
2.2.2.9 Screening of transformants 
 
Individual  colonies  of  bacteria  were  used  to  inoculate  5  ml  LB  media 
containing  50  µg/ml  ampicillin  or  kanamycin  as  appropriate  and  cultured 
overnight  at  37  °C.  Plasmid  DNA  was  prepared  using  the  QIAprep  Spin 
Miniprep  Kit  and  analyzed  for  the  presence  of  desired  insert  by  restriction 
digest  and  subsequent  visualization  by  gel  electrophoresis.  Samples  that 
tested positive were sequenced using appropriate sequencing primers. After 
sequence confirmation, plasmid DNA was used to transform fresh bacteria 
and 100 ml cultures were used to prepare DNA using QIAprep Maxiprep Kit 
(some procedures performed by Beatson Research Services). 
 
 
2.2.2.10 Primers for sequencing 
 
Primer  Sequence 
pRETROSUPER forward  CCCTTGAACCTCCTCGTTCGACC 
pRETROSUPER reverse  GAGACGTGCTACTTCCATTTGTC 
Table 6 – Primers for sequenceing 
 
 
2.2.3 Transfection 
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2.2.3.1 Transient transfection of plasmid DNA 
 
For  transient  transfection  of  plasmid  DNA  using  Lipofectamine  2000,  cells 
were set up at an appropriate density in culture dishes (e.g. 1x10
5 per well of 
a  6well  dish  for  A375MM  and  CHL-1  cells).  16-24  hours  later  DNA  was 
transfected according to the manufacturer’s instructions. Both DNA (~5-10µg) 
and Lipofectamine 2000 were diluted in OptiMEM, incubated at RT for 5min, 
then combined and incubated for a further 20min before being added directly 
to the cells. Expression was then tested for after 24-48 hours. 
 
Cells  were  also  transfected  by  nucleofection.  Cells  were  pelleted  by 
centrifugation,  resuspended  to  2  x  10
6  cells  per  ml  in  the  appropriate 
nucleofection reagent and 100 µl added to a 1.5 ml tube containing 5 µg DNA. 
Cells and DNA were pipetted into a nucleofection cuvette and placed in a 
nucleofection device (Lonza) and subjected to the appropriate program. Pre-
warmed media was added to the cuvette and cells were carefully pipetted into 
a 100mm culture plate containing 10 ml medium and cultured under standard 
conditions.  
 
 
2.2.3.2 siRNA transfections  
 
On receiving of siRNA, RNase free water was used to dilute siRNA to 20µm. 
For siRNA experiments, 4x10
4 (A375MM), 8x10
4 (MV3 and CHL-1), 1.2x10
5 
(MDA-MB-231) and 1.5x10
5 (primary mouse melanocyte) cells were treated 
with 50 to 100nmol/L of specific siRNA with Hyperfect, The cells were then 
grown for 2 days in 6 well tissue culture plate. The cells were then trypsinised 
and  counted,  replated  and  retransfected  at  the  above  concentration.  This 
process  was  repeated  again  at  4  days,  and  the  cells  finally  used  for  an 
experiment at 6 days. 
 
 
2.2.3.3 siRNA sequence for RNA interference 
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Gene  Accession 
No. 
Company, 
Cat No. 
Target Sequence 
AllStars 
Negative 
Control siRNA 
  Qiagen, 
1027281 
Nvegative control siRNA 
Mm_Pak2_1  NM_177326  Qiagen, 
SI01368654 
AAGAGATTATGGAGAAATTAA 
Mm_Pak2_2  NM_177326  Qiagen, 
SI01368668 
AAAGAAGGAATTGATCATTAA 
Mm_Nap1_1  NM_016965  Dharmacon, 
J-041033-09 
GGAGCAAGTGACCGAGAAT 
Mm_Nap1_2  NM_016965  Dharmacon, 
J-041033-
011 
TTGAAAAGGATGACGATAA 
Mm_Pak1  NM_011035  Dharmacon, 
L-048101-
00-0005 
ON-TARGETplus SMARTpool 
Mm_p34  XM_001000089  Dharmacon, 
L-043464-
01-0005 
ON-TARGETplus SMARTpool 
Mm_N-WASP  NM_028459  Dharmacon, 
L-055607-
01-0005 
ON-TARGETplus SMARTpool 
Hs_Fascin1_1  NM_003088  Dharmacon, 
J-019576-07 
GAGCATGGCTTCATCGGCT 
Hs_Fascin1_2  NM_003088  Qiagen, 
SI00421799 
CACGGGCACCCTGGACGCCAA 
Hs_p34  NM_005731  Qiagen, 
SI02661414 
AAGGATTCCATTGTGCATCAA 
Hs_MT1-
MMP 
NM_004995  Dharmacon, 
L-004145-
00-0005 
ON-TARGETplus SMARTpool 
Hs_N-WASP  NM_003941  Dharmacon, 
L-006444-
00-0005 
ON-TARGETplus SMARTpool 
Table 7 – siRNA oligo sequences  	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2.2.3.4 Retroviral Infections 
2x10
6 Phonenix-Ampho retroviral packaging cells were plated in a 100 mm 
dish  and  the  following  day  cells  were  transfected  using  calcium  chloride 
precipitation method. 5µg DNA in 440µl distilled H2O was mixed with 500 µl 2 
x  HBS  and  60  µl  2M  CaCl2  dropwise  with  vigorous  shaking  followed  by 
precipitation  for  30  minutes  at  37
oC  and  dropwise  addition  to  Phonenix 
Ampho  cells.  Viral  supernatant  was  harvested  at  12  h  intervals,  purified 
through a 0.45 µm filter and added to target cells at 1 x10
5 cells/well in 6 well 
dish with addition of polybrene at a final concentration of 5 µg/ml. After 3 
rounds  of  infection  over  36  hrs,  target  cells  were  passaged  into  100  mm 
dishes and 48 hours later selected with puromycin at 1 µg/ml (MDA-MB-231) 
and 3 µg/ml (CHL-1). All retrovirally produced cell lines were generated on at 
least  2  separate  occasions  to  ensure  the  resulting  phenotypes  were 
consistent  and,  unless  otherwise  stated,  all  resulting  cell  populations  were 
pools of selected colonies. 
 
2.2.3.5 FACS of GFP or mRFP positive cell populations 
 
A375MM cells stably expressing RFP-Lifeact, CHL-1 cells stably expressing 
GFP/RFP, GFP/RFP -X. tropicalis fascin, GFP/RFP -X. tropicalis fascin S33A, 
GFP/RFP  -X.  tropicalis  fascin  S33D  and  GFP-Lifeact  were  selected  with 
2mg/ml Geneticin. Cell pellets of 1 x10
6 were resuspended in 1 ml PBS and 
put through a 40 µm strainer. Cells expressing RFP or GFP were then sorted 
using  Becton-Dickinson  FACSAria.  Typically,  the  brightest  10  %  of  the 
positive cell population were isolated for experimental use. The FacScan was 
operated by Tom Gilbey, Beatson Institute. 
 
2.2.4 Protein immunoblotting 
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2.2.4.1 Protein extraction from cells or tissue 
Fresh tissue or cells in tissue culture dishes were washed with ice cold PBS 
and lysed in RIPA buffer with protease inhibitor cocktail and Halt phosphatase 
inhibitor  cocktail  for  10  min  on  ice.  Cells  were  scraped  and  tissue  were 
homogenized with glass tissue grinder on ice and the lysates were transferred 
to ice cold 1.5 ml tubes and then centrifuged at 13,000 rpm for 5 minutes at 4 
oC. The relatve protein concentration of the resulting supernatent was then 
determined using Precision Red Advanced Protein Assay Reagent and stored 
at –70 
oC. 
 
 
2.2.4.2 Separation of proteins by polyacrylamide gel electrophoresis 
(SDS-PAGE) 
NuPAGE LDS Sample Buffer (4X) and NuPAGE Reducing Agent (10X) were 
used to dilute protein samples to give a 1x solution and heated at 95 
oC for 3 
minutes.  Samples  were  resolved  on  precast  NuPAGE  Novex  Bis-Tris  Mini 
Gels  (10%  or  4%-12%  depend  on  size  of  protein  of  interest)  according  to 
molecular weight by electrophoresis in gel tanks with 1 x NuPAGE MOPS 
SDS Running Buffer at 200V for approximately 50 mins until the dye front had 
reached the bottom of the gel. 10ul of SeeBlue Plus2 Pre-Stained Standard 
was load on side as molecular weight marker.  
 
 
2.2.4.3 Western blotting 
Proteins, separated by polyacrylamide gel electrophoresis, were transferred 
from the gel to PVDF membrane between Whatman 3MM paper at 250mA for 
150 min in 1x NuPAGE transfer buffer. Membranes were blocked in TBST, 3 
% BSA for 1 hour at room temperature and incubated with primary antibody at 
the  appropriate  dilution,  time  and  temperature  as  advised  by  the 
manufacturer. Membranes were washed 3 times with TBST for 5 minutes, 
incubated with the appropriate secondary antibody in TBST, 3% BSA for 1 
hour at room temperature and washed 3 times with TBST for 5 minutes. All 
incubations  and  washes  were  performed  with  gentle  agitation.  Proteins  on 	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membranes  were  visualized  using  supersignal  west  femto  maximum 
sensitivity  substrate  or  supersignal  west  pico  chemiluminescent  substrate. 
The images were recorded and processed using GeneSnap software and Bio-
imaging  system.  (Syngene).  Western  blots  shown  in  figures  are 
representative  of  typical  results  obtained  on  multiple  occasions  for  each 
experiment shown. Quantification of western blots for siRNA experiments was 
done using Image J to outline the bands on the blots and calculate the pixel 
density compared with the non-targeting control.  
 
2.2.5 Cell surface biotinylation assay 
 
Cell surface proteins were biotinylated by incubating the cells with 0.5 mg/ml 
sulfo-NHS-SS-biotin  on  ice  for  15  mins.    Cells  were  then  quenched  with 
50mM NH4Cl and washed with ice cold PBS. Cells were lysed RIPA buffer 
and cleared cell lysate containing 400 µg total protein from each sample was 
incubated with NeutrAvidin Agarose Resin to pull down biotinylated proteins. 
The samples were then analyzed by immunoblotting for E-cadherin. Western 
shown  in  figures  is  representative  of  typical  results  obtained  on  multiple 
occasions for each experiment shown. 
 
2.2.6 Effector Domain Pulldown Assays 
The relative levels of GTP-bound RhoA, Rac, or Cdc42 were determined by 
an  effector  pulldown  assay  as  described  previously  (Vidali  et  al.,  2006). 
Briefly, primary melanocytes incubated with DMSO or 1 µM OHT as described 
in 2.14 were lysed in a buffer containing 50mM Tris HCl PH7.5, 1mM EDTA, 
1%  Triton  X-100,  150  mM  NaCl  and  protease  inhibitor  cocktail,  and  the 
lysates were probed with glutathione-agarose immobilized GST-Rhotekin (for 
RhoA)  or  GST-PAK1-PBD  (for  Cdc42  or  Rac)  domain  (Cytoskeleton  Inc). 
Bound proteins were analyzed by immunoblotting with anti-RhoA, -Rac1/2/3, 
or  -Cdc42  monoclonal  antibodies.  Quantification  of  relative  level  of  active 
RhoA or Cdc42 was done using ImageJ to outline the bands on the blots and 
calculate the pixel density compared with the DMSO treated control. 	 ﾠ 80	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2.2.7 Fluorescent gelatin degradation assay (Invadopodia 
assay) 
Gelatin from Porcine skin (Sigma) was labelled with Alexa Fluor 594 using 
Protein  labeling  kit  (Invitrogen)  according  to  manufacturer’s  protocol. 
Coverslips were acid-washed and coated with 50 µg/ml poly-L-lysine for 15 
min, washed with PBS, and crosslinked with 0.5% glutaraldehyde for 15 min. 
The coverslips were then inverted on an 80 µl drop of 1mg/ml Alexa Fluor 594 
conjugated  or  Oregon  Green  488-conjugated  gelatin  or  FITC-conjugated 
collagen type I for 10 min. After washing three times with PBS, the coverslips 
were then quenched with 5 mg/ml sodium borohydride for 3 mins followed by 
another three time washing with PBS. Finally, coverslips were sterilized with 
70% ethanol for 5 min and incubated in complete growth medium for 1 hour 
before  use.  To  assess  the  ability  of  cells  to  form  invadopodia,  cells  were 
cultured  on  cross-linked  fluorescent  conjugated  matrix  for  16  hours  for 
A375MM  and  3  hours  for  MDA-MB-231  cells.  CHL-1  cells  were  incubated 
overnight on cross-linked fluorescent conjugated matrix in presence of 5µM 
GM6001  MMP  inhibitor  and  invadopodia  were  assessed  2  hours  after 
washout of the inhibitor.  The area of degradation was quantified using an 
Image J plug-in written for this purpose (Manuel Forero-Vargas, unpublished 
data).  Quantification  of  area  of  degradation  was  done  in  at  least  three 
independent experiments in duplicate for each assay. 
 
2.2.8 Three dimensional collagen I degradation assay 
3D collagen degradation assay was performed as described previously (Wolf 
et al., 2003a; Wolf et al., 2007), with modifications. 1x10
6 CHL-1 cells treated 
with NT, fascin, N-WASP, MT1-MMP siRNA or 5µM GM6001 MMP inhibitor or 
cells expressing both NT or fascin siRNA and mCherry-X. tropicalis fascin, X. 
tropicalis  fascin  S33A  or  X.  tropicalis  fascin  S33D  in  150  phenol  red  free 
medium were mixed with 150 µl rat tail collagen I containing 3 µl DQ FITC- 
labeled  type  I  collagen  monomers  (2%),  16  µl  10xMEM  and  11  µl  7.5% 
bicarbonate in well of 24 well plate. Mix polymerizes after 2 to 5 min at 20°C. 	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Put  immediately  in  incubator.  When  collagen  is  cloudy,  add  each  300  µl 
phenolred-free medium.  After 40 h of culture, solid-phase collagen including 
cells was pelleted by centrifuge at 13,000 rpm for 5 minutes at 4 
oC, and the 
supernatant  containing  released  FITC-collagen  fragments  was  analyzed 
spectrofluorimentically  with  excitation  at  490  nm  and  emission  at  520  nm 
(QuantaMasterTM  40  spectrofluorometer;  Photon  technology  international). 
The  degradation  of  fibrillar  collagen  for  each  sample  was  calculated  as 
fluorescence  released  from  DQ  FITC-labeled  type  I  collagen  monomers 
subtracted  by  background  fluorescence,  which  was  calculated  by  pelleting 
nondigested cell-free collagen lattices. Quantification of degradation was done 
in at least three independent experiments in duplicate for each assay. 
 
2.2.9 Inverted Invasion Assay 
2.2.9.1 Set up of invasion assay 
Inverted invasion assays were performed as described previously (Caswell et 
al., 2007). Collagen I (PureCol Bovine Collagen, 3mg/ml) was concentrated to 
10mg/ml  using  vivaspin  15R  (Sartorius  Stedim  Biotech).  8  part  of 
concentrated  collagen  I  was  then  mixed  with  1  part  of  10xMEM  and  pH 
adjusted to 7.4 ± 0.2 by addition of 0.1M NaOH. An aliquot of matrigel, stored 
at -70 
oC, was thawed on ice and diluted 1:1 with ice-cold PBS. Then, 70 µl of 
mixture of collagen I and matrigel yielding a final collagen concentration of 
approximately 4.4 mg/ml and a final Matrigel concentration of approximately 
2.2  mg/ml  was  polymerized  in  transwell  inserts  containing  8µm  pore-size 
micropore  polycarbonate  membrane  filter  (Corning)  within  a  24  well  tissue 
culture plate (Falcon) for 2 hr at 37°C. Inserts were then inverted, 100 µl of 
cell suspension at a concentration of 5 x 10 per ml of medium was pipetted on 
to  the  underside  of  the  transwell  filter,  the  base  of  the  24  well  plate  was 
carefully replaced and the cells allow to adhere for 5 hours at 37°C. Transwell 
inserts  were  then  placed  in  1ml  serum-free  medium  in  24  well  plate,  and 
100µl normal growth medium was placed on top of the matrix, providing a 
chemotactic  gradient.  For  experiments  involving  chemical  inhibitors, 
appropriate inhibitors were added to both the serum free medium below the 	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transwell and the medium above the matrigel plug.  
 
 
2.2.9.2 Quantification of invasion assay 
72 hours after seeding, invading cells were stained by placing 500 µl of serum 
free medium containing 4 µM calcein AM above and below transwell invasion 
assays and incubating for 2 hours at 37 
oC and cells that did not cross the 
transfilter were removed with tissue and the remaining cells were visualized 
by confocal microscopy using a 10 x objective at an excitation wavelength of 
488  nm  and  emission  wavelength  of  515  nm;  serial  optical  sections  were 
captured at 10 µm intervals upwards from the underside of the transwell filter. 
The fluorescence intensity for each section was then measured using a plug-
in (Area calculator) in ImageJ, which allocates each pixel an intensity value 
and allows a threshold intensity level to be set, below which pixels are not 
displayed. The threshold intensity of the images was set in order to register 
only  cells  that  lay  within  each  individual  optical  section.  Finally,  the 
percentage of invading cells was calculated as the fluorescence intensity of 
cells invaded above 20 µg against the total fluorescence intensity of all cells 
within the images of sections taken. At least three independent experiments in 
duplicate for each sample were carried out.  
 
 
2.2.10 Transfilter migration assay  
Transwell  inserts  (Corning)  were  coated  with  20  µg/ml  human  placenta 
laminin overnight, which then blocked with 1mg/ml BSA for 1 hour and wash 
three times with PBS. For A375MM and MDA-MB-231 cells, 6x10
4 cells in 
500µl serum free medium were seeded into the top chambers of a 24-well, 
8µm pore-size micropore polycarbonate membrane ﬁlter (Corning), and the 
lower  chambers  were  ﬁlled  with  1ml  DMEM  containing  10%  FBS  as  a 
chemoattractant and incubated for 12 h at 37°C.  For MV3 and CHL cells 
3x10
4 cells in 500µl serum were seeded and incubated for 12 hours at 37°C. 
Cells  remaining  on  the  upper  surface  of  the  transfilter  were  then  carefully 	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removed with a cotton swab, and the membranes were ﬁxed and stained with 
DAPI  and  rhodamine  phalloidin.  Migration  was  quantiﬁed  by  counting  the 
migrated cells (DAPI staining) in 5 random 20x magniﬁcation ﬁelds per ﬁlter. 
At  least  three  independent  experiments  in  duplicate  for  each  sample  were 
carried out.  
 
2.2.11 2D anchorage-dependent cell growth assay  
Primary melanocytes were incubated with DMSO or 1 µM OHT for 5 days and 
then cultured in medium without DMSO or OHT for another two days. At day 
0, 1x10
4 cells were plated in each well of 6 well plates, and number of cells 
were	 ﾠtrypsinized and counted every two days (for primary melanocytes) from 
one well of 6 well plates for 8 day using CASY Cell Counter (Roche Innovats). 
For cancer cells (A375MM, MDA-MB-231, MV3 and CHL-1), at day 0, 1x10
4 
cells were plated in each well of 6 well plates. Cells were then trypsinized and 
the number of cells was counted every day for 5 days. Each point (Mean ± 
SEM) is derived from the mean of hemocytometer count of cells from three 
replicate dishes from three independent experiments. 
 
2.2.12 3D anchorage-independent cell growth assay (Agar 
growth assay)  
1.5 ml of 0.7% SeaPlaque agarose/F-12/10% FBS was added to each well of 
6-well dishes, which incubate at RT for 1 hour. 1 × 10
4 cells were plated in 1 
ml of 0.35% SeaPlaque agarose/DME/10% FBS on the top. Once solidified, 
the agarose was covered with 2.5 ml DME/10% FBS, which was changed 
twice weekly. Digital images were captured 4 wk later at room temperature 
with  a  microscope  (Axiovert  Stemi  200C;  Carl  Zeiss,  Inc.)  using  a  1.0× 
objective with a Canon 1000D camera processed with ImageJ. Number of 
colony in soft agar was quantified by determining the number of colonies >0.5 
mm in diameter 4 wk after plating. Relative size of colony was determined by 
measuring  the  diameter  of  20  biggest  colonies  in  each  sample.  Three 
replicate dishes from three independent experiments were quantified.  	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2.2.13 Flow cytometry  
Cells  were  pre-incubated  for  2  hr  with  10  uM  BrdU  and  fixed  in  70% 
ethanol/30% PBS overnight at -20 °C. Cells were then pellet, washed with 
PBS  and  bleached  with  melanin  bleach  kit.  Cells  were  treated  with 
pretreatment solution A for 2 min and followed with extensive wash with PBS 
and incubated with solution B for 1 min. After washes with PBS, cells were 
incubated with 4N HCl for 15 min and stained with mouse Anti-BrdU antibody 
(Dako, 1 in 40) in PBT (0.1% BSA+0.01% Tween 20 in PBS) for 30 min and 
followed with Alexa-488 conjugated goat anti-mouse secondary antibody (1 in 
50) in PBT for 30 min. After washes, cells were stained with propidium iodide 
(1  mg/ml)  and  RNaseA  (250  µg/ml)  for  30  min  before  processed  on  BD 
FASC-Calibur (BD bioscicence). 
 
 
2.2.14 Immunofluorescence 
Cells cultured on crosslinked gelatin coverslips were fixed and processed for 
immunofluorescence. For 2D or 3D staining with antibody to fascin, β-actin or 
cells expressing GFP-fascin, cells were fixed with -20
oC methanol at -20
oC for 
10 min and blocked for 30 min with Image-iT FX Signal Enhancer. For all 
other staining, cells were fixed in 4% formaldehyde and permeabilized for 4 
min  in  0.1%  Triton  X-100  in  PBS  and  blocked  with  Image-iT  FX  Signal 
Enhancer  for  30  min  and  incubated  with  primary  antibody  for  1  hours 
(overnight for 3D staining). Cells were washed 3 times for 5 min (30 min for 
3D staining) in PBS and primary antibodies were detected with the use of 
appropriate species- and class- specific Alexa350, Alexa488, Alexa594 and 
Alexa647-conjugated  secondary  antibodies  for  30  min  (overnight  for  3D 
staining). Samples were then examined using Olympus FV1000 inverted laser 
scanning confocal microscope or Nikon A1 inverted laser scanning confocal 
microscope or using a Zeiss Axioskop2 microscope equipped with a digital 
camera C4742-95 (Hamamatsu). 
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2.2.15 Live cell imaging  
 
2.2.15.1 Live cell imaging of invadopodia dynamics 
 
A375MM cells stably expressing RFP-Lifeact were transfected with control or 
fascin  siRNA  and  cultured  on  Oregon  Green  488-conjugated  crosslinked 
gelatin  overnight  in  presence  of  5µM  GM6001  MMP  inhibitor.  1  hour  after 
washout of the inhibitor, cells were recorded in a humidified CO2 chamber at 
37 
oC  with  an  inverted  fluorescence  microscope  (Nikon)  with  a  motorized 
stage.  Timelapse  images  were  captured  using  Metamorph  software 
(Molecular Devices) every 5 min for 15 h.  
 
 
2.2.15.2 Live cell imaging of cell morphology during invasion  
CHL-1  cells  stably  expressing  GFP-Lifeact  were  plated  on  a  glass  bottom 
microwell 35mm petri dish (MatTek Cor.) at 2x10
5 and starved overnight. The 
medium  was  then  aspirated  and  200µl  of  a  mixture  of  collagen  I-Matrigel 
(prepared as described in 2.2.9.1) was applied on top of cell monolayer and 
the gel was allowed to polymerize in 37 
oC for 2 hours. The normal growth 
medium was added to the dish and samples were incubated for 48 hours. Cell 
that has invaded into the gel was imaged. Timelapse images were captured 
every 10 mins for 10 h using an Olympus FV1000 confocal microscope in a 
37 
oC chamber with 5% CO2.  
 
 
2.2.15.3 Live cell imaging of cell migration on 2D surface 
For 2D melanocytes imaging, cells were plated overnight in glass bottomed 
dishes, which were coated with 10 µg/ml fibronectin for 1 h at 37 °C, and then 
incubated  with  1%  bovine  serum  albumin  for  20  min.  Time-lapse  video 
microscopy  was  performed  using  a  Nikon  TE2000  microscope  in  a  37°C 
chamber with 5% CO2. 
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2.2.15.4 Live cell imaging of cell morphology on 3D collagen I matrix 
For live imaging of melanocytes on 3D think layer of collagen, Fibrillar rat-tail 
Collagen I was prepared from a 3 mg/ml as described in 2.11, 500 ul was then 
set in wells of 12 well plate for 1 h at 37 °C. Cells were seeded on top of 
collagen  in  medium  and  allowed  to  adhere  for  24  hr.  Time-lapse  video 
microscopy  was  performed  using  a  Nikon  TE2000  microscope  in  a  37°C 
chamber with 5% CO2. For evaluation of the percentage of elongated cells, a 
cell  was  considered  elongated  when  its  longest  dimension  was  twice  the 
shortest.  
 
2.2.15.5 Fluorescence recovery after photobleaching (FRAP) 
FRAP was conducted using the following settings: pixel dwell time 4 µs/px, 
picture resolution 256 x 256, 2 % 488 nm or 561 nm laser power. GFP or 
mRFP signals at invadopodia were bleached using 45 % 405 nm laser power, 
4-µs/pixel  dwell  time  for  1  region  of  interest  frame.  Images  were  captured 
every 0.428s. Recovery of the signal was measured using the region analysis 
tool  of  the  Olympus  FV1000  viewer  software  and  averaged  in  Excel.  The 
resulting  data  was  corrected  for  imaging  dependent  intensity  loss  (non-
specific bleaching) and then normalized to the pre-bleached images. Each 
normalized single curve was then exported into SigmaPlot (Systat Inc.) for 
exponential  curve  fitting.  Data  were  fit  using  the  following  exponential 
functions: y = y0 + a • (1 – e-bt). The half-time of recovery for each curve was 
calculated  using  the  formula  ln2  /  b,  where  b  was  obtained  from  the 
exponential  curve  fit.  The  percentage  of  recovery  was  calculated  using 
formula:  Xm  =  F  (∞)/F  (I).  Where  F  (I)  denotes  the  average  fluorescence 
intensity before photobleaching for each normalized curve, F (∞) refers to the 
average fluorescence intensity derived from the plateau for each normalized 
curve. 
 
 
2.2.16 Ex-vivo imaging of melanoblast migration 
Experiment  set  up  was  previously  reported  with  modifications  (Mort  et  al., 	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2010).  Briefly,  a  freshly  dissected  E15.5  embryonic  skin  sample  was 
sandwiched  between  a  nucleopore  membrane  (Whatman)  and  a  gas 
permeable Lumox membrane in Greiner Lumox culture dish (Greiner Bio-One 
GmbH)  so  that  the  epidermial  side  of  skin  was  in  contact  with  lummox 
membrane.  To immobilize the sample, Growth Factor Reduced Matrige was 
used to cover the whole assembly and incubate at 37°C for 10 min. Culture 
medium  (Phenol  red  free  DMEM  supplied  with  10%  FBS  and  100  µg/ml 
primocin was finally added. For drug treatment, drugs were added to Matrigel 
and medium 1 hr before imaging. All the drugs were used at 10µM, except 
CK869  and  CK312,  which  was  used  at  20  µM,  latrunculin  A  was  used  at 
0.3µM and nocodazole was used at 1µM. Timelapse images were captured 
using  an  Olympus  FV1000  or  Nikon  A1  confocal  microscope  in  a  37°C 
chamber  with  5%  CO2 at  20x  magnification  objective  or  60x  magnification 
objective for 5 hr. 
 
 
2.2.17 Histology and staining of tissue 
2.2.17.1 Immunohistochemistry (IHC)  
Formalin-fixed  paraffin-embedded  sections  were  deparaffinized  and 
rehydrated by passage through xylene and a grade alcohol series. Antigen 
retrieval  was  performed  by  incubation  of  sections  in  microwave-heated  1x 
citrate  buffer,  pH  6.4  in  a  pressure  cooker  (see  2.2.17.2).  For  IHC  using 
alkaline phosphatase substrate kit, sections were blocked in 10% serum for 1 
hr and then sections were washed three times with 1xTBST and incubated 
with primary antibody at RT. Sections were washed three times with 1xTBST 
and incubated with secondary antibody for 1 hr and after 5 min wash with 1x 
TBST, signal for secondary antibody was amplified using Vectastain ABC kit. 
The staining was visualized with alkaline phosphatase substrate kit according 
to manufacture’s introduction (Vector laboratories, Inc.) and hematoxylin was 
used as the nuclear counterstain. For IHC using Envision kit, sections were 
blocked  with  peroxidase  block  for  5  min.  the  sections  were  washed  and 
incubated with primary antibody diluted in antibody dilute. The sections were 	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then washed three times with 1xTBST and incubated with peroxidase labeled 
polymer. After three times wash in 1xTBST, the staining was visualized with 
Liquid  DAB  +  substrate-chromogen  solution  according  to  manufacture’s 
introduction.  Slides  were  counterstained  with  haematoxylin,  prior  to  being 
dehydrated  in  increasing  concentrations  of  ethanol  and  mounted.  For 
immunofluorescence  on  embryo  sections,  after  antigen  retrieval,  sections 
were blocked with 5% serum for 1 hr and incubated with primary antibody 
overnight  at  4  °C.  Sections  were  then  washed  three  times  in  PBS  and 
incubated with fluorescent conjugated secondary antibodies for 1 h at RT and 
mounted with Prolong Gold Antifade reagent. For BrdU assay, mice were i.p. 
injected with 2.5 mg BrdU for either 2 hr or 24 hr before embryo dissection. 
For hematoxylin and eosin stain stainings, all steps were done according to 
standard  protocols  were  performed  by  C.  Nixon  and  colleagues,  Beatson 
Institute. 
 
2.2.17.2 Miarowave antigen retrieval 
Microwave  antigen  retrieval  was  performed  by  pre-heating  1500ml  Citrate 
buffer pH 6.4 in an open pressure cooker for ~15minutes until boiling. Slides 
were then placed into the solution and heated with the lid on until the pressure 
was  optimised.  Slides  were  then  heated  for  a  further  3-4  minutes,  before 
being removed and allowed to cool at room temperature for 30 minutes. 
 
2.2.17.3 Whole-mount X-Gal staining of embryos 
Embryos  or  the  dorsal  skin  from  new  born  pups  were  fixed  in  0.25% 
glutaraldehyde in PBS at 4 °C for 40 min, washed in detergent buffer and 
stained  overnight  in  X-Gal  buffer  containing  2  mg/ml  X-Gal  in 
dimethylformamide. For quantification of the epidermis-dermis distribution of 
melanoblasts in embryos, X-Gal stained embryos were paraffin-embedded, 
sectioned and counterstained with hematoxylin or eosin.  
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2.2.17.4 Whole-mount immunofluorescence staining of embryos or skin 
explants 
For whole mount immunofluorescence, embryos or skin explants were fixed in 
4% paraformaldehyde at 4 °C overnight. Embryos or skin explants were then 
washed 3X in PBS containing 1% Triton for 30 min and incubated in blocking 
buffer (PBS 1% triton+ 10% FBS 0.2% sodium azide) for 1 hr at RT. Embryos 
or  skin  explants  were  washed  another  two  times  with  blocking  buffer  and 
incubated in blocking buffer containing primary antibody for 4 days at 4 °C. 
Embryos or skin explants were washed 3X in blocking buffer for 1 hr and 3x in 
PBS 1% Triton for 10 min. Embryos or skin explants were then incubated with 
secondary antibody in blocking buffer for 4 days at 4 °C. Embryos or skin 
explants were washed 3x in PBS 1% Triton for 10 min and stored in dark at 4 
°C. 
 
2.2.18 Generation, maintenance and treatment of mouse 
colonies 
2.2.18.1 Transgenic mice  
All experiments were performed according to UK Home Office regulations. 
The  Rac1
 floxed  mice  in  C57BL6/J  background  were  previously  described 
(Walmsley  et  al.,  2003).  Tyrosinase  Cre  A  (Tyr::Cre)  mice  in  C57BL6/J 
background were previously described (Delmas et al., 2003). The Tyr::Cre 
transgene  is  integrated  on  the  X  chromosome  (Delmas  et  al.,  2003). 
Therefore, only Rac1 f/f Tyr::Cre
+/o males were analyzed as Rac1 null, which 
will carry one copy of Tyr::Cre and Rac1 f/f Tyr::Cre
+/o female were excluded 
from this study. Tyr::Cre deletion of Rac1 caused a shakiness of the mice that 
required  culling  at  around  3  week  of  age.    This  is  likely  due  to  some 
expression  of  the  Cre  in  the  neuronal  lineage  (L.  Larue,  and  R.  Mort, 
unpublished). There are no phenotypes associated with Rac1 f/+ Tyr::Cre
+/o 
animals.  Therefore,  heterozygous  genotype  with  genotypes:  Rac1  +/+ 
Tyr::Cre
+/o , Rac1 +/+ Tyr::Cre
o/o , Rac1 f/+ Tyr::Cre
o/o served as control for 
this study. LacZ/EGFP (Z/EG) mice in C57BL6/J background were previously 
described (Novak et al., 2000), N-WASP
 floxed mice in 129SvEv background 	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were previously described (Snapper et al., 2001) which were backcrossed for 
6  generations  with  C57BL6/J  mice.  DCT-LacZ  (DCT::LacZ)  mice  in  mixed 
background were previously described (Mackenzie et al., 1997). Tyrosinase 
Cre-ERT2  (Tyr::Cre-ERT2)  in  C57BL6/J  background  were  described  in 
(Yajima  et  al.,  2006).  GFP-Lifeact  floxed  mice  were  generated  by  David 
Stevenson  and  Douglas  Strathdee  (Beatson  institute)  and  INK4a-deficient 
mice in C57BL6/J background were described in (Ackermann et al., 2005; 
Serrano et al., 1996).  
 
2.2.18.2 Gentotyping 
Genomic DNA was prepared from tail or skin biopsies and genotyping of the 
transgene  was  performed  as  previously  described  (McClive  and  Sinclair, 
2001; Serrano et al., 1996) and by the company Transnetyx (Memphis, TN). 
 
 
2.2.19 Quantifications 
2.2.19.1 Melanoblast/mealnocyte migration speed, euclidean distance 
and persistence  
For  melanoblast  migration  in  skin  explants,  individual  cell  was  tracked 
manually  using  ImageJ,  Manual  Tracking  plugin,  with  distance/time 
measurements taken every 5 min for 3 hr. For melanocyte migration on 2D 
surface,  individual  cell  was  tracked  manually  every  10min  for  15  hr.  The 
migration speed (cell path/time), euclidean distance (the net movement that 
cell made), and persistence (euclidean distance/ cell path) were calculated 
using Chemotaxis Tool plugin. More then 60 cells were examined for each 
skin explants and mean value was taken, and each experiment was repeated 
with  at  least  3  skin  explants.  Mean  values  ±  s.e.m  and  statistical  analysis 
were  calculated  and  plotted  using  Graphpad  Prism  (Graphpad  Software). 
Two-tailed unpaired t-tests were conducted to determine significance. 
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2.2.19.2 Quantification of Number of Filopodia-Like Protrusions 
XY-series  of  sample  stained  with  rhodamine  phalloidin  and  DAPI  were 
captured at 0.5µm Z-spacings. The total number of filopodia like protrusions 
(judged  to  be  extending  from  the  cell  periphery)  in  each  Z-stack  was 
determined.  The  number  of  filopodia-like  protrusions  per  cell  was  then 
determined by calculating the total number of filopodia like protrusions against 
the total number of cells (DAPI staining) in the Z-stack. Each siRNA treated 
cell  population  was  analyzed  in  3  random  20x  magnification  fields  and 
duplicate in three independent experiments. 
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Chapter III 
The Actin-Bundling Protein Fascin 
Stabilizes Actin in Invadopodia and 
Potentiates Protrusive Invasion 
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3.1 Summary 
One of the defining features of invasive tumor cells is that they can degrade 
ECM  and  invade  through  the  use  of  invadopodia.    Previous  studies  have 
shown a role for fascin, an actin-bundling protein, in metastasis and invasion 
as well as tumour progression in several types of cancer. This work led to the 
discovery  that  fascin  is  an  integral  component  of  invadopodia  in  multiple 
cancer  cell  types  and  that  fascin  is  required  for  the  assembly  of  the  actin 
cytoskeleton in these structures as well as for the degradation of matrix. The 
phosphorylation state of fascin at S39, a PKC site, contributes to its regulation 
at  invadopodia.  Fascin  is  a  very  stable  component  of  invadopodia  and  its 
presence enhance the stability of actin structures at invadopodia.  Thus we 
propose a major role for fascin in invasive migration in addition to its already 
established role in the formation of filopodia. Furthermore, fascin is required 
for invasive migration into collagen I-Matrigel gels particularly in cell types that 
use an elongated mesenchymal type of motility in 3D. 
 
3.2 Introduction 
Fascin  is  an  evolutionarily  conserved  actin  bundling  protein  important  for 
filopodia dynamics in primary cells (Yamakita et al., 2009) and several types 
of cancer cells (Adams, 2004; Hashimoto et al., 2006; Vignjevic et al., 2006).  
Fascin forms stable bundles with slow dissociation kinetics in vitro (Tseng et 
al., 2001) and is regulated by phosphorylation of serine 39 by protein kinase C 
(Adams,  2004b).    Fascin  is  not  expressed  in  normal  epithelia  but  is  often 
upregulated in epithelial cancers and is associated with a poor prognosis and 
higher grade (Hashimoto et al., 2004; Vignjevic et al., 2007). 
Invadopodia are protrusions on the ventral surface of cells that have matrix 
degrading activity and adhesive functions (Buccione et al., 2009).  Tumor cells 
on  a  thin  matrix  in  vitro  form  invadopodia  rich  in  actin  and  other  actin 
assembly proteins such as Arp2/3 complex and N-WASP (Baldassarre et al., 
2006b;  Yamaguchi  et  al.,  2005).    In  vivo,  tumor  cells  are  thought  to  form 
structures resembling invadopodia (Wang et al., 2005; Wyckoff et al., 2007) 	 ﾠ 94	 ﾠ
but their function in metastasis isn’t clear. Invadopodia have highly dynamic 
actin that is assembled by both Arp2/3 complex and formins (Baldassarre et 
al., 2006; Lizarraga et al., 2009; Yamaguchi et al., 2005); they also contain 
components  of  membrane  trafficking  machinery  such  as  dynamin  and 
cortactin  (Buccione  et  al.,  2009)  and  have  been  compared  with  focal 
adhesions and podosomes (Buccione et al., 2004; Gimona et al., 2008). 
Mammalian  cells  migrate  using  both  actin-based  protrusions  and  myosin-
based contractile activities.  Tumor cells moving in a 3D matrix employ two 
major  modes  of  motility:  mesenchymal  type  motility  in  which  cells  are 
elongated and protrusive and use protease activity to navigate through dense 
matrix and amoeboid movement in which cells are more rounded and use 
acto-myosin contractility to squeeze through the matrix in a bleb-like fashion 
(Friedl and Wolf, 2003; Wolf et al., 2003a). 
In  this  Chaper,  I  have  described  a  noval  role  of  fascin  as  an  integral 
component of invadopodia and that it is important for the stability of actin in 
invadopodia. I further implicated fascin in invasive migration into collagen I-
Matrigel gels and particularly in cell types that use an elongated mesenchymal 
type of motility in 3D. This work provides a potential molecular mechanism for 
how fascin increases the invasiveness of cancer cells.  
 
3.3 Results 
3.3.1 Fascin expression in human melanocyte and melanoma 
cells 
Multiple  studies  have  reported  a  low  or  absence  of  fascin  expression  in 
normal  epithelial  tissue  but  highly  upregulated  in  more  aggressive  and 
metastatic epithelial cancers and that high fascin expression is a significant 
independent prognostic indicator of poor outcome (Hashimoto et al., 2005; 
Machesky and Li, 2010). We therefore tested if this is the case for human 
melanoma. We first investigated the expression of fascin in a panel of human 
melanoma  cell  lines  as  well  as  normal  primary  human  melanocytes  by 	 ﾠ 95	 ﾠ
western blot. Fascin expression was observed in all human melanoma cell 
lines and normal neonatal and adult epidermis melanocyte cells (Figure 3.1). 
Overall,  no  significant  difference  in  fascin  expression  between  human 
melanocyte and melanoma cells. 
 
3.3.2 Fascin Localize at filopodia and dorsal microspikes in 
A375MM melanoma cells  
A375MM  melanoma  cells  are  derived  from  the  metastases  of  metastatic 
melanoma,  thus  are  highly  invasive  (Kozlowski  et  al.,  1984).  To  study  the 
effect of fascin in human melanoma cell invasion, the distribution of fascin 
was  analyzed  in  a  A375MM  cells.  Phalloidin  staining  of  A375MM  cells 
revealed the formation of both filopodia at cell periphery and microspikes on 
the dorsal surface (Figure 3.2A). Immunostaining with fascin antibody (Figure 
3.2B) or exogenous expression of GFP-fascin showed a localization of fascin 
at both peripheral filopodia and dorsal microspikes (Figure 3.2C, E). Fascin-
enriched filopodia can also be observed on the ventral surface of cell body 
using  total  internal  reflection  fluorescence  microscopy  (Figure  3.2D). 
However,  exogenous  expression  of  GFP-fascin  in  A375MM  cells  did  not 
obviously alter the general cell morphology.  
 
3.3.3 Fascin is important for filopodia formation in A375MM 
melanoma cells  
To investigate the function of fascin in filopodia, we used two independent 
siRNA to knock down fascin in A375MM cells by 90% and 85% respectively 
(Figure  3.3  A  and  B).  We  found  that  fascin  knockdown  did  not  affect  cell 
proliferation  (Figure  3.3  C).  For  both  siRNA,  fascin  knockdown,  however, 
results in a more than 1.6 fold reduction in the formation of peripheral filopodia 
without affecting the cell spreading and formation of lamellipodia (Figure 3.4 A 
and  B).  In  addition,  we  also  observed  the  decrease  in  the  formation  of 
microspikes  in  the  dorsal  surface  of  the  cell  with  the  remaining  spikes 
appearing buckled (Data not shown). These findings are consistent with a 	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Figure 3.1. Fascin Is Expressed in Melanocytes and 
Melanoma Cells
(A) Western blot analysis of fascin expression in human (A 
melanocyte: adult epidermal melanocyte; N melanocyte: 
neonatal melanocyte; A375MM melanoma; MW266-4 
melanoma; MV3 melanoma; CHL-1 melanoma cell lines. Actin 
was probed as loading control. (B) Western blots were 
quantified and the relative intensity of fascin signal was 
normalised to total actin. The results shown are the means
±SEM of three independent experiments.  
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Figure 3.2. Localisation of fascin at filopodia in A375MM cells
Combined Z-stack images (1µm) of A375MM cells adherent on gelatin and stained with 
phalloidin (A) or anti-fascin (B) or expression of GFP-fascin (C) develop numerous filopodia 
at the periphery and microspikes on the dorsal surface and fascin localized at both 
peripheral filopodia and dorsal microspikes. (D) Total internal reflection microscopy images 
of A375MM cell expresses GFP-Fascin.  Scale bar is 10µm. (E) western blot showing 
A375MM cells transfected with human GFP-fascin. Immunoblot was probed with fascin 
antibody.
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Figure 3.3 Fascin knockdown does not alter cell growth rate in A375MM melanoma 
cells
(A) Cell lysates from A375MM human melanoma cells transiently transfected with non-
targeting pool control siRNA (NT) or fascin siRNA (sifascin 1 and sifascin 2) were analyzed 
by immunoblotting and probed for fascin. Membranes were also probed with actin antibody 
as a loading control. (B) Relative fascin expression level was qantified from 4 individual 
blots. (C) 1x104 A375MM cells express NT or fascin siRNA were plated in each well of 6 
well plates, and number of cells was counted every day for 3 days. Each point (Mean ± 
SEM) is derived from the mean of hemocytometer count of cells from three replicate dishes 
from two independent experiments. 
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 previous report (Vignjevic et al., 2006) using B16F1 mouse melanoma cells 
and suggest that fascin is required for filopodia formation in A375MM cells 
and  may  help  to  maintain  the  filopodia  stiffness.    To  further  confirm  the 
specificity of fascin knockdown phenotype on filopodia formation, we set up 
rescue experiment by expressing the GFP-tagged X. tropicalis fascin (GFP-
Xtfascin) refractory to RNAi in fascin siRNA treated cells (Hashimoto et al., 
2007).  Fascin  knockdown  cells  transfected  with  GFP-Xtfascin  resulted 
formation  of  numerous  filopodia  on  both  cell  periphery  (Figure  3.4A,  B. 
western blot of protein expression refer to Figure 3.20A) and dorsal side (Data 
not shown) with the number of filopodia statistically the same as control cells. 
Therefore, fascin knockdown phenotype could be rescued by expression of 
GFP-Xtfascin cDNA.  
 
3.3.4 Fascin is localized at invadopodia in A375MM melanoma 
cells. 
Early studies indicated that fascin is highly expressed in the invasive front 
when cancer cells start to invade into the local surrounding tissue (Hashimoto 
et al., 2005; Machesky and Li, 2010; Vignjevic et al., 2007). Invadopodia are 
finger-like  proteolytically  active  protrusions  that  extend  from  the  ventral 
surface of the cell into the surrounding matrix, causing the focal pericellular 
degradation of ECM to promote cell invasion (Ayala et al., 2006; Buccione et 
al., 2009; Weaver, 2006; Yamaguchi et al., 2006). Therefore we examined 
whether  fascin  was  localized  to  invadopodia.  Interestingly, 
immunoﬂuorescence with two different antibodies to target endogenous fascin 
showed colocalization of fascin with actin and p34-Arc (ARPC2), a subunit of 
Arp2/3 complex, at invadopodia (Figure 3.5 A and B). In addition, GFP-fascin 
also  colocalized  with  cortactin  at  invadopodia  (Figure  3.5  C).  Thus,  fascin 
clearly localizes at invadopodia in A375MM cells. 	 ﾠ 100	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Figure 3.4. Fascin knockdown reduces filopodia formation in A375MM cells
(A)  F-actin organization in A375MM cells. A375MM cells transfected with fascin siRNAs (siFascin 
1 and siFascin 2) adherent on gelatin were fixed and stained with rhodamine phalloidin. Fascin 
knockdown cells showed fewer peripheral filopodia compared to cells transfected with control NT 
siRNA and cells expressing both Fascin siRNA (siFascin 1) and rescued with GFP-X.tropicalis 
fascin. Examples of filopodia are arrowed. Bars, 10µm.
(B) Quantification of filopodia. The number of peripheral fiopodia was counted from 90 phalloidin 
stained cells in three independent experiments.  Error bars: Mean ± SEM. **, P< 0.01 compared 
to control cells by t-test.	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Figure 3.5. Fascin localize to invadopodia in A375MM melanoma cells
(A) A375MM cells on Oregon Green 488 gelatin matrix (shown as grey) immunolabeled with anti-
fascin (55K2) and anti-p34-Arc (Arp2/3 complex). Both X-Y and X-Z view were showen. Individual 
invadopodia were white arrowed (B) A375MM cells on Oregon Green 488 gelatin matrix 
immunolabeled with anti-fascin (primary SPM133) and anti-actin. (C) A375MM cells expressing 
GFP-fascin on Alexa594 labelled gelatin matrix immunolabeled with anti-cortactin. Example 
invadopodia are arrowed. Scale bar is 10µm.
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3.3.5 Fascin is localized throughout the comet structure of 
invadopodia and localization of filopodia proteins at 
invadopodia.  
A recent study of invadopodia dynamics revealed a comet-like organization 
resembling bacteria-propelling actin tails with cortactin and Arp2/3 complex 
distributed  throughout  the  comet  structure,  while  N-WASP  was  only 
concentrated at the “head” section (Baldassarre et al., 2006). Consistent with 
that study, we also observed numerous comet tails, which appeared tethered 
near the head with a dynamic tail that spins, at degradation sites in A375MM 
cells,  somewhat  reminiscent  of  a  corkscrew  (Movie  1  Part  1).  Only  large 
invadopodia appeared as obvious comets (Figure 3.6). We found that Arp2/3 
complex,  cortactin,  and  fascin  localized  throughout  comet  heads  and  tails 
(Figure 3.6A, B, C and Movie 1 Part 2 and 3), whereas N-WASP concentrated 
mostly in the head (Figure 3.6D Part 4 and 5), which may be recruited to and 
activated  at  comet  heads  by  phosphoinositides  (Figure  3.6).  In  addition  to 
fascin,  IRSP53,  IRTKS  and  mDia2,  which  are  proteins  that  promote  the 
formation  of  filopodia  (Millard  et  al.,  2007;  Scita  et  al.,  2008;  Yang  et  al., 
2007), also localized at invadopodia in A375MM (Figure 3.7). Taken together, 
these data suggested that invadopodia might be a hybrid structure containing 
both actin branches and bundles. 
 
3.3.6 Fascin is required for invadopodia formation and ECM 
degradation in human A375MM melanoma cells. 
To determine whether fascin function is necessary for invadopodia formation, 
RNA interference was used to knock down fascin in A375MM cells. A375MM 
cells expressing control or fascin siRNA were cultured on crosslinked Oregon 
Green  488-conjugated  gelatin  or  FITC-conjugated  collagen  I  matrix  for  16 
hours. Cells were then fixed and stained for actin and cortactin to visualize the 
invadopodia puncta (Figure 3.8A).  The area of degradation was quantified 
using a semi-automated ImageJ plugin (created by John Dawson and Manuel 
Forero-Vargas, Birmingham University).  The total areas of degradation per  	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Figure 3.6. Localization of different proteins at invadopodia-associated actin comets
(A-D) A375MM cells were incubated on crosslinked gelatin matrix for 16 hours and then fixed and 
proteins were localized as labeled on the panels. 3D reconstruction of individual actin comets are 
shown with head indicated by green dashed circles and tail indicated by cyan dashed line. All 
scale bars are 10µm.	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Figure 3.7. Localization of filopodia proteins at invadopodia
A375MM transiently transfected with GFP-mDia2 (A), myc-IRTKS (B) and myc-IRSP53 
(C) was incubated on crosslinked Alexa594 conjugated gelatin matrix for 16 hours and 
fixed. Myc-IRTKS and myc-IRSP53 transfected cells were stained with 9E10 myc 
antibody followed by secondary Alexa488 conjugated antibody. Cells expressing low 
levels of myc-IRSP53 were selected for testing the localization. Examples of 
invadopodia are arrowed. Bars, 10µm.	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Figure 3.8. Fascin is required for the formation of invadopodia in A375MM cells. (A)
Representative images from in vitro matrix degradation assay. Cells transfected with NT 
control or fascin siRNAs (siFascin 1 and siFascin 2) on Oregon Green 488 matrix (shown as 
grey) and stained with rhodamine phalloidin and anti-cortactin to localize invadopodia. the 
scale bar is 10µm. (B) Left: relative area of degradation per cell on gelatin (black) and 
collagen I (white). Middle: number of invadopodia per cell on gelatin (black) and collagen I 
(white). Right: area of degradation per invadopod of the ten biggest degradations per cell on 
gelatin (black) and collagen I (white). All error bars indicate mean ± standard error of the 
mean (SEM). **p < 0.01 by t test. Invadopodia were defined as puncta enriched for actin, 
cortactin, and gelatin degradation.
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cell in fascin-depleted cells were reduced by more than two-fold compared 
with control cells (Figure 3.8B). To determine whether there was a change in 
the size of individual invadopodia, we also measured the area of degradation 
from individual invadopodia from control and fascin knockdown cells. Fascin 
depletion  in  A375MM  cells  results  in  about  1.6-fold  reduction  the  area  of 
degradation of individual invadopodia (Figure 3.8B). Finally, there was more 
than  three-fold  reduction  in  the  number  of  invadopodia  per  cell  in  fascin 
knockdown  cells  (Figure  3.8B).  Together,  this  data  indicates  that  fascin  is 
important for invadopodia formation by affecting both the number and size of 
invadopodia in A375MM cells and this effect is not matrix specific.  
 
3.3.7 Fascin is localized at peripheral membrane ruffles and 
invadopodia in human CHL-1 melanoma cells. 
In order to determine whether the effect of fascin on invadopodia formation is 
cell type specific, CHL-1, another human melanoma cell line, which has a 
moderate  level  of  fascin  expression  was  used  (Figure  3.1).  Moreover,  the 
morphology  of  this  cell  line  was  distinct  to  A375MM,  with  cells  showing  a 
highly ruffling morphology but very few filopodia like protrusions. In contrast to 
A375MM cells, CHL-1 cells barely form any filopodia and immunostaining of 
endogenous  fascin  with  antibody  or  transient  expression  of  GFP-fascin  in 
CHL-1  cells  showed  the  colocalization  of  fascin  with  actin  or  p34-Arc  in 
peripheral  membrane  ruffles  (Figure  3.9A).  Importantly,  We  found  the 
colocalization of endogenous fascin or GFP-fascin with actin or p34-Arc at 
invadopodia (Figure 3.9A,B) indicates that fascin localization at invadopodia is 
not cell type specific.  
 
3.3.8 Fascin is required for invadopodia formation and ECM 
degradation in human CHL-1 melanoma cells. 
To test whether the endogenous fascin is important for invadopodia function, 
fascin levels were depleted by transiently transfecting cells with two individual 	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Figure 3.9. Fascin localize to invadopodia in CHL-1 melanoma cells
(A) CHL-1 human melanoma cells on Oregon Green 488 gelatin matrix (gray) with anti-fascin 
(55K2) and anti-actin. (B) CHL-1 cells expressing GFP-fascin on Alexa594 gelatin matrix (gray) 
stained with anti-p34-Arc (ARPC2). Arrows show individual invadopodia. .Scale bar is 10µm.	 ﾠ 108	 ﾠ
 siRNA in CHL-1 cells (Figure 3.10A). No dramatic change in cell growth was 
observed  (Figure  3.10B).  Moreover,  no  huge  morphology  change  was 
observed in CHL-1 cells on tissue culture plastic, although CHL-1 cells were 
slightly  more  spread  and  less  ruffling  in  the  absence  of  fascin  (Data  not 
shown).  
Because CHL-1 cells were very efficient to form invadopodia as compared to 
A375 cells, which the whole area under the cells was often degraded after 
culture  overnight  on  crosslinked  gelatin  (Figure  3.11B),  which  makes  the 
quantification  of  degradation  by  individual  invadopodia  become  impossible. 
Interestingly, A357MM cells only form invadopdia under the centre of the cell 
body (Figure 3.12A), which has been reported previously to be close to Golgi 
complex (Baldassarre et al., 2003) and this close spatial relationship with the 
Golgi complex is believed to be important for invadopodia function. However 
invadopodia formed by CHL-1 cells were all over the cell body (Figure 3.11B), 
suggesting that it may not be necessary for invadopodia or degradations to be 
close to the Golgi complex in all cell types.   
To explore the role of fascin in invadopodia formation in CHL-1 cells, we used 
a different protocol. In this case, cells express NT or fascin siRNA were plated 
on  crosslinked  gelatin  or  collagen  I  overnight  in  presence  of  5µm  of 
metalloprotease inhibitor GM6001. Cell capacity to form invadopodia was then 
assessed by wash off the GM6001 for 2 h. Fascin depletion in CHL-1 cells 
results in a significant reduction in the area of degradation per cell as well as 
area of degradation of individual invadopodia on both crosslinked gelatin and 
collagen  I  matrix.  In  addition,  we  observed  a  significant  decrease  in  the 
number of invadopodia per cell in fascin knockdown cells (Figure 3.12B, C). 
Furthermore,  N-WASP  depletion  in  CHL-1  also  reduces  invaodpodia 
formation  (Figure  3.12  A-C).  Together,  this  data  indicates  that  fascin  is 
important for invadopodia formation by affecting both the number and size of 
invadopodia  in  CHL-1  cells.  This  effect  thus  is  not  matrix  specific  and  is 
conserved in melanoma cells.   
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Figure 3.10 Fascin knockdown does not alter cell growth rate in CHL-1 melanoma 
cells
(A) Cell lysates from CHL-1 human melanoma cells transiently transfected with non-
targeting pool control siRNA (NT) or fascin siRNA (sifascin 1 and sifascin 2) were analyzed 
by immunoblotting and probed for fascin. Membranes were also probed with actin antibody 
as a loading control.  (B) 1x104 CHL-1 cells express NT or fascin siRNA were plated in 
each well of 6 well plates, and number of cells was counted every day for 3 days. Each 
point (Mean ± SEM) is derived from the mean of hemocytometer count of cells from three 
replicate dishes from two independent experiments. 
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Figure 3.11. Comparison of invadopodia formation by A375MM and CHL-1 melanoma 
cells
(A)A375MM or (B) CHL-1 human melanoma cells were plated on Oregon Green 488 gelatin 
matrix for 16 h. Cells were fixed and stained with anti-p34. Scale bar is 10µm.
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Figure 3.12. Fascin is required for the formation of invadopodia in CHL-1 cells. (A) Cell 
lysates from CHL-1 human melanoma cells transiently transfected with non-targeting pool control 
siRNA (NT) or N-WASP siRNA were analyzed by immunoblotting and probed for N-WASP. 
Membranes were also probed with actin antibody as a loading control.  (B)Representative images 
from in vitro matrix degradation assay. Cells transfected with NT control, fascin siRNAs (siFascin 1 
and siFascin 2), N-WASP siRNA or treated with 5µM GM6001 on Oregon Green 488 matrix 
(shown as grey) and stained with rhodamine phalloidin and anti-cortactin to localize invadopodia. 
the scale bar is 10µm. (B) Top: relative area of degradation per cell on gelatin (black) and collagen 
I (white). Middle: number of invadopodia per cell on gelatin (black) and collagen I (white). Bottom: 
area of degradation per invadopod of the ten biggest degradations per cell on crosslinked gelatin 
(black) and collagen I (white). All error bars indicate mean ± standard error of the mean (SEM). **p 
< 0.01 by t test. Invadopodia were defined as puncta enriched for actin, cortactin, and gelatin 
degradation.	 ﾠ 112	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3.3.9 Fascin localized at invadopodia in SCC9 human head 
and neck squamous cell carcinoma cells and MDA-MB-231 
human breast adenocarcinoma cells. 
We  have  shown  that  fascin  is  important  for  invadopodia  formation  in 
melanoma cells. We next investigated if fascin is important for invadopodia 
formation  in  cells  derived  from  cancer  types  other  than  melanoma.  SCC9 
human  head  and  neck  squamous  cell  carcinoma  cells  (HNSCC)  form 
invadopodia  when  cultured  on  crosslinked  ECM  (Lucas  et  al.,  2010).  We 
found that endogenous fascin co-localizes nicely with actin or Arp2/3 complex 
at  invadopodia  (Figure  3.13).  Similarly,  endogenous  fascin  or  exogenous 
fascin-GFP co-localize with gelatin degradations (Figure 3.14A) in MDA-MB-
231 human breast adenocarcinoma cells, a cell type that is very commonly 
used  for  invadopodia  study.    In  addition,  transient  or  stable  knockdown  of 
fascin  significantly  reduce  invadopodia  degradation  in  MDA-MB-231  cells 
(Figure 3.14B-E). Furthermore, siRNA against p34-Arc (ARPC2) in MDA-MB-
231 cells also reduced invadopodia degradation. Similar to other cell types, 
we found that fascin knockdown did not affect MDA-MB-231 cell proliferation 
(Figure 3.15). Together, these results demonstrate a general importance of 
fascin for invadopodia formation on various matrices and cells from different 
cancer types.  
 
3.3.10 Filopodia formation depends on fascin phosphorylation 
Phosphorylation  of  fascin  at  serine  39  is  important  for  its  actin  bundling 
activity in vitro (Ono et al., 1997; Yamakita et al., 1996). To examine the roles 
of  serine  39  phosphorylation  in  filopodia  formation,  A375MM  cells  were 
transiently transfected with GFP-fascin, or two different phosphorylation-state 
mutants of fascin, GFP-fascin S39A, an active dephosphomimic that retains 
its actin-bundling activity, or GFP-fascin S39E, an inactive phosphomimic that 
has  lost  its  actin-bundling  activity  but  that  retains  PKC-binding  activity 
(Vignjevic et al., 2006). Interestingly, A375MM cells expressing H. sapiens 
GFP-fascin, GFP-fascin S39A showed similar morphology with formation 	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Figure 3.13. Fascin localize to invadopodia in SCC9 human squamous cell carcinoma 
cells
(A) SCC9  cells on Oregon Green 488 gelatin matrix (gray) with anti-fascin (55K2) and (A) anti-
p34-Arc and (B) anti-actin. Arrows show individual invadopodia. .Scale bar is 10µm.	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Figure 3.14. Fascin is required for the formation of invadopodia in MBA-MB-231 human 
breast adenocarcinoma cells. (A) Top: MDA-MB-231 cell on Oregon Green 488 gelatin matrix 
(gray) with anti-fascin (55K2). Bottom: MDA-MB-231 cell expressing GFP-fascin on Alexa594 
gelatin matrix (gray)  Arrows show individual invadopodia. (B) Cell lysates from MDA-MB-231 cells 
transiently transfected with NT, fascin or p34-ARC siRNA were analyzed by immunoblotting and 
probed with antibodies as indicated. Membranes were also probed with actin antibody as a loading 
control.  (C)Representative images from in vitro matrix degradation assay. Cells transfected with 
NT control, fascin siRNAs or p34-ARC siRNA on Oregon Green 488 matrix (shown as grey) and 
stained with rhodamine phalloidin. Relative area of degradation per cell on gelatin. (D) Cell lysates 
from MDA-MB-231 cells expressing empty LMP vector or vectors contain fascin shRNA were 
analyzed by immunoblotting and probed with antibodies as indicated. (E) Representative images 
from in vitro matrix degradation assay. Cells expressing empty LMP vector or vectors contain 
fascin shRNA on Oregon Green 488 matrix (shown as grey) and stained with Alexa350 phalloidin. 
Relative area of degradation per cell on gelatin. All error bars indicate mean ± standard error of the 
mean (SEM). **p < 0.01 by t test. All scale bars are 10µm.
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Figure 3.15 Fascin knockdown does not alter cell growth rate in MDA-MB-231 breast 
cancer adenocarcinoma cells 
1x104 MBA-MD-231 cells express NT or fascin siRNA were plated in each well of 6 well 
plates, and number of cells was counted every day for 3 days. Each point (Mean ± SEM) 
is derived from the mean of hemocytometer count of cells from three replicate dishes from 
two independent experiments. 	 ﾠ 116	 ﾠ
numerous  microspikes  on  the  dorsal  surface  of  the  cells  (Figure  3.16A). 
However,  expression  of  GFP-fascin  S39E  inhibits  the  formation  of 
microspikes on the surface of the cells (Figure 3.16A). To further confirm this 
effect, X. tropicalis GFP-fascin (Xtfascin), GFP- Xtfascin S33A (Serine 33 in 
X.  tropicalis  is  equivalent  to  serine  39  in  H.  sapiens  fascin.  Also  see 
(Hashimoto et al., 2007) or GFP- Xtfascin S33D were transiently expressed in 
A431  epithelial  carcinoma  cells  and  cells  were  plated  on  glass  coverslips 
overnight  and  fixed.  Consistent  with  data  for  H.  sapiens  GFP-fascin,  cells 
expressing  GFP-  Xtfascin  or  GFP-Xtfascin  S33A  in  A431  cell  showed 
formation  of  filopodia  (Figure  3.16B).  Expression  of  GFP-Xtfascin  S33D, 
however,  suppresses  the  formation  of  filopodia  (Figure  3.16B).  Together, 
these data indicate that Serine 39 phosphorylation regulates fascin activity 
and formation of filopodia. These also suggest that the inactive phosphomimic 
mutant of fascin has a dominant-negative effect on filopodia formation. 
 
 
3.3.11 Phosphorylation of fascin regulates formation of 
invadopodia in CHL-1 cells 
We have shown that the phosphorylation of fascin at serine 39 regulates the 
formation filopodia. To determine whether fascin phosphorylation is likely to 
regulate  invadopodia  formation,  we  made  fascin  knockdown  cells  with 
expression of GFP, GFP-Xtfascin, GFP-Xtfascin S33A or GFP-Xtfascin S33D. 
Knockdown of fascin in CHL-1 cells did not alter the expression of Xtfascin 
(Figure  3.17).  Knockdown  of  endogenous  fascin  strongly  reduced  the  total 
area of degradation per cell; area of degradation of single invadopodia and 
number of invadopodia per cell as compared to control and this cannot be 
rescued by expressing GFP in the cells (Figure 3.18).  Invadopodia formation 
can be fully restored by express of wild type GFP-Xtfascin or GFP-Xtfascin 
S33A  (Figure  3.18).  In  addition,  both  of  these  proteins  localized  to 
invadopodia  together  with  cortactin  (Figure  3.19).  Although  there  was  no 
defect  on  cell  spreading,  expression  of  GFP-Xtfascin  S33D  in  fascin 
knockdown CHL-1 cells failed to rescue the formation of invadopodia with the  	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Figure 3.16. Effects of fascin mutants on filopodia formation in A375MM and A431 
cells
 (A) Combined Z-stack images (1µm) of A375MM melanoma cells expressing H. sapiens 
GFP-fascin, GFP-fascin S39A or GFP-fascin S39E were spreaded on glass coverslip 
overnight. (B) A431 epithelial carcinoma cells expressing  GFP-X. tropicalis fascin, GFP-X. 
tropicalis fascin  S33A or GFP- X. tropicalis fascin S33D were spreaded on glass coverslip 
overnight and fixed. Inserts show formation of filopodia. Scale bar is 10µm.	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Figure 3.17. Expression of X.tropicalis fascin in fascin knockdown CHL-1 cells.
Western blot showing CHL-1 cells stably expressing GFP, GFP-X. tropicalis fascin, GFP-X. 
tropicalis fascin S33A, and GFP-X. tropicalis fascin S33D were transfected with non-targeting (NT) 
control siRNA or fascin siRNA (siFascin 1). Immunoblots were probed with anti-fascin and anti-
actin as loading control.	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Figure 3.18. Fascin Regulation at Serine 39 Is Important for Invadopodia 
Formation in CHL-1 cells(C) Top: relative area of degradation on gelatin per cell. 
Middle: number of invadopodia per cell. Invadopodia were defined as puncta enriched 
for actin, cortactin, and gelatin degradation. Bottom: area of degradation per invadopod 
of the ten biggest degradations per cell on crosslinked gelatin.; Error bars show mean
±SEM. ** p < 0.01 by t test. 
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Figure 3.19. Localization of fascin mutants in fascin knockdown CHL-1 
cells
CHL-1 cells stably expressing GFP, GFP-X. tropicalis fascin, GFP-X. tropicalis 
fascin S33A, and GFP-X. tropicalis fascin S33D were transfected with non-
targeting (NT) control siRNA or fascin siRNA (siFascin 1), cultured on Alexa594 
gelatin matrix, and labeled with anti-cortactin. Arrows show invadopodia. Scale 
bars represent 10 µm.	 ﾠ 121	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total area of degradation per cell, area of degradation of single invadopodia 
and number of invadopodia per cell remaining similar to the fascin knockdown 
cells (Figure 3.18). Furthermore, GFP-Xtfascin S33D appeared diffuse with 
weak localization to residual invadopodia (Figure 3.19).  
 
 
3.3.12 Phosphorylation of fascin regulates formation of 
invadopodia in A375MM cells 
We have shown that fascin phosphorylation at serine 39 is very important for 
invadopodia  formation  in  CHL-1  cells.  To  further  confirm  these  results, 
A375MM cells expressing GFP, GFP-Xtfascin, GFP-Xtfascin S33A or GFP-
Xtfascin S33D were transfected with NT or fascin siRNA. Western blotting 
indicated that GFP-Xtfascin, GFP-Xtfascin S33A and GFP-Xtfascin S33D was 
not susceptible to the human fascin siRNA (Figure 3.20A). Similar to CHL-1 
cells, invadopodia formation was fully restored by expression of GFP-Xtfascin 
or GFP-Xtfascin S33A in fascin knockdown A375MM cells (Figure 3.21). Both 
of  these  proteins  localized  to  invadopodia  together  with  cortactin  (Figure 
3.20B).  GFP-Xtfascin  S33D  failed  to  rescue  invadopodia  formation  (Figure 
3.21).  In  a  few  of  GFP-Xtfascin  S33D  expressing  cells  with  recognizable 
invadopodia-like staining, GFP-Xtfascin S33D was also weakly localized at 
invadopodia  together  with  cortactin,  although  appeared  diffuse  with  weak 
localization  to  invadopodia  (Figure  3.20B).  In  addition,  expression  of  H. 
sapiens GFP-fascin S39E in wild-type A375MM cells significantly decreased 
matrix degradation (Figure 3.22). However, expression of human GFP-fascin 
or  GFP-fascin  S39A  did  not  significantly  affect  extracellular  matrix  (ECM) 
degradation  (Figure  3.22).  Together,  these  data  suggest  that  the  actin-
bundling activity of fascin may be required for invadopodia formation and that 
the inactive phosphomimic mutant of fascin has a dominant-negative effect. 	 ﾠ 122	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Figure 3.20. Localization of fascin mutants in fascin knockdown A375MM cells
Western blot showing A375 cells stably expressing GFP, GFP-X. tropicalis fascin, GFP-X. 
tropicalis fascin S33A, and GFP-X. tropicalis fascin S33D were transfected with non-targeting 
(NT) control siRNA or fascin siRNA (siFascin 1). Immunoblots were probed with anti-fascin and 
anti-actin as loading control. (B) A375 cells expressing GFP, GFP-X. tropicalis fascin, GFP-X. 
tropicalis fascin S33A, and GFP-X. tropicalis fascin S33D were transfected with non-
targeting (NT) control siRNA or fascin siRNA (siFascin 1), cultured on Alexa594 gelatin matrix, 
and labeled with anti-cortactin. Arrows show invadopodia. Scale bars represent 10 µm.
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Figure 3.21. Fascin Regulation at Serine 39 Is Important for Invadopodia 
Formation in A375MM cells Top: relative area of degradation on gelatin per cell. 
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of the ten biggest degradations per cell on crosslinked gelatin.; error bars show mean
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Figure 3.22. Expression of GFP-Fascin S39E Suppresses Invadopodia Formation in 
A375MM Cells
A375MM cells transiently transfected with GFP, H. sapiens GFP-fascin, H. sapiens GFP-
fascin S39A and H. sapiens GFP-fascin S39E were cultured on crosslinked Alexa594 
conjugated gelatin matrix for 16 hours. Quantifications of invadopodia on gelatin from three 
independent experiments in duplicate as described in Figure 1. (Mean ± SEM). **, P< 0.01 
compared to control cells by t-test.	 ﾠ 125	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3.3.13 Fascin regulates actin stability at invadopodia 
To  understand  how  fascin  controls  actin  dynamics  at  invadopodia,  the 
turnover  rates  of  GFP-tagged  actin,  cortactin,  N-WASP,  p21-Arc  (ARPC3), 
and fascin at invadopodia was examined (Figure 3.23) via FRAP. Although 
invadopodia persisted for hours, cortactin, N-WASP, and p21-Arc all rapidly 
recovered to more than 80% of prebleach values, and the recovery kinetics 
agree  fairly  closely  with  previously  published  values  for  turnover  of  actin, 
cortactin,  and  Arp2/3  complex  in  lamellipodia  (Lai  et  al.,  2008).  Actin, 
however, only recovered to about 70% prebleach level, suggesting that 30% 
of actin is trapped (Figure 3.23 and Movie 2). Although fascin at invadopodia 
recovered to nearly prebleach level, the recovery rate of fascin was >10-fold 
slower than that of actin, cortactin, N-WASP, and p21-Arc with half time of 
recovery of about 65 seconds (Figure 3.23 and Movie 2). Fascin turnover in 
filopodia  was  more  rapid,  with  a  half-time  of  recovery  of  about  9  seconds 
(Figure 3.23 in agreement with (Aratyn et al., 2007; Vignjevic et al., 2006) and 
96% recovery. Together, these results indicate that rather than form a stable 
complex fascin, actin, cortactin, N-WASP, p21-Arc (ARPC3) at invadopodia 
undergo a constant association/dissociation cycle and majority of the proteins 
are dynamic. Fascin is particularly stable at invadopodia, perhaps to provide a 
platform for force production. 
 
Previous  reports  implicated  fascin  in  stabilization  of  membrane  protrusions 
and alteration of the equilibrium of actin polymerization (Yamakita et al., 2009; 
Yamashiro et al., 1998). In order to study whether the level of fascin in cells 
could  change  the  actin  dynamics  at  invadopodia,  the  actin  dynamics  were 
compared  in  fascin-depleted  and  -overexpressing  cells  via  FRAP  (Figure 
3.24A). The mobile fraction of actin at invadopodia was significantly increased 
in fascin knockdown cells and decreased in GFP-fascin-overexpressing cells 
(Figure 3.24B). However, the bulk turnover rates of actin at invadopodia were 
almost  unaffected  (Figure  3.24B,  recovery  half-time).  Thus,  the  amount  of 
actin  trapped  at  invadopodia  is  at  least  partially  dependent  on  fascin,  but 
rapidly cycling actin may not be bundled by fascin. This is consistent with the 
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Figure 3.23. Fascin is Stably Associated with Invadopodia
(A) A375MM cells transiently transfected with GFP-cortactin, GFP-p21, GFP-N- WASP, GFP-actin 
and GFP-fascin were cultured on crosslinked Alexa594 gelatin matrix for 16 hr and analyzed by 
confocal microscope at 37°C. Invadopodia were defined as colocalization of GFP tagged protein 
with gelatin matrix degradation. Images from time-lapse movies of FRAP experiments before and 
after photobleaching on GFP- cortactin, GFP-actin, GFP-p21, GFP-N-WASP at invadopodia 
(arrowed) and GFP- fascin at invadopodia (arrowed) and filopodia (boxed). Bars, right, 10µm, left, 
1µm. Time in sec. (A) The recovery kinetics of GFP-cortactin (green triangles) (n = 28), GFP-actin 
(purple crosses) (n = 31), GFP-p21-Arc (red squares) (n = 30), GFP-N-WASP (blue diamond) (n = 
30) at invadopodia, GFP-fascin at invadopodia (light blue x symbols) (n = 22), and filopodia 
(orange dots) (n = 25) after photobleaching. Mobile fraction and half-time of recovery are indicated 
as mean ± SEM.
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Figure 3.24. Fascin Knockdown Reduces Actin Recovery in Invadopoda
(A) A375MM cells expressing control or fascin siRNA transiently cotransfected 
with EGFP-fascin and mRFP-actin or transfected with mRFP-actin were cultured 
on crosslinked gelatin matrix for 16 hours. Images represented time-lapse 
sequence of FRAP experiments before and after photobleaching of mRFP-actin at 
invadopodia (arrowed). (B) Recovery kinetics of mRFP-actin at invadopodia in 
cells expressing NT control siRNA (blue diamond) (n = 50), GFP-fascin and 
control siRNA (EGFP- fascin) (green triangles) (n = 47), or fascin siRNA (siFascin) 
(red squares) (n = 45). Percentage of mobile fraction and half-time of recovery for 
each condition are indicated as mean ± SEM; **p < 0.01 by t test.	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 presence  of  unbundled  highly  dynamic  actin,  which  is  likely  being  rapidly 
turned over to produce force for motility and more stable actin in association 
with fascin to provide longevity of protrusions.  
 
Because  fascin  stabilizes  the  filamentous  actin  at  invadopodia  and  itself 
exchanges slowly at invadopodia, this suggests that fascin might function at 
invadopodia to provide a more stable platform for degradation of matrix. To 
test this, the dynamics of invadopodia in control and fascin depleted A375MM 
cells were compared by time-lapse microscopy. Most (>50%) invadopodia in 
A375MM cells persisted for up to and beyond 6 to 8 hr (Figure 3.25 and Movie 
3). Fascin knockdown cells formed fewer invadopodia, and invadopodia were 
generally  smaller  and  shorter  lived  (approximately  50%  of  invadopodia 
persisted for less than 2 hr) (Figure 3.25 and Movie 3). Together, these data 
indicate  that  fascin  is  important  for  invadopodia  stability  and  function,  by 
regulating the number and size of invadopodia, as well as their lifetime.  
 
 
3.3.14 Fascin and metalloproteases are not required for 
A375MM melanoma cell invasion  
We have shown that fascin stabilizes actin at invadopodia. We investigated 
the role for fascin in invasion of melanoma cells into 3D Collagen I/Matrigel 
matrix, a process that takes place over the timescale of days and which might 
require  long-lived  invasive  protrusions.  Consistent  with  previous  reports, 
migrating  A375MM  cells  in  collagen  I-Matrigel  appeared  rounded, 
characteristic  of  the  so-called  amoeboid  type  of  migration  (Figure  3.26A) 
(Gadea et al., 2008; Sanz-Moreno et al., 2008). Fascin protein levels were 
depleted  by  siRNA  and  the  resulting  cells  were  assayed  in  the  inverse 
invasion assay. Surprisingly, The invasion of A375MM cells was found not to 
be  dependent  on  endogenous  fascin  (Figure  3.26B).  In  addition,  fascin 
knockdown had no apparent effect on the rounded shape of A375MM cells in 
3D Collagen I/Matrigel matrix (Figure 3.26A). Furthermore, fascin knockdown 
in A375MM cells had no effect on cell migration cross the filter in transwell  
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Figure 3.25. Fascin Knockdown reduces Lifetime of Invadopoda
(A) Time-lapse image sequence of A375MM cells stably expressing RFP-Lifeact 
were transfected with control or fascin siRNA and cultured on Oregon Green 488-
conjugated crosslinked gelatin overnight in presence of 5μM GM6001 MMP 
inhibitor. Time-lapse image was taken within 1 hour after washout of the inhibitor.  
Scale bars represent 10 µm. Red arrowheads show invadopodia and blue 
arrowheads show gelatin degradation. (B) Time-lapse lifetime of invadopodia was 
calculated with data from 30 cells from at least three independent experiments. n 
represents the total number of invadopodia analyzed. 
5 mins 15 mins 30 mins 45 mins 60 mins 75 mins 90 mins	 ﾠ 130	 ﾠ
 
   
!"!#
!"$#
!"%#
!"&#
!"'#
("!#
("$#
!"#
$%&'$(%)#*#
$%&'$(%)#+#
,-.//*#
0
1
2
'
3
4
1
#
%
)
4
'
$
%
5
)
#
6
7
+
/
8
9
:
#
NT siFascin 1 siFascin 2
DAPI
20µm
0µm 60µm
NT siFascin 1 siFascin 2 GM6001 
Phalloidin
DAPI
NT
siFascin 1
siFascin 2
GM6001
NT
siFascin 1
siFascin 2 
GM6001
0.0
0.5
1.0
1.5
R
e
l
a
t
i
v
e
 
M
i
g
r
a
t
i
o
n
Figure 3.26. A375MM cells migration and invasion is fascin and MMP independent  
(A) A375MM cells in collagen I-Matrigel matrix treated with NT, fascin siRNA or 5µM 
GM6001 were fixed and stained with rhodamine phalloidin and DAPI. Serial of z-stack 
images were taken with 0.5 µm interval and combined. (B) Representative images of 
A375MM cells invading into 3D collagen I-Matrigel matrix. Quantification of relative 
invasion >20 µM into collagen I-Matrigel.  Error bars show mean ± SEM. ** p < 0.01 by t 
test. (C) Representative images of transfilter migration assay. A375MM cells expressing 
NT or fascin siRNA crossed the filter were fixed and stained with DAPI. Quantification of 
relative migration of A375MM cells crossed filter. Scale bars represent 10 µm.
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migration assay. Metalloprotease and matrix degradation have been showed 
previously to be not required for cell invade using amoeboid type of migration 
(Wyckoff et al., 2006). Treatments to inhibit protease activity did not affect 
invasion, migration and morphology of A375MM cells. Together, these results 
demonstrate  that  fascin  and  metalloproteases  do  not  contribute  to  the 
invasion of A375MM melanoma cells and that amoeboid type cells may be 
less dependent on invadopodia for invasion. 
 
 
3.3.15 Mesenchymal-type cancer cells require fascin during 
cell invasion in a 3D environment 
In  contrast  to  A375MM  cells  which  use  an  amoeboid  type  migration  for 
invasion, CHL-1 melanoma cells have been shown to use a more elongated 
lamellipodia-driven mesenchymal type of migration in 3D (Sanz-Moreno et al., 
2008). In addition, during invasion into collagen I-Matrigel matrix, CHL-1 cells 
appeared  elongated  and  very  spiky,  with  many  long,  fine  actin-rich 
protrusions,  many  of  which  showed  abundant  fascin  (Figure  3.27B).    To 
investigate the effect of fascin on invasion and migration of CHL-1 cells, fascin 
was  depleted  using  either  siRNA  transient  or  shRNA  stable  knockdown 
(Figure  3.27E),  and  invasiveness  of  resulting  cells  was  measured  using 
inverse  invasion  assay  and  transwell  migration  assay.  The  invasion  and 
migration of CHL-1 cells were significantly reduced when fascin was depleted 
(Figure 3.27G, D). I also examined whether fascin is required for cell invasion 
in 3D matrix using another melanoma cell line: MV3 and MDA-MB-231 human 
breast adenocarcinoma cell line in which both cell displayed mesenchymal 
type of migration (Friedl et al., 1997; Wolf et al., 2007). Fascin knockdown in 
both cell lines resulted in significant reduction in cell invasion through the 3D 
Collagen I/Matrigel matrix and migration through the filter (Figure 3.28 and 
3.29).  Collectively,  these  findings  suggest  that  cells,  which  use  a 
mesenchymal type of migration for invasion into 3D matrix may selectively 
require fascin. 
 
To test if fascin is required for collagen degradation in 3D, the ability of NT or  	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Figure 3.27. Fascin is required for efficient mesenchymal-type invasion in 3D
(A) Western blot of CHL-1 cells expressing NT control siRNA, MT1-MMP siRNA probed with anti-
MT1-MMP, and anti-actin loading control. (B) Left: CHL-1 in collagen I-Matrigel matrix fixed and 
stained with anti-fascin (55K2). Serial Z stack images (0.5 µm) were combined and shown here. 
Scale bars represent 10 mm. Right: densitometric analysis of fascin signal with arrows at peak 
fascin intensities.
(C) CHL-1 cells in 3D collagen I-Matrigel matrix treated with siRNA or inhibitor (as indicated) were 
fixed and stained with rhodamine phalloidin and DAPI. Serial Z stack images (0.5 µm interval) were 
combined. Filopod-like protrusions were arrowed.
(D) Relative migration cross the filter (light grey), relative invasion >20 mM into collagen I-Matrigel 
(black), relative release of soluble fluorescein isothiocyanate (FITC) from collagenolysis caused by 
CHL-1 cells within 3D FITC-collagen lattices (white), and relative number of filopod-like protrusions 
per cell (dark gray). (E) Western blot of CHL-1 cells stably express LMP vector or fascin shRNA 
probed with anti-fascin, and anti-actin loading control. (F) CHL-1 cells in 3D collagen I-Matrigel 
matrix stably express LMP vector or fascin shRNA fixed and stained with rhodamine phalloidin. 
Filopod-like protrusions were arrowed. Scale bars represent 10 µm.  (G) Relative invasion >20 µM 
into collagen I-Matrigel. All error bars show mean ± SEM. **p < 0.01 and *p < 0.05 by t test. 
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Figure 3.28. Fascin is required by MV3 Melanoma cells for efficient migratin and invasion
(A) Western blot of MV3 melanoma cells expressing NT control siRNA or fascin  siRNA probed 
with anti-fascin, and anti-actin as loading control. (B) Representative images of transfilter 
migration assay. MV3 cells expressing NT or fascin siRNA crossed the filter were fixed and 
stained with DAPI.  (C) Quantification of relative migration of MV3 crossed filter. (D) 
Representative images of MV3 cells invading into 3D collagen I-Matrigel matrix.  (E) 
Quantification of relative invasion >20 µM into collagen I-Matrigel.  Error bars show mean ± SEM. 
** p < 0.01, * p < 0.05 by t test. 
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Figure 3.29. Fascin is required by MDA-MB-231 for efficient migratin and invasion
(A) Representative images of transfilter migration assay. MDA-MB-231 cells expressing NT 
or fascin siRNA crossed the filter were fixed and stained with DAPI. (B) Quantification of 
relative migration of MBA-MB-231 cell crossed filter. (C) Representative images of MDA-
MB-231 cells invading into 3D collagen I-Matrigel matrix.  (D) Quantification of relative 
invasion >20 µM into collagen I-Matrigel.  Error bars show mean ± SEM. ** p < 0.01 by t test. 
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Fascin siRNA expressing CHL-1 cells to degradate 3D collagen matrix was 
measured using FITC collagen release assay as previously described (Wolf et 
al.,  2003a;  Wolf  et  al.,  2007).  3D  collagen  degradation  was  significantly 
deceased upon fascin knockdown (Figure 3.27D). In addition, the shape of 
CHL-1 cells were changed by either transient or stable fascin knockdown, with 
a decrease in filopod-like protrusions and some remaining small puncta and 
stubby protrusions (Figure 3.27C, D, F and Movie 4). I postulated that finger-
like  protrusions  in  CHL-1  cells  could  be  invasive  filopodia  and  aid  the 
movement  of  mesenchymal-type  cells  in  3D  matrix.  The  requirements  for 
other components of invadopodia, including N-WASP, which organizes Arp2/3 
complex  mediated  actin  assembly,  and  the  transmembrane  matrix 
metalloprotease MT1-MMP, which controls matrix degradation at invadopodia 
were  probed.  Knockdown  of  N-WASP,  which  causes  a  reduction  of 
invadopodia (Figure 3.12) but no change in the filopod-like protrusions in 3D 
(Figure 3.27C, D), reduced both invasion collagen I-Matrigel matrix and 3D 
collagen degradation (Figure 3.27D). Likewise, the MMP inhibitor GM6001 or 
siRNA  reduction  of  MT1-MMP  (Figure  3.27A)  did  not  affect  filopod-like 
protrusions in 3D matrix but significantly reduced invasion of mesenchymal-
type cells and 3D collagen degradation (Figure 3.27A, C, D; 3.28D, E and 
3.29C, D and Movie 4). These results show that filopod-like protrusions alone 
are  not  sufficient  for  3D  invasion  and  suggest  that  invadopodia  or  their 
equivalents  in  3D  are  required  for  mesenchymal-type  cells  to  degrade  the 
matrix during 3D invasion.  
 
3.3.16 Fascin phosphorylation regulates mesenchymal-type 
cancer cell invasion, degradation in 3D environment 
In  order  to  examine  the  effect  of  fascin  bundling  activity  on  cell  invasion, 
Xtfascin S33A and Xtfascin S33D were used to rescue fascin knockdown in 
CHL-1 cells. Wild type Xtfascin or Xtfascin S33A restored the normal number 
of  protrusions,  relative  invasion,  migration  and  3D  collagen  degradation, 
whereas Xtfascin S33D did not (Figure 3.30).  	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Figure 3.30. Fascin dephosphorylation at Serine 39 is required for efficient migration and 
mesenchymal-type invasion.
(A) CHL-1 cells in 3D collagen I-Matrigel matrix treated with siRNA were rescued with Xtfascin 
constructs (as indicated) were fixed and stained with rhodamine phalloidin and DAPI. Serial Z stack 
images (0.5 µm interval) were combined. Scale bars represent 10 µm. Filopod-like protrusions were 
arrowed. (B) Quantification of relative migration cross the filter (light grey), relative invasion >20 µm 
into collagen I-Matrigel (black), relative release of soluble fluorescein isothiocyanate (FITC) from 
collagenolysis caused by CHL-1 cells within 3D FITC-collagen lattices (white), and relative number 
of filopod-like protrusions per cell (dark gray) in cells expressing GFP/RFP and NT siRNA, GFP/
RFP and siFascin, or GFP/RFP-Xtfascin and mutants, as indicated in the figure. All error bars show 
mean ± SEM. **p < 0.01 by t test.  
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Taken  together,  these  data  suggest  that  actin  bundling  activity  fascin  is 
important  for  the  formation  of  stable  actin-based  degradative  structures 
(invadopodia  on  2D  matrix  and  their  equivalent  in  3D)  and  for  filopod-like 
protrusions that contribute to invasion in 2D and in 3D. Formation of filopodia 
alone was not sufficient for optimal migration in 3D because knockdown of N-
WASP  and  MT1-MMP  reduced  invasion  but  didn’t  reduce  the  formation  of 
filopod-like protrusions.  
 
3.4 Discussion 
3.4.1 Fascin localize with actin at invaodpodia actin comet 
structures 
Invadopodia have been most closely compared with podosomes, which are 
dot-shaped F-actin containing structures found in cells such as osteoclasts, 
endothelial  cells  and  macrophages  (Buccione  et  al.,  2004).  Unlike 
podosomes,  however,  invadopodia  appear  as  highly  dynamic  actin  comet 
structures  similar  to  those  previously  described  on  intracellular  pathogens 
such as Listeria monocytogenes or other bacteria and viruses (Baldassarre et 
al., 2006; Lambrechts et al., 2008).  These comet-like structures also have 
been described on endocytic vesicles in various cells (Fehrenbacher et al., 
2003) and are thought to function in trafficking.  We provide new insight into 
the mechanism of actin dynamics at these comet-like structures.  We show 
that invadopodia comets appear to be tethered and the tail spins somewhat 
reminiscent of a corkscrew (Movie 1 part 1).  We found that Arp2/3 complex 
and cortactin localized largely throughout the actin comet structure, together 
with fascin, whilst N-WASP was localized primarily at the head.  This agrees 
with a model whereby N-WASP orchestrates the activation of Arp2/3 complex 
in  association  with  a  PIP2-rich  membrane  surface  (Caldieri  and  Buccione, 
2010;  Yamaguchi  and  Oikawa,  2010),  forming  an  actin  tail  consisting  of  a 
branched network.  The role of fascin seems to be to stabilize some of the 
actin in the tail of the comet to provide a platform for force production and 
possibly also to aid in the secretion of metalloproteases. 	 ﾠ 138	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3.4.2 Fascin and filopodia proteins are required for 
invadopodia formation 
Our  studies  suggest  that  invadopodia contain  not  only  branched  actin,  but 
also  longer  straight  networks  found  in  fascin  microspikes  and  in  filopodia. 
Diaphanous  related  formins  were  shown  to  be  important  players  in 
invadopodia  assembly  (Lizárraga  et  al.,  2009)  also  supporting  the  role  of 
unbranched  actin  at  these  structures.    Knockdown  of  DRFs1-3  greatly 
reduced  matrix  degradation  and  invadopodia  formation  in  MDA-MB-231 
breast  cancer  cells  and  that  this  also  affected  invasion  of  these  cells  into 
Matrigel.    We  find  that  DRF  proteins,  IRSp53  and  the  related  IRTKS  also 
localize  to  invadopodia,  although  knockdown  of  IRSp53  did  not  prevent 
invadopodia formation in our experiments (Data not shown). It is interesting to 
note that once a network is initiated by Arp2/3 complex, the actin bundling 
activity  of  fascin  can  drive  Listeria  monocytogenes  propulsion  in  vitro, 
producing actin tails with long straight actin filaments (Brieher et al., 2004).  
This implies that actin bundling activity can contribute to protrusive force and 
motility in cells. In addition, recent study using EM revealed a dense array of 
thin filaments resembling actin bundles at the very tip of the protrusions or at 
the  sides  during  elongation  of  invadopodia  (Schoumacher  et  al.,  2010). 
Moreover,  fascin  depleted  cells  form  much  shorter  invadopodia 
(Schoumacher et al., 2010), which strongly support our idea that fascin may 
bind to parallel bundles of slowly exchanging actin filaments that can generate 
force  and  structural  stability  for  invadopodia  over  long  periods  of  time. 
Although  invadopodia  have  properties  of  invasive  filopodia,  since  several 
filopodia-inducing  proteins  are  found  to  have  an  important  role  in  their 
formation and stability, they are clearly different from filopodia, as they contain 
actin comet structures not seen in typical filopodia.  
 
3.4.3 Fascin stablizes actin at invadopodia 
In vitro, fascin forms parallel-polarized bundles of actin filaments and shows a 
very  slow  exchange  rate  compared  with  other  bundling  proteins  such  as 	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alpha-actinin  (Tseng  and  Wirtz,  2004).    Fascin  also  formed  side-branched 
networks in vitro, which is interesting in light of the localization of fascin to 
lamellipodia  and  the  effects  of  fascin  knockdown  on  mesenchymal  type 
motility (Adams et al., 1999).  We found that fascin overexpression increased 
the amount of actin trapped at invadopodia in photobleaching experiments, 
while a decrease in fascin expression increased the mobile fraction of actin 
filaments.  This suggests that in invadopodia, at least some fraction of the 
fascin forms stable actin bundles that do not exhange on the time scale of 
minutes.  This observation is consistent with our observation that most single 
invadopodia persist for more than 10 hours in cultured cells (supplementary 
movies and our unpublished observations).  These structures are distinct from 
what have previously been termed short-lived precursor structures in MTLn3 
cells (Chan et al., 2009; Cortesio et al., 2008; Yamaguchi et al., 2005).  Many 
types  of  actin  puncta  have  been  reported  in  cultured  cells  including  what 
appear  to  be  small  surface  ruffles  and  also  endocytic  events,  so  we  only 
counted invadopodia as degradative structures.  Myosin-II and myosin V can 
drive the sliding of actin-fascin bundles (Ishikawa et al., 2003) suggesting that 
in  filopodia,  myosins  may  drive  retrograde  flow  of  filopodial  actin  bundles 
(Kovar, 2007). Myosin-X is an actin-based motor, which uses its motor activity 
to  move  forward  along  actin  filaments  to  the  tips  of  filopodia.  Intersetly, 
myosin-X  has  been  shown  to  be  required  for  invadopodia  formation 
(Schoumacher et al., 2010). This suggests that myosin-X could work as a 
molecular  motor  transporting  molecule  such  as  VASP  (Tokuo  and  Ikebe, 
2004)  and  possibly  MMPs  to  the  tip  of  invadopodia.  Since  we  found  that 
fascin is required for the degradative function of invadopodia, we speculate 
that fascin bundles may also serve as a platform for cargo transport and the 
secretion of metalloproteases at invadopodia.  
  
3.4.4 Fascin is selectively required for invasion of 
mesenchymal-type cancer cells 
We found that not only was fascin required for invadopodia assembly and 
matrix degradation, but it also impacted significantly on the ability of some 
cancer  cells  to  migrate  into  collagen/matrigel  3D  plugs.    Our  studies  have 	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raised the question of whether mesenchymal cells need invadopodia more 
than amoeboid cells for invasion into 3D matrix.  This is interesting in light of 
other studies showing that cells use a combination of rounded acto-myosin 
based  motility  termed  “amoeboid”  and  elongated  protrusive  motility  termed 
“mesenchymal” (Sahai, 2005; Sahai and Marshall, 2003; Wolf et al., 2003a).  
Mesenchymal motility is defined in some studies as requiring protease activity 
and  involving  Rac1  induced  lamellipodial  protrusions.    We  find  that,  in 
general,  loss  of  fascin  impairs  invasion  of  cells  that  use  primarily 
mesenchymal motility.  Thus, our data suggest that amoeboid cells might not 
need  invadopodia  for  their  invasion  and  agree  with  a  role  for  fascin  in 
protrusions  as  well  as  matrix  invasion  and  degradation.    Interestingly, 
Huttenlocher and colleagues also published that they observed a separation 
between enhanced invadopodia formation and the invasive capacity of cancer 
cells  (Chan  et  al.,  2009).    They  showed  that  FAK  deficient  MTLn3  cells 
showed impaired invasion across Matrigel coated filters, yet had enhanced 
capacity  to  form  invadopodia.    This  likely  reflects  the  complex  nature  of 
invasion,  which  requires  a  fine  balance  of  adhesion,  migration  and  matrix 
remodeling, as well as perhaps that MTLn3 cells use a primarily amoeboid 
mode of motility in 3D gels (Wyckoff et al., 2006). 
Previous studies suggest that cell leading edges are not necessarily major 
places of matrix degradation but rather that degradation happens at lateral 
points  where  the  matrix  restricts  the  cell  movement  and  at  structures  that 
have  been  called  ‘‘lytic  protrusions’’  (Wolf  and  Friedl,  2009).  Some  of  the 
filopod-like protrusions in CHL-1 cells may be involved in matrix remodeling 
because they all contained GFP-MT1-MMP (data not shown). However, our 
data  strongly  suggest  that  matrix  remodeling  promoted  by  ‘‘invadopodia 
equivalents’’  is  more  important  for  efficient  cell  invasion  than  filopod-like 
protrusions.  Attempt  to  identify  "invadopodia  equivalents"  in  3D  was 
unsuccessful as most of antibodies that we use to label invadopodia (anti-
cortactin,  anti-p34)  in  2D  do  not  work  in  3D  collagen  I-matigel  matrix. 
‘‘Invadopodia equivalents’’ may be smaller and more transient in 3D than in 
2D on very stiff matrix, analogous to focal adhesions (Cukierman et al., 2001). 
Moreover, invadopodia formation in cells grown on a 3D dense matrix based 	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on cell-free dermis suggest a different morphology of invadopodia in 2D and 
3D and matrix-degrading activity of invadopoida is localized to the base of 
invadopodia rather than at matrix-penetrating protrusions (Tolde et al., 2010). 
Historically,  invadopodia  were  first  described  as  invasive  finger-like 
protrusions  into  gelatin  beads  (Chen,  1989;  Mueller  and  Chen,  1991),  but 
invadopodia with obvious actin comet tails have not yet been visualized in 3D 
gels. We find that fascin promotes long protrusions in 3D and stabilizes actin 
in  invadopodia  and  that  this  enhanced  stability  allows  for  more  efficient 
invasion by mesenchymal cells, both in 2D and in 3D. 
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Chapter IV 
Rac1 drives melanoblast organization 
during mouse development by 
orchestrating pseudopod-driven motility 
and cell cycle progression. 
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4.1 Summary 
During embryogenesis, melanoblasts proliferate and migrate ventrally through 
the developing dermis and epidermis as single cells. I demonstrate here that 
targeted  deletion  of  Rac1  in  the  melanoblasts  of  developing  mice  causes 
defects in migration, cell cycle progression and cytokinesis.  Rac1 null cells 
migrate  markedly  less  efficiently,  but  global  steering,  crossing  the 
dermal/epidermal  junction  and homing  to  hair  follicles  are  normal.  
Melanoblasts navigate in the epidermis using two classes of protrusion: short 
stubs and long pseudopods.  Short stubs are driven by actin assembly, but 
unexpectedly  are  independent  of  Rac1,  Arp2/3  complex,  myosin  or 
microtubules.    Rac1  positively  regulates  the  frequency  of  initiation  of  long 
pseudopods,  which  promote  migration  speed  and  directional  flexibility. 
Scar/WAVE  and  Arp2/3  complex  drive  actin  assembly  for  long  pseudopod 
extension, which is also microtubule dependent.  Myosin contractility balances 
the extension of long pseudopods by effecting retraction and allowing force 
generation for movement through the complex 3D epidermal environment. 
 
4.2 Introduction 
Mammalian  melanoblasts  are  the  precursor  cells  of  melanocytes;  they 
emerge from the neural tube during embryogenesis, with other neural crest 
cells  and  migrate  and  proliferate  to  populate  the  skin  and  hair  follicles. 
Genetic studies in the mouse have made a considerable contribution to our 
understanding  of  melanoblast  development,  identifying  over  127  genes 
essential to normal pigmentation (Bennett and Lamoreux, 2003). Of the loci 
that  have  been  cloned,  over  one  third  comprise  genes  that  regulate 
melanocyte  development.  Mutations  in  these  genes  often  manifest 
themselves as ‘white-spotting’ phenotypes, as a consequence of defects in 
melanocyte precursor proliferation, survival, migration and/or tissue invasion 
(Baxter  et  al.,  2004).  From  these  studies,  several  molecules  involved  in 
melanoblast pathfinding have been identified, including both receptor tyrosine 	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kinases  (e.g.  Kit)  and  G-  protein-coupled  receptors  (e.g.  Ednrb)  and  their 
ligands  (KitL  and  Endothelin3,  respectively).  However,  how  melanoblasts 
migrate in during development and how these molecules affect melanoblast 
behaviour  are  still  unknown.  Recently,  a  high  power  ex-vivo  microscopic 
method (Mort et al., 2010) became available so that we are now in a position 
to understand the mechanisms of migration of these fascinating cells. 
 
Rac1 is the major ubiquitous isoform of Rac expressed in mammalian tissues, 
with Rac2 being primarily hematopoietic and Rac3 being expressed in some 
regions  of  the  brain  (Didsbury  et  al.,  1989;  Haataja  et  al.,  1997).    Rac1 
controls  assembly  of  the  actin  cytoskeleton  via  a  number  of  signaling 
pathways, the major ones being activation of the Scar/WAVE complex leading 
to Arp2/3 complex mediated actin nucleation (Insall and Machesky, 2009) and 
activation of p21-activated kinase (PAK) and LIM kinase leading to changes in 
cofilin  phosphorylation  and  actin  turnover  (Delorme  et  al.,  2007).    Both  of 
these  pathways  are  thought  to  be  important  in  normal  and  cancer  cell 
migration.  Loss of Rac1 in tissue culture and primary cells leads to a loss of 
lamellipodia and a general reduction of migration speed (Guo et al., 2006; 
McCarty et al., 2005a; Vidali et al., 2006).  Rac1 depletion also reduces focal 
adhesions and stress fibers in mouse embryonic fibroblasts (Delorme et al., 
2007; Guo et al., 2006; Vidali et al., 2006). 
In  vivo,  we  have  limited  knowledge  of  the  role  of  Rac1  in  migration.  
Drosophila  oocyte  border  cells,  which  migrate  through  the  egg  chamber 
collectively  as  a  small  cluster,  are  unable  to  migrate  when  they  express 
dominant negative Rac (Bianco et al., 2007; Duchek et al., 2001; Geisbrecht 
and Montell, 2004; Murphy and Montell, 1996; Wang et al., 2010) and their 
motility  can  be  induced  by  photoactivation  of  a  Rac  analog  (Wang  et  al., 
2010).  Border cells use cadherin-based adhesion to navigate among nurse 
cells and Rac triggers the generation of long protrusions made by leader cells 
during this migration (Bianco et al., 2007; Duchek et al., 2001; Geisbrecht and 
Montell, 2004; Murphy and Montell, 1996).  Likewise, sequestration of Rac1 
activity in zebrafish germ cells inhibits actin brush formation, cell polarity and 
migration  (Kardash  et  al.,  2010).    In  zebrafish  embryos,  neural  crest  cell 	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migration  toward  SDF-1  is  regulated  by  Rac1  (Theveneau  et  al.,  2010). 
Mouse  anterior  visceral  endoderm  (AVE)  cells  also  require  Rac1  for 
protrusion formation and collective migration to the developing anterior side of 
the embryo between days E5.5-6.0 during body axis specification (Migeotte et 
al.,  2010).    Surprisingly,  mouse  neural  crest  cells  do  not  require  Rac1  for 
homing to initial target structures, but Rac1 loss impairs proliferation (Fuchs et 
al., 2009). Thus Rac1 emerges as an important controller of in vivo migration, 
but our mechanistic insight is limited. 
Rac is activated downstream of Ras and can activate JNK1, possibly via Pak 
kinases to stimulate cell cycle progression (Olson et al., 1995).  Both cell-cell 
and  cell-matrix  adhesion  transmit  signals  to  increase  cyclin  D1  levels  for 
progression through the cell cycle and Rac1, together with ERK regulates this 
signaling (Fournier et al., 2008; Klein et al., 2008).  The mechanism by which 
Rac1 controls cyclin D1 mRNA levels is not known. Rac1 is tightly regulated 
in cytokinesis, both temporally and spatially and is inhibited at the cleavage 
furrow by centralspindlin, a GTPase activator (GAP) (Canman et al., 2008). 
No  positive  role  for  Rac1  in  cytokinesis  has  been  demonstrated  to  our 
knowledge. 
In the present Chapter, I have described here an important role for Rac1 in 
migration, proliferation and cytokinesis in mouse embryonic melanoblasts in 
skin ex vivo and revealing an important role for Rac1 as a coordinator of the 
rate of protrusion generation during migration. In addition, Rac1 deletion in 
melanoblasts results inability of cells to mount a Rac – Scar/WAVE – Arp2/3 
mediated protrusion response for migration. Surprisingly, though, Rac1 null 
melanoblasts can still use short stubby protrusions to migrate independently 
of this pathway by a novel actin-driven mechanism.  
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4.3 Results 
4.3.1 Rac1 loss in melanoblasts causes coat color defects, 
indicating impaired migration and proliferation 
To assess the functions of Rac1 in the melanocyte lineage in vivo, we crossed 
mice carrying a floxed allele of Rac1 (Corbetta et al., 2009; Walmsley et al., 
2003) with mice expressing Cre recombinase under control of the tyrosinase 
promoter  (Tyr::Cre)  (Delmas  et  al.,  2003)  (Figure  4.1A)  in  a  C57BL6/J 
background.    Rac1  f/f  Tyr::Cre
+/o  mice  were  born  healthy  at  the  expected 
Mendelian  ratio,  however,  they  were  smaller  than  littermates  and  they 
exhibited tremor (Figure 4.2 and Methods). Recombination was confirmed by 
genomic  PCR,  amplifying  distinct  fragments  for  wild-type,  floxed,  or  null 
alleles of Rac1, respectively (Corbetta et al., 2009).  The Rac1 null allele was 
only  observed  together  with  Tyr::Cre  (Figure  4.1B)  indicating  efficient 
recombination in the melanocytes. 
Rac1  f/f  Tyr::Cre
+/o mice  (n=15)  exhibited  a  distinctive  white  patch  of  hair 
along their ventral region, ranging in size from half to whole the width of the 
mouse underside (Figure 4.3). In addition, more than 80% of the mice had at 
least one white patch along the dorsal midline (Figure 4.3, white arrows) as 
well as white hairs among the black dorsal fur. The limbs and tail in all Rac1 
f/f  Tyr::Cre
+/o  mice  were  also  hypopigmented  (Figures  4.3B  and  C). 
Dopachrome  tautomerase  (Dct),  is  involved  in  the  biosynthesis  of  melanin 
(Tsukamoto et al., 1992). Dct is first expressed in embryonic melanoblasts 
(E10)  and  is  still  expressed  later  in  melanocytes  and  stem  cellsin  adults 
(Nishimura  et  al.,  2002)  thus  can  be  used  as  melanocyte  specific  marker. 
Histological  analysis  of  P14  control  skin  or  black  areas  of  the  Rac1  f/f 
Tyr::Cre
+/o  mice  with  DCT  antibody  showed  melanocytes  in  hair  follicles 
(Figures 4.4A and C), indicating that some melanocytes lacking Rac1 can still 
home  correctly.  Whereas,  no  melanocytes  were  present  in  dorsal  white 
patches or ventral skin of Rac1 f/f Tyr::Cre
+/o mice (Figure 4.4B). Thus, Rac1 
deficiency in melanocytes causes a pigmentation defect resulting from a lack 
of melanocytes in areas distal to their migration origin near the neural tube. 	 ﾠ 147	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Figure 4.1 Rac1 conditional knockout in melanocytes 
(A) Gene targeting strategy for generating Rac1 f/f Tyr::Cre+/o mice. Cre 
recombinase, under control of the tyrosinase promoter, mediates the excision of 
Rac1 in the melanocyte lineage. (B) A representative genotyping assay using 
DNA extracted from melanocyte-rich ear skin for: wild-type (left lane), Rac1 f/f 
Tyr::Cre+/o (middle lane) and Rac1 f/f Tyr::Creo/o (right lane). Sex of mice is 
determined using male-specific maker Sry and universal maker Myog. 	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Figure 4.2 Rac1 f/f Tyr::Cre+/o mice show decreased body size compared to 
control litter mates.
Box plot of quantification of body weight of mice at day 7 (A) and day 14(B). 
Lower quartile, median, and upper quartile are shown. At least 6 mice from 3 
different litters were quantified. **, P< 0.01 compared to control by t-test. 	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Figure 4.3 Rac1 specific deletion in melanocytic cells results in 
hypopigmentation in C57BL6 mice. 
(A) Coat-color of P14 Rac1 f/f Tyr::Cre+/o  (Rac1 f/f) mouse with control 
littermate (Ctr). Left: dorsal side. Right: Ventral side. White arrows point to typical 
dorsal white patches.  (B) Forelimb of P14 Rac1 f/f Tyr::Cre+/o mouse with 
control littermate. (C) Tails of control and Rac1 f/f Tyr::Cre+/o . 	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Figure 4.4 Rac1 f/f Tyr::Cre+/o show absence of melanoblasts in dorsal and 
ventral patches. (A) Dorsal and ventral skin of P14 control and (B) Rac1 f/f 
Tyr::Cre+/o; dorsal skin from white patch and ventral skin with anti-DCT 
(melanocyte). Insets show hair follicles. (C) Dorsal skin (pigmented region) of 
P14 of Rac1 f/f Tyr::Cre+/o were subjected to immunohistochemical analysis with 
antibody against DCT to detect melanocytes. Scale bars 100µm.	 ﾠ 151	 ﾠ
4.3.2 Rac1 null melanoblasts progress towards the normal 
target areas of the embryo, but fail to complete population of 
the embryo skin 
Mouse melanoblasts migrate out of the neural tube around E10 and continue 
to proliferate and migrate to fill the skin by the time of birth. The melanoblast 
distribution was examined to determine whether loss of Rac1 affected number 
and position of melanoblasts between E11.5 and E15.5 using a DCT::LacZ 
transgene (Mackenzie et al., 1997). On E11.5, when the Tyr::Cre is expressed 
(Delmas et al., 2007; Delmas et al., 2003), the number and distribution of 
melanoblasts were similar in control and Rac1 f/f Tyr::Cre
+/o embryos (Figures 
4.5A,  E).  In  E13.5  control  embryos,  the  melanoblast  population  started  to 
expand ventrally (Figures 4.5B, E). By E15.5, melanoblasts colonized almost 
the entire embryo (Figures 4.5C, E). However, by E13.5, there were fewer 
melanoblasts in Rac1 f/f Tyr::Cre
+/o embryos than controls and this difference 
increased  by  E15.5  (Figures  4.5B,  C,  E).  The  E15.5  Rac1  f/f  Tyr::Cre
+/o 
embryos  also  displayed  a  notable  absence  of  melanoblasts  on  both  the 
ventral  region  and  limbs  corresponding  to  the  future  unpigmented  region 
(Figures 4.5C, D). Additionally, Rac1 depleted melanoblasts appeared less 
elongated  than  controls  (Figure  4.6).    Melanoblasts  in  Rac1  f/f  Tyr::Cre
+/o 
failed to cover the entire dorsal midline region on E15.5 accounting for the 
future  dorsal  white  patches  (Figure  4.7).  Furthermore,  Rac1  f/f  Tyr::Cre
+/o 
showed half the normal number of melanoblasts at P0.5 after birth (Figure 
4.8).  Thus,  Rac1  is  important  for  melanoblast  position  and  number  during 
embryogenesis. However, it is also clear that melanoblasts lacking Rac1 can 
still  proliferate,  migrate,  home  to  hair  follicles  and  produce  and  secrete 
melanin to pigment the hair, albeit less efficiently than those expressing Rac1. 
 
4.3.3 Melanoblasts migrate in embryo epidermis with Rac1 
driven long pseudopods and Rac1 independent short stubs 
To investigate the functions of Rac1 in melanoblast migration in vivo, mice  	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Figure 4.5 Loss of Rac1 alters melanoblast number and position from 
E13.5. (A-C) !-galactosidase stained whole mount DCT::LacZ control and Rac1 f/
f Tyr::Cre+/o embryos at E11.5, E13.5 and E15.5. White dot lines in A, B and C 
indicate the trunk regions in which melanoblasts were quantified in box plot as 
shown in (E).  Each image is representative of at least 5 embryos from four 
different litters. (D) Enlarged images of forelimb from E15.5 DCT::LacZ control 
and Rac1 f/f Tyr::Cre+/o embryos. (E) Quantification of melanoblasts in 
DCT::LacZ control and Rac1 f/f Tyr::Cre+/o littermate embryos at E11.5, 13.5 and 
15.5 from (>=5 embryos, 4 litters). Lower quartile, median, and upper quartile are 
shown. **, P< 0.01 by t-test  Scale bars are 1mm.	 ﾠ 153	 ﾠ
 
Ctr Rac1 f/f E15.5
 Figure 4.6 Loss of Rac1 alters melanoblast morphology in vivo. Enlarged 
images of  !-galactosidase stained whole mount E15.5 DCT::LacZ control (left) 
and Rac1 f/f Tyr::Cre+/o (right) embryos trunk regions showing individual 
melanoblasts. Scale bar is 50µm.	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Figure 4.7 Rac1 f/f Tyr::Cre+/o mice show paucity of melanoblasts at the dorsal midline. (A) 
Diagram showing where melanoblasts emerge from the neural tube into the neural crest area (also 
called migration staging area) leaving the dorsal midline devoid of melanoblasts until they commence 
both dorsal (red arrows) and ventral migration (black arrows). (B-F) Images of dorsal side of 
DCT::LacZ control and Rac1 f/f Tyr::Cre+/o embryos at (B) 11.5 (C) E12.5, (D) E13.5, (E) E14.5 and 
(F) E15.5. Note that at E11.5-13.5, melanoblasts were absent from the dorsal midline in both control 
and Rac1 f/f Tyr::Cre+/o embryos. From E14.5 to E15.5, melanoblasts start to migrate into the dorsal 
midline and eventually cover the whole area. However, fewer melanoblasts migrate into dorsal midline 
in Rac1 f/f Tyr::Cre+/o embryos at E14.5, which results in unpopulated patches by E15.5 (white 
arrowed). Scale bars are (B-F) 1mm. 	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Figure 4.8. Loss of Rac1 alters melanocytes number in new born 
pups. (A) Representative images of !-galactosidase stained dorsal 
skin samples DCT::LacZ control (left) and Rac1 f/f Tyr::Cre+/o (right) 
pups at P0.5. Each image is from (>= 3 pups, 3 litters). Insets show 
representative thresholded images used in quantification. (B) Relative 
area covered by melanocytes per image for control and Rac1 f/f 
Tyr::Cre+/o. Data derived from (5 images each from >=3 pups, 3 
litters). Lower quartile, median, and upper quartile are shown. **, P< 
0.01 by t-test. Scale bar is 100µm.	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carrying a Z/EG double reporter transgene (Novak et al., 2000) were crossed 
onto the Rac1 f/f Tyr::Cre
+/o background to allow specific GFP-expression in 
the melanoblast lineage.  E15.5 embryonic trunk skin was then imaged as 
previously described (Mort et al., 2010). Skin explants consisted of epidermis, 
developing hair follicles and part of the dermis with most melanoblasts in the 
epidermis above the basement membrane among the keratinocytes (Movie 
5). GFP-labelled melanoblasts in whole mounted skin explants exhibited an 
elongated  morphology.  They  showed  long  cellular  protrusions  (>cell  body 
width)  traversing  the  regions  in  between  adjacent  keratinocytes  that  had 
microtubule cores with several actin rich tips (Figure 4.9 and Movie 5). 3D 
reconstructions revealed a rounded cell body with frequently one or two long 
protrusions, one of which was in the direction of migration (Figure 4.10, Movie 
5). Melanoblasts and keratinocytes express E-cadherin and use E-cadherin to 
contact each other in the developing mouse embryo epidermis  (Figures 4.9 
and  4.11).  Loss  of  Rac1  did  not  detectably  alter  E-cadherin  localization  in 
Rac1  f/f  Tyr::Cre+/o  melanoblasts  or  melanoblast  position  relative  to 
keratinocyte neighbors (Figure 4.11). Keratinocytes also do not require Rac1 
for adherence junctions in vivo (Benitah et al., 2005; Chrostek et al., 2006). It 
is likely that loss of Rac1 in melanoblasts didn’t completely disrupt their cell-
cell  contacts.  In  summary,  melanoblasts  exhibit  elongated  shape  and  long 
protrusions between neighboring keratinocytes, which are rich in tubulin and 
actin and may use E-cadherin to contact the neighboring keratinocytes. Loss 
of melanoblast Rac1 gives cells a more rounded shape, but does not cause 
any  detectable  defects  in  melanoblast  positioning  in  contact  with 
keratinocytes.	 ﾠ
Live  time-lapse  imaging  of  embryo  skin  explants  revealed  severe  motility 
defects  in  Rac1  null  melanoblasts.    At  any  one  time,  nearly  every  normal 
melanoblast had at least one long protrusion (average 0.9 per cell) compared 
with  average  0.2  per  cell  for  Rac1  nulls  (Figure  4.12A  white  arrows  long 
protrusions, yellow arrows short stub protrusions and Figure 5.12B, Movie 5).  
Around  35%  of  the  Rac1  depleted  melanoblasts  and  only  4%  of  normal 
melanoblasts showed no protrusions (Figure 4.12C).  Long protrusions were 	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Figure 4.9. Epidermal melanoblasts display an elongated shape with 
long protrusions. Combined Z-stack image (1µm depth) of E13.5 Z/EG 
Tyr::Cre+/o control embryo stained with phalloidin, anti-tubulin and DAPI. 
Insets show distal tips (yellow arrowed). All scale bars are 10µm	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Figure 4.10. Epidermal melanoblasts forms long protrusions in skin 
explants. 3D reconstruction of E15.5 GFP-melanoblasts.  Scale bars are 
10µm	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Figure 4.11. Rac1 depleted melanoblast showed normal E-cadherin 
localization. Representative combined Z-stack images (1µm depth) of 
sections from E15.5 control and Rac1 f/f Tyr::Cre+/o embryos stained for 
Collagen IV, E- cadherin, DCT and DAPI. “E” denotes epidermis and “D” 
denotes dermis above and below the red line of collagen IV staining that 
delineates the basement membrane. The insets are shown as X-Y and X-Z 
projections to view the melanoblasts relative to surrounding keratinocytes. 
Scale bar is 10µm.
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Figure 4.12. Loss of Rac1 in melanoblasts reduces the number of long 
protrusions. (A) Combined Z-stack images (1µm depth) of melanoblasts in 
skin explants from Z/EG+/o Tyr::Cre+/o and Z/EG+/o Rac1 f/f Tyr::Cre+/o 
embryos. Long protrusions and short protrusions are white and yellow 
arrowed respectively. (B) Number of long/short protrusions per melanoblast 
n>60 cells per explant >= 3 explants per genotype. (C) Proportion of 
melanoblasts with long/short protrusions. Error bars indicate Mean ± SEM. **, 
P< 0.01, by t-test. Scale bar is 10µm.	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 long-lived,  with  an  average  lifetime  of  1h  (Figure  4.13A  and  B).    The 
protrusions in Rac1 depleted cells were much shorter-lived (Figure 4.13A and 
B) and the rate at which Rac1 depleted cells initiated long protrusions was 
nearly 3-fold decreased (Figure 4.13C, Movie 6). In contrast to Drosophila 
embryos  or  mouse  AVE  cells  where  Rac1  was  required  for  movement 
(Migeotte  et  al.,  2010;  Murphy  and  Montell,  1996)  around  90%  of  Rac1 
depleted  melanoblasts  migrated  despite  having  only  short  stubs  (Figure 
4.14B), although the average speed was around 50% slower than controls 
(Figures 4.14A, C and Movie 6). The formation of short stubs was always 
followed  directly  by  the  translocation  of  the  cell  body  in  Rac1  null 
melanoblasts,  unlike  in  controls  where  short  stubs  elongated  into  long 
pseudopods  and  cells  frequently  changed  direction,  making  them  less 
persistent than Rac1 null cells (Figures 4.14D and Movies 6).  Thus Rac1 null 
cells were impaired in long pseudopod generation leading to a reduction in 
speed  and  protrusion  lifetime.  Rac1  loss  also  decreased  the  frequency  of 
protrusion initiation, indicating a role for Rac1 as an initiator and potentiator of 
protrusion.  
 
4.3.4 The actin dynamics of Rac1 knockout melanoblasts 
migrate in embryo epidermis 
Short stub protrusion formation occurred completely independently of Rac1 
(Figure 4.13 B, C). To distinguish short protrusions from blebs, we created a 
conditional  Lifeact  expressing  mouse  where  we  could  monitor  F-actin 
dynamics specifically in melanoblasts ex-vivo. Blebs arise by a dissociation 
between  the  cell  cortex  and  plasma  membrane,  followed  by  a  gradual 
recruitment  of  actin  and  myosin  and  bleb  retraction  (Charras  and  Paluch, 
2008).  Live  time-lapse  video  of  melanoblasts  expressing  lifeact  driven  by 
Tyr::Cre expression revealed bright flashes of F-actin near the 
tips and in the bodies of both long and short protrusions (Figure 4.15A yellow 
arrows and Movies 7). In contrast, when we added 50µM LY294002, a PI-3- 
kinase  inhibitor,  to  skin  explants,  we  induced  blebbing,  which  could  be 
followed with the lifeact probe (Figure 4.15A and Movie 7). Blebs were clearly  	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Figure 4.13. Loss of Rac1 in melanoblasts reduces lifetime and 
frequency of  long protrusions. (A) Live cell imaging of protrusion dynamics 
in explants. Images captured every 5 min, yellow arrows - protrusions. (B) 
Lifetime of actively growing short/long protrusions formed in 20 cells per 
explant from >= 3 explants. (C) Frequency of short and long protrusion 
formation. Error bars indicate Mean ± SEM. **, P< 0.01, by t-test. Scale bar is 
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Figure 4.14. Loss of Rac1 in melanoblasts decreases the migration speed but 
increases in persistence (A) 3 hr tracks of individual melanoblast migration in 
skin explants, black tracks indicated migrated faster than average control, red 
indicates slower. (B) Speed distribution. >300 melanoblasts from three explants 
were randomly selected and mean migration speed over 3hr was plotted according 
to frequency in the population. (C) Migration speed. (D) Persistance. Error bars 
indicate Mean ± SEM. **, P< 0.01. *, P< 0.05 by t-test. 
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Figure 4.15. The actin dynamics of control and Rac1 depleted melanoblasts in E15.5 
skin explants. (A) !Live cell imaging of F-actin dynamics in GFP- Lifeact f/f Tyr::Cre+/o 
control or GFP-Lifeact f/f Rac1 f/f Tyr::Cre+/o explants or control explant treated with 
50µM Ly294002. Yellow arrows - protrusions/blebs. (B) Frequency of blebs and short 
protrusions (C) Lifetime of blebs and protrusions. Error bars indicate Mean ± SEM. **, P< 
0.01, by t-test. Scale bars are 10µm.
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distinct  in  shape,  as  short  stubs  in  Rac1  null  melanoblasts  often  included 
spiky  protrusions  (Figure  4.15A,  yellow  arrows,  Movie  7).  They  also  had 
distinct actin distribution; Actin accumulated at the neck region (Figure 4.15A, 
15”)  and  then  later  as  they  began  to  retract  actin  accumulated  near  the 
periphery  of  blebs  (Figure  4.15A,  30”),  while  it  was  distributed  throughout 
short  protrusions  (Figure  4.15A  and  Movie  7).  Furthermore  blebs  occurred 
with high frequency (Figure 4.15B) and were much shorter-lived than short 
protrusions (Figure 4.15C). Thus Rac1 null cells were impaired in long but not 
short pseudopod generation leading to a reduction in speed and protrusion 
lifetime.  Rac1  loss  also  decreased  the  frequency  of  long  but  not  short 
protrusion initiation, indicating a role for Rac1 as an initiator and potentiator of 
long protrusions that drive migration. Short stub protrusions are distinct from 
classical blebs and thus emerge as a novel Rac1-independent form of actin-
based  pseudopod.  In  addition,  protusions  formed  by  Rac1  depleted 
melanoblasts also contain tubulin rich core (Figure 4.16), indicated that tubulin 
orientation is not affected by Rac1 deletion. 
 
4.3.5 Rac1 contributes to focal adhesion formation in vitro, 
but is not required for melanoblast contact with the basement 
membrane in vivo. 
It  was  unclear  whether  melanoblasts  in  skin  required  Rac1  for  long 
protrusions because of the environment of the skin or because melanoblasts 
are  somehow  different  from  fibroblasts,  which  require  Rac1  for  wide  fan-
shaped lamellipodia in culture (Delorme et al., 2007; Guo et al., 2006; Vidali et 
al., 2006). Cultured immortalized primary melanocytes from 1-day pups were 
examined  using  conditional  inducible  Rac1  deletion.    Rac1  deletion  was 
induced  with  tamoxifen  analog  4-hydroxytamoxifen  (OHT),  using 
Tyr::CreERT2
+/o  Ink4a-Arf
-/-  Rac1  f/f  melanocytes  plated  on  fibronectin 
(Ackermann et al., 2005; Serrano et al., 1996).  Anti-DCT staining confirmed 
that our cultures were nearly purely melanocytes (Figure 4.17A) and Rac1 
was lost during 4 days of OHT treatment (Figure 4.17B and 4.18A) without  
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Figure 4.16. The actin and tubulin localization is not affected by Rac1 depletion in 
melanoblasts. Combined Z-stack image (1µm depth) of E15.5 GFP-Lifeact f/f Tyr::Cre
+/o control embryo stained with phalloidin, anti-tubulin and DAPI. Insets show distal tips 
(yellow arrowed) and tubulin riched core (white arrowed). (B) Sections from E15.5 
control and Rac1 f/f Tyr::Cre+/o embryo stained with anti-Rac1-GTP, anti-DCT and 
DAPI. All scale bars are 10µm.	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Figure 4.17. Induced Rac1 deletion affects melanocytes morphology. (A) Rac1 f/f 
Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cells (clone#4) on fibronectin coated 
glass coverslips were fixed and stained with rhodamine phalloidin and anti-DCT to 
confirm the purity of melanocytes.  Hela human cervical cancer cells were used as 
negative control for DCT antibody. (B) Immunoblots of cell lysates extracted from OHT 
treated Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cells (#4) as indicated 
were probed with antibody against Rac1 and GAPDH (loading control), which showed 
deletion of Rac1 after 4 days. (C) DMSO or OHT treated Rac1 f/f Tyr::CreERT2+/o 
Ink4a-Arf-/- primary melanocyte cells (#3 and #4) on dished were trypsined and 
subjected to cell size analysis using CASY Cell Counter according to manufacture's 
instruction. (D) DMSO or OHT treated Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- primary 
melanocyte cells (#4) on fibronectin coated glass coverslips were fixed and stained with 
rhodamine phalloidin. (E) Qantification of cell body width/length ratio. Error bars indicate 
Mean ± SEM from 50 cells **, P< 0.01. by t-test. All scale bars are 10µm.
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Figure 4.18. Rac1 controls lamellipodia and stress fiber formation, focal adhesion 
density  in primary mouse melanocytes. (A) DMSO or OHT treated Rac1 f/f 
Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cells (#4) on fibronectin coated glass 
coverslips were fixed and stained with rhodamine phalloidin and anti-Rac1 as indicated. (B) 
DMSO or OHT treated Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cells (#4) 
on fibronectin coated glass coverslips were fixed and stained with rhodamine phalloidin, anti-
p34 and anti-paxillin as indicated. (C) DMSO or OHT treated Rac1 f/f Tyr::CreERT2+/o Ink4a-
Arf-/- primary melanocyte cells (#4) on fibronectin coated glass coverslips were fixed and 
stained with rhodamine phalloidin and anti-Abi1 as indicated.  (D) Enlarged picture of focal 
adhesion (anti-paxillin) from inserts of figure B. (E) Number of focal adhesions in two 
independent primary melanocyte cell lines. More than 50 cells were scored per experiment 
and experiments repeated three times. All error bars indicate Mean ± SEM. **, P< 0.01 by t-
test. All scale bars are 10µm.
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affecting  the  size  of  melanocytes  (Figure  4.17C).    DMSO  treated  control 
melanocytes continuously formed lamellipodia during migration (Figure 4.17D 
and Movie 8) and Arp2/3 complex and Scar/WAVE complex strongly localized 
to lamellipodia protrusions (Figures 4.18B and C). In contrast, Rac1-deleted 
melanocytes  displayed  elongated  cell  morphology  that  lacked  lamellipodia 
(Figures 4.17D, E and 4.18). Expression levels of WAVE complex (WAVE1, 
WAVE2 and Nap1) and Arp2/3 complex (p34) remained unchanged in OHT 
treated  melanocytes  (Figure  4.19).  No  upregulation  of  other  Rac  family 
members  (Rac2  and  Rac3)  (Figure  4.19A)  and  no  alteration  of  activity  of 
Cdc42 and RhoA were observed (Figure 4.20).  Rac1 depleted cells failed to 
form  any  lamellipodia  during  migration  with  absence  Arp2/3  or  WAVE 
complex localization at the periphery (Figure 4.18B, C and Movie 8), they also 
had fewer focal complex/adhesions (Figure 4.18B, D and E), but expression 
of paxillin, vinculin and β1-integrin was unchanged (Figure 4.19A). Migration 
was severely impaired following Rac1 loss (Figure 4.21). However, in vivo the 
same  number  of  control  and  Rac1  deleted  melanoblasts  contacted  the 
basement membrane (BM) at E15.5 (Figures 4.22) indicating that the ability to 
recognize  and  contact  this  structure  is  intact  (Figure  4.22).  Furthermore, 
expression  levels  of  E-cadherin  and  ZO-1  (Figure  4.19A)  and  surface 
expression of E-cadherin were normal in cultured Rac1 depleted melanocytes 
(Figure  4.19B).    Thus,  loss  of  Rac1  in  cultured  melanocytes  parallels 
observations in fibroblasts that lamellipodia and focal adhesions are affected 
(Guo  et  al.,  2006),  but  Rac1  depleted  melanoblasts  can  still  position 
themselves relative to the basement membrane in vivo. The specific nature of 
Rac1  involvement  in  adhesion  in  vivo  requires  further  study,  as  these 
interactions are complex. 
 
4.3.6 Melanoblasts migrate individually in developing skin 
using a novel form of long protrusion based on microtubules 
and Arp2/3 complex 
We further analysed the motility of melanoblasts in live skin explants to  
   	 ﾠ 170	 ﾠ
   
p34 (Arp2/3)(34kDa)
Cortactin (80/85kDa)
#3 #3 #4 #4
OHT + + - -
Rac1 (21kDa)
Rac1/2/3 (21kDa)
Cdc42 (22kDa)
SCAR/WAVE2 (84kDa)
Nap1 (125kDa)
Vinculin (117kDa)
DCT (75kDa)
N-WASP (65kDa)
SCAR/WAVE1 (84kDa)
!1 integrin (88kDa)
E-Cadherin (120kDa)
ZO-1 (220kDa)
RhoA (24kDa)
 Paxillin (68kDa)
p-S19 MLC (18kDa)
E-cadherin IP
E-cadherin Input 1/50
#4 #4
+ - OHT
A
B
Figure 4.19. Levels of various cytoskeletal proteins in melanocytes or skin explants 
following loss of Rac1 or treatment with inhibitors. (A) Cell lysates from two independent 
Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cell lines (#3 and #4) treated with 
DMSO or OHT were separated by SDS-PAGE, transferred to PVDF membranes and probed 
with antibodies as indicated. (B) Cell surface protein from Rac1 f/f Tyr::CreERT2+/o Ink4a-
Arf-/- primary melanocyte cell lines (#4) treated with DMSO or OHT were biotinylated for 15 
mins on ice. Surface E-cadherin and total E-cadherin were probed with E-cadherin antibody.
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Figure 4.20. Rac1 depletion in mouse primary melanocyte had not effect on level of 
active RhoA and Cdc42. Relative levels of active GTP-bound RhoA, Cdc42 and Rac from 
primary melanocyte cell line (#4) treated with DMSO or OHT were measured by use of 
Rhotekin (for RhoA) or Pak1-PBD (for Cdc42 and Rac) domain. Relative levels were 
quantified and the relative intensity of active Rho GTPase (GTP bound) signal was 
normalised to total Rho GTPase. The results shown are the means of three independent 
experiments.  	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Figure 4.21. Rac1 controls  migration speed in primary mouse melanocytes. (A) 
10 hr tracks of individual melanocytes (#4) treated with DMSO or OHT migrate on 
fibronectin coated dish. (B) Random migration speed and (C) Persistance of two 
independent Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cell lines (#3 
and #4) on fibronectin coated glass bottomed dish treated with DMSO or OHT. More 
than 50 cells were scored per experiment and experiments repeated three times. All 
error bars indicate Mean ± SEM. **, P< 0.01, *, P< 0.05 by t-test. 
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Figure 4.22. Rac1 knockout does not affect the proportion of melanoblasts 
contacting the basement membrane Representative combined Z-stack images (1µm 
depth) of sections from E15.5 control and Rac1 f/f Tyr::Cre+/o embryos stained for 
Collagen IV to visualize basement membrane, DCT (melanoblasts) and DAPI (DNA). 
Melanoblasts contacting the basement membrane were yellow arrowed, which those 
contacting the basement membrane were white arrowed. Percentage of melanoblasts 
attached to the basement membrane in control and Rac1 f/f Tyr::Cre+/o embryos. More 
than 200 cells were examined per embryo from at least three embryos for each genotype. 	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understand  more  about  the  molecular  mechanism  of  movement  within  the 
keratinocyte layer. Inhibition of actin polymerization (latrunculin A) or tubulin 
polymerization (nocodazole) nearly completely stopped migration (Figure 4.23 
and 4.24 and Movie 9). Microtubule stabilization with taxol slowed migration 
(Figure  4.24  and  Movie  9).  In  addition,  latrunculin  A  severely  inhibited 
formation  in  both  long  and  short  stub  protrusions,  whereas  nocodazole  or 
taxol only inhibited formation of long protrusions (Figures 4.23 and 4.24 and 
Movie  9).  Long  protrusions  formed  by  melanoblasts  in  skin  are  thus 
fundamentally  different  from  lamellipodia,  in  that  microtubule  dynamics  are 
required  for  normal  protrusion  extension  and  subsequent  cell  translocation 
(Ballestrem et al., 2000; Verkhovsky et al., 1999). However, the mechanism 
by which microtubules act is likely to be complex, as previous studies showed 
that  microtubules  sequester  RhoGEFs,  such  as  GEFH1  and  their 
depolymerization can alter Rho activity and contractility in cells (Redd et al., 
2006; Takesono et al., 2010; Zhou et al., 2010). We therefore tested whether 
inhibiting myosin-II mediated contractility in nocodazole treated melanoblasts 
could  compensate  for  a  possible  increase  in  Rho  activity  caused  by 
microtubule  depolymerization.  Indeed,  the  Rho-kinase  inhibitor  Y27632 
restored the formation of protrusions in melanoblasts in nocodazole treated 
explants and cells cultured in vitro back to the levels seen in wild-type cells 
but  did  not  restore  the  migration  speed  (Figures  4.24  and  Movie  9). 
Furthermore,  long  protrusions  formed  in  the  presence  of  Y27632  and 
nocodazole were devoid of visible microtubules (Figure 4.24G) indicating that 
microtubules do not perform an essential structural role in long protrusions. 
Together,  these  data  indicate  that  actin  and  tubulin  dynamics  are  very 
important  for  melanoblast  migration  in  epidermis,  and  that  microtubule 
depolymerization may trigger RhoA activation in melanoblasts in vivo. 
 
Myosin-II mediated contraction is important for cell body translocation, but not 
for Rac1 mediated lamellipodia assembly in cultured cells (Ponti et al., 2004; 
Vidali  et  al.,  2006).  We  investigated  the  role  of  myosin-II  in  melanoblast 
migration and long protrusion formation using ROCK (Y27632) or myosin II 
inhibitor (Blebbistatin). At the concentrations we used, Y27632 treated skin  	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Figure 4.23. Melanoblast migration and protrusions are regulated by actin.
(A) Combined Z-stack images (1µm depth) of Z/EG+/o Tyr::Cre+/o melanoblasts in skin 
explants treated with inhibitor as indicated. (B) Migration speed. (C) Number of long 
and short protrusions per melanoblast for > 60 cells per explant from >= 3 explants per 
genotype. (D) Proportion of melanoblasts with short or long protrusions. (E) Lifetime of 
actively growing protrusions. (F) Frequency of protrusions formed in 20 cells per 
explant from >= three explants per condition. Error bars indicate Mean ± SEM. **, P< 
0.01. *, P<0.05 by t-test. Scale bar 10µm.
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Figure 4.24. Melanoblast migration and protrusions are regulated by microtubules
(A) Combined Z-stack images (1µm depth) of Z/EG+/o Tyr::Cre+/o melanoblasts in skin explants 
treated with inhibitor as indicated. (B) Migration speed. (C) Number of long and short protrusions per 
melanoblast for > 60 cells per explant from >= 3 explants per genotype. (D) Proportion of 
melanoblasts with short or long protrusions. (E) Lifetime of actively growing protrusions. (F) 
Frequency of protrusions formed in 20 cells per explant from >= three explants per condition. (G)
Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- (#4) primary melanocytes treated with DMSO or Y27632 or 
nocodazole or both Y27632 and nocodazole were plated on 3D collagen I matrix. Cells were stained 
with rhodamine phalloidin, anti-tubulin and DAPI. Yellow arrows indicate accumulation of tubulin in 
protruions (for DMSO and Y27632) or in cell body (Y27632+nocodazole). (H) % cells with elongated 
morphology and (I) Number of protrusions per cell for >300 cells x 3 repeats. Error bars indicate 
Mean ± SEM. **, P< 0.01, *, P< 0.05 by t-test. Scale bar 10µm. 	 ﾠ 177	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explants exhibited a reduction in myosin light chain phosphorylation (Figure 
4.25A) without any obvious change in keratinocyte actin structure or tissue 
integrity (Figure 4.25B). Both Y27632 and Blebbistatin caused a near halt in 
melanoblast  migration  (Figures  4.25D),  but  a  significant  increase  in  the 
number of both short stubs and long apparently thinner protrusions (Figures 
4.25C,  E,  F  and  Movie  9).  Protrusion  formation  occurred  with  the  same 
frequency  as  in  controls  (Figure  4.25G)  but  protrusions  were  about  2-fold 
longer lived (Figure 4.25H). Thus, myosin II activity is not required for the 
initiation  of  protrusions  but  is  important  for  the  retraction  dynamics  of 
protrusions  and  for  melanoblast  translocation  among  keratinocytes  in 
epidermis. 
To  test  whether  high  contractility  in  Rac1  depleted  melanoblasts  might  be 
inhibiting protrusion formation, we inhibited Rho-kinase with Y27632.  These 
cells showed even slower migration than untreated Rac1 depleted or Y27632 
treated control explants (Figure 4.25D, Movie 9), but they displayed a similar 
number of long protrusions to control cells with Rac1 (Figure 4.25C, D and E).  
These protrusions were around 2-fold longer-lived than controls (Figure 5E).  
Cell migration was mostly halted (Figure 4.25H, Movie 9).  Importantly, long 
protrusions in Rac1 depleted cells formed with a 3-fold lower frequency than 
controls, regardless of myosin inhibition (Figure 4.25G, Movie 9) and inhibiting 
myosin  didn’t  increase  the  frequency  of  protrusion  formation  in  normal 
melanoblasts (Figure 4.25G).  We also did not see any obvious difference in 
myosin  light  chain  phosphorylation  between  normal  and  Rac1  null 
melanocytes  in  vitro  (Figure  4.19A).    Thus,  Rac  and  myosin  are  not 
apparently opposing each other, but rather when Rac is active, myosin-based 
contractility  mediates  protrusion  retraction  and  enables  long  protrusions  to 
generate  force  for  movement.    When  Rac  is  not  present,  long  protrusions 
rarely  form  and  if  they  do  form,  they  are  weaker  and  less  resistant  to 
contractile  forces.    Thus  Rac  controls  the  rate  of  protrusion  formation  and 
myosin  controls  contractility  that  mediates  retraction  as  well  as  generating 
pulling and squeezing forces for motility. 
Pak kinases have been implicated in motility downstream of Rac1 (Edwards 	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Figure 4.25. Melanoblast migration and protrusions are regulated myosin (A) Western 
blots of lysates extracted from skin explants treated with either DMSO or drug as indicated. 
Blots were then probed with antibody as indicated. (B) Confocal images of E15.5 epidermis 
from Z/EG+/o Tyr::Cre+/o explants treated with drugs as indicated for 5 hr. the explants were 
fixed and stained with rhodamine phalloidin and DAPI. (C) Combined Z-stack images (1µm 
depth) of Z/EG+/o Tyr::Cre+/o control or Z/EG+/o Rac1 f/f Tyr::Cre+/o (Rac1 f/f) 
melanoblasts in skin explants treated with inhibitor as indicated. (D) Migration speed. (E) 
Number of long and short protrusions per melanoblast for > 60 cells per explant from >= 3 
explants per genotype. (F) Proportion of melanoblasts with short or long protrusions. (G) 
Frequency of protrusions formed in 20 cells per explant from >= three explants per 
condition. (H) Lifetime of actively growing protrusions.  Error bars indicate Mean ± SEM. **, 
P< 0.01. *, P<0.05 by t-test. Scale bar 10µm.	 ﾠ 179	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 et al., 1999; Smith et al., 2008; Yang et al., 1998), so we explored the role of 
the conventional PAKs 1-3 (group I Paks) and their downstream targets in 
migration. Treatment of skin explants with Pak inhibitor (IPA-3) (Deacon et al., 
2008) and its downstream targets LIM kinase (LIMKi) (Scott et al., 2010) and 
ERK (U0126, a MEK1/2 inhibitor that inhibits ERK1/2 activation) showed no 
effect on melanobast motility despite reducing phosphorylation of their targets 
in skin explants (Figure 4.26, Movie 9 and data not shown). In addition, siRNA 
knockdown of Pak2, the only group I Pak isoform expressed in melanocytes 
(Figures  4.27A  and  B),  did  not  change  melanocyte  morphology  on  3D 
collagen  I  matrix  (Figure  4.27C  and  Movie  10).  Furthermore,  despite  the 
decrease in Pak2 and ERK phosphorlyation in our melanocyte cell lines (#3 
and  #4)  in  vitro  (Figure  4.27D),  we  found  no  detectable  changes  in 
phosphorlylation  of  LIMK  effector  cofilin  between  DMSO  and  OHT  treated 
melanocytes (Figure 4.27F). Thus, Rac1 regulates melanoblast migration in 
epidermis and formation of long protrusions through pathways other than Pak 
or its downstream targets. 
The main effector of actin nucleation downstream of Rac is the Scar/WAVE 
complex;  it  activates  Arp2/3  complex  to  induce  branched  actin  assembly. 
Since  we  could  not  use  a  pharmacological  inhibitor  of  Scar/WAVE,  RNA 
interference was used to knock down Arp2/3 complex (p34 siRNA), WAVE 
complex (Nap1 siRNA) in primary melanocytes in vitro.  Knockdown of p34 or 
Nap1,  which,  for  Nap1,  also  caused  significant  reduction  of  expression  of
 
other WAVE complex constituents (Figures 4.28A and B), however, caused a 
dramatic  morphological  change  similar  to  loss  of  Rac1  or  Arp2/3  complex 
(Figures 4.28C Movie 10) in 3D. We also investigated the function of Arp2/3 
complex  in  melanoblast  migration  by  treating  skin  explants  with  inhibitor 
against  Arp2/3  complex  (CK-869)  (Nolen  et  al.,  2009).    CK-869  reduced 
melanoblast  migration  in  explants  without  affect  keratinocyte  actin 
organization  (Figure  4.29A  and  C).  The  control  compound  CK-312  had  no 
effect  (Figure  4.29B-G  and  Movie  9).  In  addition,  melanoblasts  in  CK-869 
treated explants resembled Rac1 deleted cells with significant reduction in the 
formation of long but not short stub protrusions (Figures 4.29B, D and E). The 
frequency of protrusion initiation and lifetime of each protrusion was also  	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Figure 4.26. PAK signaling is not required for melanoblast migration and formation of  
protrusions (A) Western blots of lysates extracted from skin explants treated with either 
DMSO or drug as indicated. Blots were then probed with antibody as indicated. (B) 
Combined Z-stack images (1µm depth) of Z/EG+/o Tyr::Cre+/o control or Z/EG+/o Rac1 f/f 
Tyr::Cre+/o (Rac1 f/f) melanoblasts in skin explants treated with inhibitor and/or of genotype 
as indicated. (C) Migration speed. (D) Number of long and short protrusions per melanoblast 
for > 60 cells per explant from >= 3 explants per genotype. (E) Proportion of melanoblasts 
with short or long protrusions. (F) Lifetime of actively growing protrusions. (G) Frequency of 
protrusions formed in 20 cells per explant from >= three explants per condition. Error bars 
indicate Mean ± SEM.  Scale bar 10µm.	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Figure 4.27. Pak2 is not required for formation of long protrusions of primary 
murine melanocytes  (A) Immunoblots of primary mouse melanocytes transfected with 
NT, Pak1 and Pak2 siRNA. The same blot was probed with anti-Pak1, anti-Pak1/2/3 
and anti-GAPDH as loading control. NIH3T3 mouse fibroblast lysate was used as 
positive control for Pak1.  (B) Immunoblots of  Pak2 siRNA treated melanoblasts probed 
with anti-Pak2 and anti-GAPDH as loading. (C) Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- 
(#4) primary melanocytes treated siRNA as indicated on collagen I, showing actin 
(phalloidin), microtubules (anti-tubulin) or DNA (DAPI) (D) % cells with elongated 
morphology and (E) Number of protrusions per cell for >300 cells x 3 repeats. Error 
bars indicate Mean ± SEM. (F) Cell lysates from two independent Rac1 f/f 
Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cell lines (#3 and #4) treated with 
DMSO or OHT were separated by SDS-PAGE, transferred to PVDF membranes and 
probed with antibodies as indicated. Scale bar 10µm.
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Figure 4.28. Primary murine melanocytes cultured on collagen require the Rac1-WAVE-
Arp2/3 pathway for long protrusions. (A) Immunoblots of NT or p34-Arc.siRNA treated 
melanoblasts probed with p34-Arc and GAPDH antibody. (B) Immunoblots showing 
knockdown of Nap1 in melanocytes; anti-WAVE1 and anti-WAVE2 show the loss of WAVE 
complex. GAPDH was probed as loading control. (C) Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- 
(#4) primary melanocytes treated with OHT or siRNA as indicated on collagen I, showing actin 
(phalloidin), microtubules (anti-tubulin) or DNA (DAPI) (D) % cells with elongated morphology 
and (E) Number of protrusions per cell for >300 cells x 3 repeats. Error bars indicate Mean ± 
SEM. **, P< 0.01 by t-test. Scale bar 10µm.
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Figure 4.29. Arp2/3 complex is required for melanoblast migration and formation of  
protrusions (A) Confocal images of E15.5 epidermis from Z/EG+/o Tyr::Cre+/o explants 
treated with drugs as indicated for 5 hr. the explants were fixed and stained with rhodamine 
phalloidin and DAPI. (B) Combined Z-stack images (1µm depth) of Z/EG+/o Tyr::Cre+/o 
melanoblasts in skin explants treated with inhibitor as indicated. (C) Migration speed. (D) 
Number of long and short protrusions per melanoblast for > 60 cells per explant from >= 3 
explants per genotype. (E) Proportion of melanoblasts with short or long protrusions. (F) 
Lifetime of actively growing protrusions. (G) Frequency of protrusions formed in 20 cells per 
explant from >= three explants per condition. Error bars indicate Mean ± SEM. **, P< 0.01. 
Scale bar 10µm.	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decreased (Figures 4.29F and G).  Surprisingly, this indicates that short stub 
protrusions form independently of Arp2/3 complex, but that Scar/WAVE and 
Arp2/3 are the major effectors driving actin dynamics in long protrusions. 
In addition to Scar/WAVE, Arp2/3 complex can also be activated by N-WASP 
to  drive  efficient  invasive  cell  migration  (Insall  and  Machesky,  2009; 
Machesky, 2008) and N-WASP is robustly expressed in primary melanocytes 
(Figure  4.19A).  Surprisingly,  melanoblasts  lacking  N-WASP  in  Z/EG
+/o  N-
WASP f/f Tyr::Cre
+/o explants (Snapper et al., 2001) showed no difference in 
migration and formation of long protrusions as compared with melanoblasts in 
Z/EG
+/o Tyr::Cre
+/o control explants (Figure 4.30 and Movie 9).  Additionally, 
the  Tyr::Cre  deletion  of  N-WASP  revealed  no  coat  color  changes  in  a 
C57Bl6/J  background  (Figure  4.31A)  and  the  number  and  position  of 
melanoblasts in E15.5 DCT::LacZ N-WASP f/f Tyr::Cre
+/o  embryos showed 
no  differences  to  control  (Figure  4.30B-E),  indicating  normal  melanocyte 
lineage function in the absence of N-WASP.  Furthermore, depletion of N-
WASP  in  melanocytes  in  vitro  did  not  alter  melanocyte  morphology  in  3D 
(Figures  4.32  and  Movie  10).  In  summary,  Rac1  regulates  melanoblast 
migration in epidermis and formation of long protrusions through Scar/WAVE 
and Arp2/3 mediated actin assembly and independently of N-WASP. 
 
4.3.7 Melanoblast motility across the basement membrane 
and in skin is not invasive 
We were surprised that loss of N-WASP did not produce any apparent defects 
in  melanoblast  migration  in  the  skin  and  it  raised  the  question  of  whether 
melanoblasts use invasive matrix degrading migration during embryogenesis. 
N-WASP and Rac are essential for the formation of invadopodia by melanoma 
cells  and  for  invasion  of  cultured  cells  into  collagen  gels  (Li  et  al.,  2010; 
Nakahara et al., 2003; Yamaguchi et al., 2005).  To further explore the idea 
that  melanoblast  migration  in  skin  is  not  invasive,  we  examined  if 
metalloprotease (MMP) is required for the formation of long protrusions and 
migration of melanoblasts by treating the Z/EG
+/o Tyr::Cre
+/o control skin 	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Figure 4.30. N-WASP is not required for melanoblast migration and formation of  
protrusions (A) Combined Z-stack images (1µm depth) of Z/EG+/o N-WASP f/f Tyr::Cre+/o 
melanoblasts in skin explants (B) Migration speed. (C) Number of long and short protrusions 
per melanoblast for > 60 cells per explant from >= 3 explants per genotype. (D) Proportion of 
melanoblasts with short or long protrusions. (E) Lifetime of actively growing protrusions. (F) 
Frequency of protrusions formed in 20 cells per explant from >= three explants per condition. 
Error bars indicate Mean ± SEM. Scale bar 10µm.	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Figure 4.31. N-WASP f/f Tyr::Cre+/o mice revealed normal coat colour and distribution of 
melanoblasts  (A) Ventral coat-color of P14 N-WASP f/f Tyr::Cre+/o mouse. Inset shows hind 
limb. (B) !-galactosidase stained whole mount DCT::LacZ control (left) and N-WASP f/f Tyr::Cre
+/o (right) embryos at E15.5. White dot lines in B indicate the trunk regions in which 
melanoblasts were quantified in box plot as shown in (E).  Each image is representative of 4 
embryos from two different litters. (C) Enlarged images of E15.5 trunk regions showing individual 
melanoblasts. (D) Enlarged images of forelimb from E15.5 DCT::LacZ control (left) and N-WASP 
f/f Tyr::Cre+/o (right) embryos. (E) Quantification of melanoblasts in DCT::LacZ control and N-
WASP f/f Tyr::Cre+/o littermate embryos at E15.5 from 4 embryos from 2 different litters. Lower 
quartile, median, and upper quartile are shown. Scale bars are (B, D) 1mm, (C) 50µm.	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Figure 4.32. N-WASP is not required for formation of long protrusions in primary 
murine melanocytes  (A) Immunoblots showing knockdown of N-WASP in primary mouse 
melanocytesGAPDH - loading control. (B) Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- (#4) 
primary melanocytes treated N-WASP siRNA as indicated on collagen I, showing actin 
(phalloidin), microtubules (anti-tubulin) or DNA (DAPI) (C) % cells with elongated 
morphology and (D) Number of protrusions per cell for >300 cells x 3 repeats. Error bars 
indicate Mean ± SEM. **, P< 0.01 by t-test. Scale bar 10µm.
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 explants with MMP inhibitor (GM6001). However, long protrusions and cell 
migration speed were not affected (Figures 4.33 and Movie 9), indicating that 
MMPs are not required for melanoblast migration in the epidermis. 
During  mouse  embryogenesis,  melanoblasts  migrate  from  dermis  to 
epidermis between E11.5 and E13.5 and this involves crossing the embryonic 
epidermal BM (Figure 4.34A).  This is potentially a step in migration where 
melanoblasts would need to use invasive migration.  However, the lack of a 
pigmentation  defect  (Figure  4.30)  in  the  Tyr::Cre
+/o  N-WASP  f/f  mouse 
suggests that melanoblasts do not need invadopod-like structures mediated 
by N-WASP either for migration or for crossing the embryonic BM. To confirm 
this, the trunk region of X-gal stained Dct::LacZ control, Rac1 f/f Tyr::Cre
+/o 
and  N-WASP  f/f  Tyr::Cre
+/o  embryos  were  sectioned  and  the  proportion  of 
melanoblasts  in  the  three  distinct  skin  layers:  dermis,  epidermis  and 
epidermal/dermal  junction  of  the  skin  tissue  sections  was  determined.  On 
E13.5 and E15.5, the relative distribution of melanoblasts within each of the 
skin  layers  did  not  differ  significantly  between  Rac1  depleted  or  N-WASP 
depleted or control embryos (Figures 4.34B, C). Thus, melanoblast migration 
from dermis to epidermis is unaffected by loss of Rac1 or N-WASP. 
 
4.3.8 Rac1 is required for normal cell cycle progression of 
melanoblasts during embryogenesis 
It was clear that melanoblast position in developing embryos was affected by 
the loss of Rac1 due to defects in migration, but we also observed a decrease 
in the number of melanoblasts that required further investigation. The number 
of melanoblasts undergoing the cell-cycle or apoptosis were determined by 
co-expression  of  DCT  (melanoblast)  and  Ki67  (proliferation)  or  cleaved 
caspase3 (CC3, apoptosis) in E15.5 control or Rac1 f/f Tyr::Cre
+/o embryos. 
The  average  percentage  of  melanoblasts  expressing  either  Ki67  or  CC3 
between control and Rac1 depleted sections was not significantly changed 
(Figure 4.35A and data not shown), indicating that melanoblast reduction in  	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Figure 4.33. Metalloproteases is not required for melanoblast migration and formation 
of  protrusions (A) Combined Z-stack images (1µm depth) of Z/EG+/o Tyr::Cre+/o 
melanoblasts in skin explants treated with 10µM GM6001. (B) Migration speed. (C) Number 
of long and short protrusions per melanoblast for > 60 cells per explant from >= 3 explants 
per genotype. (D) Proportion of melanoblasts with short or long protrusions. (E) Lifetime of 
actively growing protrusions. (F) Frequency of protrusions formed in 20 cells per explant 
from >= three explants per condition. Error bars indicate Mean ± SEM. Scale bar 10µm.	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Figure 4.34. Rac1 or N-WASP knockout does not affect melanoblast migration from 
dermis to epidermis (A) Dorsolateral pathway Melanoblasts migrate from dermis to 
epidermis and finally hair follicles from E9.5 to E17.5. Image adapted from http://
php.med.unsw.edu.au/embryology/index.php?title=Neural_Crest_Development. (B) 
Images of sections and quantification of localization of melanoblasts in E13.5 DCT::LacZ 
control and Rac1 f/f Tyr::Cre+/o embryos. (C) Images of stains and quantification of 
localization of melanoblasts in E15.5 DCT::LacZ control, , Rac1 f/f Tyr::Cre+/o and N-
WASP f/f Tyr::Cre+/o embryos. More then 200 cells were examined per embryo from at 
least three embryos for each genotype. Melanoblasts are black arrowed. Black dot lines 
in each picture represent the epi/dermal junction. Scale bars are (B and C) 20µm. 
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Figure 4.35. Rac1 is required for melanoblast cell cycle progression in vivo. (A-D) 
Representative images of sections from E15.5 control (left) and Rac1 f/f Tyr::Cre+/o (right) 
embryos stained for anti-Ki67 (proliferation) (A), anti-BrdU (proliferation) (B and C) or anti-
PH3 (phospho-histone 3, mitosis) (D) with anti-DCT (melanoblast) and DAPI (DNA).  The 
DCT-positive cells expressing Ki67, BrdU or PH3 are yellow arrowed and DCT-positive cells 
that do not co-localize with Ki67, BrdU or PH3 are white arrowed. Proportions of DCT and 
Ki67, BrdU or PH3 positive cells are shown. At least 3 embryos per genotype and 200 cells 
per embryo analyzed. Error bars indicate Mean ± SEM. **, P< 0.01 *, P<0.05 by t-test. 
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Rac1 f/f Tyr::Cre
+/o embryos is not a consequence of reduced numbers of 
cells undergoing the cell cycle or apoptosis. Next, we examined whether loss 
of Rac1 induced a cell cycle progression defect in melanoblasts. We observed 
a significant decrease in BrdU incorporation into Rac1 depleted melanoblasts 
when animals were given either a 2hr or 24hr pulse before sacrifice (Figures 
4.35B  and  C).  Furthermore,  there  was  a  significant  reduction  in  the 
percentage  of  phospho-histone  3  (PH3,  mitosis)  positive  melanoblasts  in 
Rac1  f/f  Tyr::Cre
+/o  embryos  (Figure  4.35D).  Consistent  with  in  vivo 
observations, the growth rate of OHT treated melanocyte cell lines #3 and #4 
(Tyr::CreERT2
+/o Ink4a-Arf
-/- Rac1 f/f) was significant decreased compared to 
their  DMSO  treated  control.  Whereas,  growth  rate  and  cell  morphology  of 
OHT treated control melanocyte cell line #2 (Tyr::CreERT2
o/o Ink4a-Arf
-/- Rac1 
f/f) was unaffected (Figures 4.36A, B  and data not shown). Flow cytometry 
analysis of Rac1 knockout melanocytes showed shifting to the G1 phase with 
a significant reduction of cells in S phase as compared to control (Figures 
4.36C,  D).  Thus,  Rac1  is  required  for  normal  G1-S  phase  cell  cycle 
progression but not cell cycle entry or prevention of apoptosis in melanoblasts 
in vivo. 
 
4.3.9 Rac1 is required for efficient cytokinesis of melanoblasts 
during embryogenesis 
Time-lapse  videos  revealed  alterations  in  cytokinesis  of  Rac1  deficient 
melanoblasts  that  likely  also  contribute  to  growth  rate  slowing.	 ﾠ	 ﾠNormal 
melanoblasts  in  Z/EG
+/o  Tyr::Cre
+/o  control  explants  undergo  very  efficient 
cytokinesis in skin explants , taking about 10 minutes to first show a cleavage 
furrow and about 30min from the initiation of furrowing to the separation of two 
daughter cells (Figures 4.37A, B). Interestingly, Rac1 depleted melanoblasts 
formed a furrow with normal timing, but exhibited a 3- fold delay in time to 
separation  (Figures  4.37A,  B  and  Movie  11)  and  the  two  daughter  cells 
migrated  apart  more  slowly  (Figure  4.37C).  Despite  the  strong  delay  in 
cytokinesis, Rac1 f/f Tyr::Cre+/o melanoblasts did not become multinucleate 
(data not shown) indicating that Rac1 is not essential for cytokinesis but  	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Figure 4.36. Rac1 is required for melanocyte cell cycle progression in vitro. (A) 
Western blots of lysates from Rac1 f/f Tyr::CreERT2o/o Ink4a-Arf-/- (#2) and two 
independent Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cell lines (#3 
and #4) treated with DMSO or OHT probed with anti-Rac1 and anti-GAPDH (loading 
control). (B) Growth curve of melanocyte cell lines (#2, #3 and #4) treated with DMSO 
or OHT. Each point (Mean ± SEM) is derived from 3 replicate dishes from 3 
independent experiments. (C) Representative experiment from Rac1 f/f 
Tyr::CreERT2+/o Ink4a-Arf-/- (#4) melanocytes treated with DMSO or OHT were 
pulse-labeled for 2 h with BrdU, and analyzed by flow cytometry for BrdU 
incorporation and propidium iodide (PI) labeling. Cells in the different states are 
indicated. (D) % cells in each phase as calculated from (C). Results are from 3 
independent experiments. Error bars: Mean ± SEM. **, P< 0.01 by t-test. Scale bar 
10µm.	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Figure 4.37. Rac1 knockout in melanoblasts delays cytokinesis in skin explants. (A) 
Representative live-cell imaging of melanoblasts in Z/EG+/o Tyr::Cre+/o control,  Z/EG+/o Rac1 f/
f  Tyr::Cre+/o skin explants undergo cytokinesis. Images were captured every 5 min. Time-point 
of the initiation of furrowing was yellow squared, Time-point in which two daughter cells 
separated was red squared. (B) The duration or cytokinesis, from initiation of furrowing to 
separation of two daughter cells. Error bars indicate Mean ± SEM of 20 cells from 10 divisions. 
**, P< 0.01 by t-test. (C) Quantification of migration speed of daughter melanoblasts in the skin 
explants for 1 hr after cytokinesis. 20 daughter melanoblasts from 10 divisions were examined. 
All error bars indicate Mean ± SEM **, P< 0.01 by t-test. Scale bar 10µm.	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required for efficient daughter cell separation in vivo. To see if the cytokinesis 
defect  also  exists  in  vitro,  control  and  Rac1  depleted  melanocytes  were 
subjected for live time imaging. Interestingly, no obvious delay of cytokinesis 
was  found  in  Rac1  depleted  melanocytes  on  2D  cell  culture  dish  (Figure 
4.38). Together, these data suggest a more significant requirement for Rac to 
control cytokinesis in the tissue environment than in culture dishes. 
 
4.4 Discussion 
4.4.1 Melanoblasts move using a mixture of short Rac1-
independent and long Rac1-dependent protrusions. 
Melanoblasts extend a mixture of long and short protrusions in skin and short 
protrusions  mature  into  long  ones.    Short  stubby  protrusions  require  actin 
assembly  but  not  microtubules,  myosin  or  components  of  the  Rac-
Scar/WAVE-Arp2/3 pathway.  They might initiate by stochastic actin assembly 
reactions  that  are  normally  cycling  in  the  melanoblasts  (Betz  et  al.,  2009; 
Michelot et al., 2007) or by some form of signaling.  A candidate to signal 
short protrusion initiation might be Rho, which was found to precede Rac in 
motile cultured cells (Pertz et al., 2006) and downstream might lie diaphanous 
related formins (DRFs), to initiate formation of unbranched actin networks that 
could later serve as a platform for Arp2/3 mediated actin assembly.  DRFs are 
attractive  candidates,  since  they  also  coordinate  actin  and  microtubule 
assembly and dynamics (Palazzo et al., 2001). Indeed, expression of GFP-
mDia1 or GFP- mDia2 in normal and Rac1 null melanocytes on 3D collagen I 
matrix showed localization at tips of long and short protrusions (Figure 4.39). 
However,  further  studies  are  required  to  elucidate  the  role  of  formins  in 
melanoblast motility. Treatment of skin explants with broad formin inhibitor 
(SMIFH2) (Rizvi et al., 2009) resulted in massive cell death within half hour 
incubation even at 100nM inhibitor (Data not shown), indicating that formin 
function may be crucial for melanoblast survival or that this inhibitor is toxic to 
our skin explants. In the future, we hope to understand the role of individual  	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Figure 4.38. Rac1 deletion in mouse primary melanoblasts does not affect cytokinesis in 
vitro. (A) Representative stills from live-cell imaging of DMSO or OHT treated Rac1 f/f 
Tyr::CreERT2+/o Ink4a-Arf-/- primary melanocyte cells (#4) in culture on fibronectin coated 
coverslips undergoing cytokinesis. Images were captured every 10 min. Initiation of furrowing is 
yellow squared; Daughter cell separation point is red squared. (B) Quantification of the duration 
of cytokinesis from initiation of furrowing to separation of two daughter cells. Error bars indicate 
Mean ± SEM of 20 cells from 10 divisions. Scale bars 10µm.
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Figure 4.39 Localization of mDia2 to short protrusions. Rac1 f/f Tyr::CreERT2+/o Ink4a-Arf-/- 
(#4) primary melanocytes expressing GFP- mDia1, GFP-mDia2, GFP-p21-Arc or GFP-N-WASP 
treated with DMSO or OHT as indicated were plated on 3D collagen I matrix. Cells were stained with 
rhodamine phalloidin and DAPI. Yellow arrows indicate co-localization of GFP- tagged protein and 
actin at tips of protrusions. Scale bar is 10µm.	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formins in melanoblast motility using mouse genetic experiments. Additionally, 
Small and colleagues propose that lamellipodial protrusions can be driven by 
proteins  such  as  Mena/VASP,  which  can  support  extension  of  actin-based 
unbranched networks (Urban et al., 2010). It remains to be determined the 
relative roles of other actin network inducing proteins in stub protrusions. Our 
data suggest that short stubs are distinct from blebs (Fackler and Grosse, 
2008), as they generally are thin and spiky or jagged in shape (rather than 
lobule-shaped  like  blebs)  and  they  are  rich  in  dynamic  filamentous  actin, 
similar to longer protrusions. Short stubs are thus novel Rac1 independent 
actin structures that can act as precursors to long pseudopods and might not 
occur on rigid flat substrates, where lamellipodia dominate. 
 
Melanoblast  long  protrusions  required  on  actin,  microtubules  and  the  Rac-
Scar/WAVE-Arp2/3  pathway,  but  not  myosin.    Long  protrusions  traversed 
between keratinocytes, often spanning the length of 2 or 3 keratinocytes and 
existing in multiple planes, appearing to contact keratinocytes all over their 
surfaces.  Melanoblast  long  protrusions  have  in  common  with  neurite 
processes that they are microtubule-rich and have actin-rich tips.  However, 
while  Rac1  and  the  Scar/WAVE  complex  are  important  for  lamellipodia  of 
neuronal growth cones, the growth of long microtubule-rich processes from 
neuronal cells in culture wasn’t ablated by loss of Rac1 or inhibition of Arp2/3 
complex (Strasser et al., 2004; Tahirovic et al., 2010).  A cell type that might 
be comparable to melanoblasts for migration in vivo is chick embryo muscle 
precursor,  which  migrates  from  somites  into  the  limb  bud.    Horwitz  and 
colleagues showed that these cells extend long stable protrusions similar in 
lifetime to melanoblasts (50 min vs 60 min in our study) and migrate with 
similar average speed (37µm/hr vs 30µm/hr in our study).  They also found 
that dominant negative Rac stopped migration and limited protrusion (Knight 
et al., 2000). 
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4.4.2 Rac1 controls the frequency of long pseudopod 
extension 
We  were  surprised  that  overall  migration  and  directional  steering  of 
melanoblasts occurred normally in the majority of dorsal areas of the mouse 
skin.  It was also unexpected that when myosin was inhibited, Rac1 was no 
longer required for long pseudopod generation; but it still strongly controlled 
the frequency of generation of long pseudopods.  This only became apparent 
when  we  inhibited  myosin  activity  in  skin  explants  by  adding  Y27632  or 
blebbistatin, so it might be interesting to apply these compounds to Drosophila 
border  cells  or  Rac1  deficient  AVE  cells.  Scar/WAVE  and  Arp2/3  complex 
might be able to generate long pseudopodia in a Rac-independent manner in 
the  case  where  cortical  tension  and  contractility  is  low  enough  to  be 
permissive  for  this.    This  may  depend  on  other  signaling,  such  as  via 
phosphorylation (Lebensohn and Kirschner, 2009) or phospholipid or adapter 
protein interactions (Chen et al., 2010). While Rac1 is a major controller, it is 
likely that multiple signal inputs modulate the Scar/WAVE complex. 
 
4.4.3 Loss of Rac1 affects focal adhesion formation but not 
contact with BM or cell-cell adhesion structures 
Adhesion to extracellular matrix was likely affected by loss of Rac1, since in 
culture,  melanocytes  depleted  for  Rac1  showed  reduced  focal  adhesions.  
This could alter the lifetime of long protrusions and their ability to adhere for 
force  generation  towards  translocation.    However,  we  could  not  find  any 
change  in  the  percentage  of  melanoblasts  contacting  the  basement 
membrane in embryo skin, indicating that cells didn’t likely completely lose 
contact  between  integrins  and  extracellular  matrix.  E-cadherin  and  actin 
surrounding the melanoblasts and neighboring keratinocytes in skin explant 
whole  mounts  appeared  normal,  as  did  levels  of  E-cadherin  or  ZO-1 
expressed by cultured melanocytes following Rac1 depletion.  We can’t be 
sure that melanoblasts are making E-cadherin junctions with keratinocytes, 
but the extension of long protrusions into the spaces between keratinocytes, 
coupled with the precedent in other systems (Geisbrecht and Montell, 2002; 	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Kardash et al., 2010) suggests that E-cadherin is a good candidate to mediate 
interactions between these cells.  This requires further study, such as with E-
cadherin depleted melanoblasts or cadherin-blocking reagents. 
 
4.4.4 Melanoblast motility across the basement membrane 
and in skin is not invasive 
Melanoblasts  traverse  at  least  three  very  different  tissue  environments  on 
their journey from the neural tube to the epidermis and hair follicles.  They first 
emerge in the dermis, a complex matrix of collagen and proteoglycans and 
they migrate in the dermis until around E13.5, when they cross what appears 
as a collagen-rich BM into the epidermis.  At E13.5, the epidermis is only ~1 
cell-layer thick (Figure 4.34B) but by E15.5, multiple keratinocyte layers are 
present and around half of melanoblasts are touching the BM, but ~70% have 
crossed over and are above the BM (Figure 4.34C).  We can find no evidence 
that this motility depends on either N-WASP or Rac, which are important for 
the  assembly  of  invadopodia  (Li  et  al.,  2010;  Nakahara  et  al.,  2003; 
Yamaguchi et al., 2005) and for the invasion of cancer cells into 3D matrix 
(Kurisu et al., 2004; Li et al., 2010).  Furthermore, migration of melanoblasts 
within the skin was not affected by inhibition of MMPs.  Thus early dermal 
ECM  and  epidermal  BM  are  likely  permissive  to  cell  transmigration 
independent of pericellular proteolysis, whch is similar to lymphatic endothelial 
BM and dendritic cells (Pflicke and Sixt, 2009).   During melanoma formation, 
the  acquisition  of  a  BM  degrading  ability  is  thus  unlikely  to  be  a  simple 
reversion  to  the  normal  melanoblast  genetic  programme.  Melanoma  cells 
require  N-WASP  for  efficient  invasion  in  vitro  and  use  MT1-MMP  to  make 
invadopodia (Li et al., 2010), but melanoblasts do not appear to depend on 
similar invasive behavior during embryogenesis.	 ﾠ
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4.4.5 Rac1 is required for normal cell cycle progression and 
cytokinesis of melanoblasts during embryogenesis 
Rac1  is  important  for  G1  progression  of  melanoblasts  during  normal 
development.    A  major  controller  of  melanoblast  proliferation  is  c-kit,  a 
tyrosine kinase receptor, which signals to Ras and activates entry into the cell 
cycle via PI3-kinase, Akt and MEK pathways (Smalley, 2009).  Rac1 is well 
documented  to  act  downstream  of  Ras  in  concert  with  PI3-kinase  and  to 
regulate  G1  progression  in  vitro  (Olson  et  al.,  1995).  However,  unlike 
melanoblasts, anterior visceral endoderm cells can dispense with Rac1 for 
proliferation (Migeotte et al., 2010).  Murine neural crest cells have increased 
apoptosis with loss of Rac1 induced by wnt-1 cre, unlike melanoblasts with 
Tyr::Cre (Thomas et al., 2010).  We wonder if Rac1 loss affects stem cell 
survival  of  melanocytes  in  hair  follicles,  as  was  the  case  for  keratinocytes 
(Benitah et al., 2005; Chrostek et al., 2006), but some expression of Tyr::Cre 
in  the  nervous  system  (Tonks  et  al.,  2003)  caused  a  shakiness  of  Rac1 
deleted mice that required culling before they could be aged over several hair 
cycles. 
There  is  little  precedent  for  the  positive  involvement  of  Rac  in  control  of 
cytokinesis, so it was surprising to find a 3-fold increase in time to divide in 
Rac1  null  cells.    However,  Rac  drives  the  assembly  of  the  cortexillin-actin 
networks in dividing Dictyostelium cells (Faix, 2002) and recently Insall and 
colleagues  found  that  Scar/WAVE  proteins  enabled  cells  to  repolarize  and 
crawl  apart  following  cleavage,  suggesting  a  late  requirement  for  Rac  at 
opposite poles of the dividing cells (King et al., 2010).  In C. elegans early 
cleavage  furrow  formation,  Rac1  inhibited  by  a  complex  containing  the 
RacGEF  CYK4  and  centralspindlin,  so  that  Rho  can  effect  contractility 
(Canman et al., 2008).  Rac1 depleted melanoblasts dividing in skin could still 
round up with the normal timing, but took far longer to divide, indicating a 
likely requirement for Rac1 in adhesion of the dividing cell to the surrounding 
milleu and repolarization of the dividing cells to then crawl apart. This defect 
wasn’t seen in cultured cells, indicating that it was specific to the epidermal 
environment.    So  while  in  early  cytokinesis,  Rac1  may  be  inhibited  at  the 	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furrow, later cytokinesis may in some tissue environments utilize activation of 
Rac for adhesion, polarization and migration of the two daughter cells. 
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5.1 Summary 
Rac1  is  important  for  Ras-mediated  transformation  in  vitro,  but  its  role 
downstream of Ras, especially N-Ras, is not fully understood. The aim of this 
chapter was to characterise the role of Rac1 in mice with melanocyte specific 
expression activated N-Ras transgene. This work led to the identification that 
Rac1 is required for activated N-Ras induced dermal melanocytes survival in 
vivo. In addition, melanoblast migration and proliferation in conditional Rac1 
knockout mouse embryos cannot be compensated by expression of activated 
N-Ras.  
 
5.2 Introduction 
By  switches  between  inactive  GDP-  and  active  GTP-bound  states,  small 
GTPases function as critical relays in communicating signals from outside of 
the cell to the nucleus. Ras subfamily small GTPases is activated upon ligand 
engagement of membrane receptors and mediates cell growth, differentiation 
and survival (Downward, 2003). Such pleiotropic effects depend on the ability 
of Ras-GTP to activate multiple signaling pathways through direct binding to 
effector proteins. Mutations in the Ras proto-oncogene family (H-Ras, N-Ras 
and  K-Ras)  are  amongst  the  most  frequently  mutated  genes  in  human 
cancers, being found in 20% to 30% of all human tumours (Downward, 2003). 
The  most  common  mutations  are  found  at  residue  G12  in  the  phosphate-
binding loop and the catalytic residue Q61 (Malumbres and Barbacid, 2003). 
Constitutively Active N-Ras
Q61K are frequently found in nevi and early-stage 
melanomas  (Platz  et  al.,  2008).  Expression  of  dominant-active  human  N-
Ras
Q61K  to  the  melanocyte  lineage  by  tyrosinase  regulatory  sequences  in 
mice  results  hyperpigmented  skin  (Ackermann  et  al.,  2005),  which  can 
develop  cutaneous  metastasizing  melanoma  on  an  INK4a-Deficient 
background at 6 months . 
Growing evidence have identified that the MAPK pathway as a key effector in 
Ras signaling (Cook and McCormick, 1994; Marshall, 1995). However, the 
recruitment  of  many  other  Ras  targets  is  indispensable  to  elicit  a  full  Ras 	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biological response. Among these Ras-dependent, Raf-independent pathways 
are those connecting Ras to the Rho family of small GTPases. In contrast to 
the relatively frequent incidence of activating mutations in Ras genes, there 
are  no  published  reports  of  activating  Rho  mutations  in  human  tumors. 
However, numerous lines of research indicate that Rho proteins do indeed 
contribute to cancer (Sahai and Marshall, 2002). 
 
Rac1 small Rho GTPase has been known for over 15 years to be essential for 
Ras-induced transformation, at least in vitro (Qiu et al., 1995b), but relatively 
little  is  known  about  its  role  in  cancer  in  vivo.    Rac  is  essential  for 
transformation  in  a  K-Ras
G12D  activated  lung  cancer  model  (Kissil  et  al., 
2007a). In addition, Samuel at al, showed that Rac1 is required for K-Ras
 G12D 
driven epithelial cell hyperproliferation and that Rac1 activity is elevated in 
tissues  expressing  mutant  oncogenic  K-Ras  (Samuel  et  al.,  2011).  Rac  is 
activated downstream of Ras and can activate 70 kDa ribosomal S6 kinase 
(Chou and Blenis, 1996) and JNK1, which for JNK1, possibly via Pak kinases 
to stimulate cell cycle progression (Olson et al., 1995).  
 
The aim of this Chapter was to identify of role of Rac1 downstream of active 
N-Ras
Q61K in melanocytes in vivo. I demonstrate here that Rac1 is required for 
activated N-Ras induced dermal melanocytes survival in vivo. Activated N-
Ras does not play a role within melanoblast migration and proliferation during 
embryogenesis.  
 
5.3 Results 
5.3.1 Activated N-Ras doesn’t compensate for loss of Rac1 in 
either melanoblast migration or proliferation 
I  have  demonstrated  in  the  last  Chapter  that  Rac1  loss  in  melanoblasts 
causes coat colour defects in mice, which is due to impaired migration and 
proliferation. It has been shown that expression of dominant-active human N-
Ras
Q61K  under  control  of  tyrosinase  promoter  in  mice  results  in 	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hyperpigmented  skin  (Ackermann  et  al.,  2005),  which  is  due  to 
hyperproliferation of melanocytes. To investigate whether hypopigmentation 
resulting  from  Rac1  knockout  can  be  overcome  by  activated  N-Ras 
expression,  mice  carrying  a  Tyr::N-Ras
Q61K  transgene  were  crossed  onto 
Rac1  f/f  or  Dct::LacZ  background.  Tyr::N-Ras
Q61K+/o  control  and  Tyr::N-
Ras
Q61K+/o  Rac1  f/f    Tyr::Cre
+/o  mice  were  born  healthy  at  the  expected 
Mendelian ratio. Consistent with the previous report (Ackermann et al., 2005), 
Tyr::N-Ras
Q61K+/o control mice have much darkened skin compared to wild-
type  mice  (Figure  5.1A,  D).  Histological  analysis  of  P14  Tyr::N-Ras
Q61K+/o 
control ventral skin revealed presence of increased number of melanocytes 
not  just  in  hair  follicles  but  also  the  dermis  below  the  epidermis  and 
throughout the fatty tissue (Figure 5.2). Interestingly, Tyr::N-Ras
Q61K+/o Rac1 
f/f Tyr::Cre
+/o mice revealed no effect on the pattern or colour of the areas of 
unpigmented skin (Figure 5.1A, B). This was further confirmed by the fact that 
the number of white patches on the dorsal skin between Dct::LacZ Tyr::N-
Ras
Q61K+/o  Rac1  f/f  Tyr::Cre
+/o  and  Dct::LacZ  Rac1  f/f  Tyr::Cre
+/o  mice  was 
similar (Figure 5.1C). Strikingly, despite the large increase in the numbers of 
melanocytes in skin in adult mice, quantification of number of melanoblasts in 
E15.5 embryos or P0.5 skin only showed a slight increase in the presence of 
activated  N-Ras  in  a  normal  background  (Figure  5.3  and  5.4),  and  a 
significant reduction in melanoblast number in Rac1 f/f Tyr::Cre
+/o embryos 
regardless of the presence of activated N-Ras, indicating that activated N-Ras 
doesn’t  likely  confer  a  hyperproliferation  of  melanoblasts  during 
embryogensis. Indeed, we found that the coat colour was indistinguishable 
between  control  and  Tyr::N-Ras
Q61K+/o  control  mice  just  after  birth  (Figure 
5.5A), and coat colour in Tyr::N-Ras
Q61K+/o control mice become darker after 
day 3 (Figure 5.5B and C), suggesting that the melanocyte hyperproliferation 
phenotype in Tyr::N-Ras
Q61K+/o mice was developed after birth. 
In addition, we also noted that expression of activated N-Ras didn’t affect the 
morphology, motility, protrusion dynamics, epidermal/dermal localization and 
cytokinesis of either normal or Rac1 depleted melanoblasts detectably (Figure 
5.6, 5.7, 5.8, 5.9 and data not shown).  In summary, the cell cycle or motility  
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Figure 5.1 Expression of N-RasQ61K in the melanocyte lineage doesn’t 
rescue the loss of Rac1. (A) Coat-color of dorsal side (left) and ventral side 
(right) of P14 Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o (Rac1 f/f N-Ras) mouse 
with its Tyr::N-RasQ61K+/o (N-Ras) control littermate. Three typical white 
patches on the dorsal side of the Rac1 f/f N-Ras mouse were white arrows. (B) 
Coat-color of forelimb and tail of P14 Rac1 f/f N-Ras mouse with its Ctr N-Ras 
control littermate. (C) Quantification of number of white patches on dorsal surface 
for genotypes of number of mice as indicated. (D)Coat-color of dorsal side (left) 
and ventral side (right) of P14 Rac1 f/f Tyr::Cre+/o (Rac1 f/f) mouse with its 
control littermate. Typical white patches on the dorsal side of the Rac1 f/f mouse 
were white arrowed. 
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Figure 5.2 Melanocytes were absent in ventral white patches of Tyr::N-
RasQ61K+/o Rac1 f/f Tyr::Cre+/o.  Immunohistochemical analysis of ventral 
skin from P14 Ctr N-Ras and Rac1 f/f N-Ras mice with anti-DCT to detect 
melanocytes. Example of typical pocket of excess dermal melanocytes in Ctr N-
Ras mouse is black arrowed. Scale bars 100µm.	 ﾠ 209	 ﾠ
 
   
Ctr Ctr N-Ras Rac1 f/f Rac1 f/f N-Ras
E15.5
A
Ctr
Ctr N-Ras
Rac1 f/f
Rac1 f/f N-Ras
0
5000
10000
15000
**
ns
ns
N
u
m
b
e
r
 
o
f
 
m
e
l
a
n
o
b
l
a
s
t B
Figure 5.3 Expression of N-RasQ61K in the melanocyte lineage doesn’t rescue the 
effect of loss of Rac1 on melanoblast number and distribution. (A) Images of !-
galactosidase stained whole mount DCT::LacZ embryos: control,  Tyr::N-RasQ61K+/o control, 
Rac1 f/f Tyr::Cre+/o  and Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o  embryos at E15.5. Each 
image is representative of at least 5 embryos from four different litters. Insets show higher 
magnification of belly area and cell shpae. White dot lines in A indicate the trunk regions in 
which melanoblasts were quantified in box plot as shown in (B). (B) Number of melanoblasts 
in DCT::LacZ embryos including control, Tyr::N-RasQ61K+/o control, Rac1 f/f Tyr::Cre+/o and 
Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o at E15.5. At least 5 embryos from four different litters 
were examined. Lower quartile, median, and upper quartile are shown. **, P< 0.01 compared 
to control by t-test.  The scale bar is 1mm. 	 ﾠ 210	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Figure 5.4 Expression of N-RasQ61K in the melanocyte lineage doesn’t rescue the 
effect of loss of Rac1 on melanocytes number in new born pups. (A)  Representative 
images of !-galactosidase stained skin samples taken from dorsal side of DCT::LacZ Tyr::N-
RasQ61K+/o control (left) and DCT::LacZ Tyr::N-RasQ61K+/o Rac1 f/f  Tyr::Cre+/o (right) 
newborn pups at P0.5. Representative images of threshold area covered by melanocytes 
(white squared). (H) Relative area covered by melanocytes per image for DCT::LacZ control, 
DCT::LacZ Tyr::N-RasQ61K+/o control, DCT::LacZ Rac1 f/f Tyr::Cre+/o and DCT::LacZ Tyr::N-
RasQ61K+/o Rac1 f/f Tyr::Cre+/o. Data derived from five images per skin sample from at least 
3 pups from three different litters. Lower quartile, median, and upper quartile are shown. **, P< 
0.01 by t-test. The scale bar is 100µm. 	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Figure 5.5 Expression of Tyr::N-RasQ61K in mice induce skin hyperproliferation after 
birth.   Representative images of dorsal skin colour of control and Tyr::N-RasQ61K+/o control 
mice on P0.5 (A) and P3 (B). (C) Representative images of dorsal skin of control and Tyr::N-
RasQ61K+/o control, Rac1 f/f Tyr::Cre+/o and  Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o mice 
on P7. 	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defects caused by loss of Rac1 are not compensated for by activated N-Ras 
and N-Ras hyperactivation in a normal or Rac-depleted background has no 
detectable effect on melanoblast motility during embryogenesis. 
 
5.3.2 Rac1 is required for activated N-Ras induced 
hyperproliferation of epidermal/dermal melanocytes in vivo 
I have demonstrated within this chapter that expression of activated N-Ras 
does  not  play  a  role  within  melanoblast  migration  and  proliferation  during 
embryogenesis  and  Tyr::N-Ras
Q61K+/o  Rac1  f/f  Tyr::Cre
+/o  mice  revealed  no 
rescue on hypopigmentation. However, careful inspection of pigmented area 
of P14 Tyr::N-Ras
Q61K+/o Rac1 f/f Tyr::Cre
+/o mice revealed that the coat colour 
were  lighter  than  Tyr::N-Ras
Q61K+/o  control  mice  (Figure  5.1),  indicating  a 
possible growth defect of melanocytes. Histological analysis of distribution of 
melanocytes  using  pigmented  dorsal  skin  from  Tyr::N-Ras
Q61K+/o  Rac1  f/f 
Tyr::Cre
+/o showed excess melanocytes in hair follicle (Figure 5.10B), which 
also  found  in  Tyr::N-Ras
Q61K+/o  control  mice  (Figure  5.10A).  However,  In 
Tyr::N-Ras
Q61K+/o control mice, melanocytes accumulated in epidermis/dermis 
and throughout the fatty tissue (Figure 5.10A). Interestingly, We did not see 
any melanocytes in the dermis in skin taken from Tyr::N-Ras
Q61K+/o Rac1 f/f 
Tyr::Cre
+/o mice (Figure 5.10B). Together, these data indicate that Rac1 is 
required  for  Tyr::N-Ras
Q61K+/o  induced  epidermal/dermal  localization  of 
melanocytes. 
 
5.3.3 Expression of N-Ras
Q61K promotes survival of 
epidermal/dermal melanocytes via Rac1  
I have demonstrated that the melanocyte distribution in dermis/epidermis was 
not affected by expression active N-Ras
Q61K during embryogenesis, therefore 
the appearance of epidermal/dermal melanocytes in active N-Ras
Q61K control 
mice could either be due to better survival of residual epidermal melanocytes 
after birth, or migration of melanocytes from hair follicle to dermis during hair  	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Figure 5.6. Expression of N-RasQ61K did not rescue protrusion defects 
caused by deletion of Rac1. (A) Combined Z-stack images (1µm depth) of 
melanoblasts in skin explants from Z/EG+/o Tyr::N-RasQ61K+/o Tyr::Cre+/o 
control and Z/EG+/o Tyr::N-RasQ61K+/o Rac1 f/f Tyr::Cre+/o embryos. Long 
protrusions and short protrusions are white and yellow arrowed respectively. 
(B) Number of long/short protrusions per melanoblast n>60 cells per explant 
>= 3 explants per genotype. (C) Proportion of melanoblasts with long/short 
protrusions. Error bars indicate Mean ± SEM. **, P< 0.01, by t-test. Scale bar 
is 10µm.	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Figure 5.7. Expression of N-RasQ61K did not rescue migration defects 
caused by deletion of Rac1. (A) 3 hr tracks of individual melanoblast migration in 
skin explants, black tracks indicated migrated faster than average control, red 
indicates slower. (B) Migration speed. >300 melanoblasts from three explants were 
randomly selected. Error bars indicate Mean ± SEM. **, P< 0.01, by t-test. 	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Figure 5.8. Expression of N-RasQ61K did not rescue lifetime and frequency of 
protrusion defects caused by deletion of Rac1.(A) Live cell imaging of protrusion 
dynamics in explants. Images captured every 5 min, yellow arrows - protrusions. (B) 
Frequency of protrusion formation. (C) Lifetime of actively growing protrusions formed 
in 20 cells per explant from >= 3 explants. Error bars indicate Mean ± SEM. **, P< 
0.01, by t-test. Scale bar is 10µm.	 ﾠ 216	 ﾠ
 
Ctr 
Ctr N-Ras
Rac1 f/f
Rac1 f/f N-Ras
0
50
100
150 Dermis 
Epidermis
Epi/Dermal Junction
P
e
r
c
e
n
t
a
g
e
 
o
f
 
L
a
c
Z
+
 
C
e
l
l
s
Figure 5.9 Expression of N-RasQ61K in the melanocyte does not affect 
melanoblast migration from dermis to epidermis. (A) Images show the 
localization of melanoblasts in E15.5 DCT::LacZ  Tyr::N-RasQ61K control and Tyr::N-
RasQ61KRac1 f/f Tyr::Cre+/o embryos. (B) Quantification of localization of 
melanoblast in E15.5 DCT::LacZ  control, Tyr::N-RasQ61K control, Rac1 f/f Tyr::Cre
+/o and Tyr::N-RasQ61KRac1 f/f Tyr::Cre+/o embryos. More then 200 cells were 
examined per embryo from at least three embryos for each genotype. Melanoblasts 
are black arrowed. Black dot lines in each picture represent the epi/dermal junction. 
Scale bar is 20µm. 
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Figure 5.10 Rac1 is required for  N-RasQ61K induced survival of dermal 
melanocytes in mice. Immunohistochemical analysis of dorsal skin from P14 
Tyr::N-RasQ61K control (A) and Tyr::N-RasQ61KRac1 f/f Tyr::Cre+/o (B) mice 
with anti-DCT to detect melanocytes. High magnification images of hair follicle 
and  dermis were shown Example of typical pocket of excess dermal 
melanocytes in Ctr N-Ras mouse is black arrowed. Scale bars 100µm.	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follicle  morphogensis.  In  order  to  study  how  active  N-Ras
Q61K  induces 
melanocyte localization in dermis and how Rac1 deletion affects this, the first 
hair  follicle  cycle  was  tracked  by  taking  dorsal  skin  from  control,  Tyr::N-
Ras
Q61K+/o control and Tyr::N-Ras
Q61K+/o Rac1 f/f Tyr::Cre
+/o mice at day 0.5, 3, 
5, 14, and 21. The skin were then sectioned and stained with DCT antibody to 
analyse the distribution of melanocytes (Figure 5.11 and 5.12). In both control 
and Tyr::N-Ras
Q61K+/o Rac1 f/f Tyr::Cre
+/o mice, melanocytes in the epidermis 
gradually  disappeared  from  day  0.5  to  day  3  (Figure  5.11A  and  5.12). 
However, in Tyr::N-Ras
Q61K+/o control mice, melanocytes in epidermis survived 
from  day  0.5  and  number  of  melanocytes  in  epidermis  increased  as  the 
mouse getting older (5.11B), indicating that expression of N-Ras
Q61K promotes 
melanocyte survival in epidermis/dermis and Rac1 is required for this. 
Although Rac1 is required for N-Ras
Q61K promoted melanocyte survival in the 
epidermis/dermis, melanocytes hyperproliferation during anagen phase was 
found  in  the  hair  follicle  of  both  Tyr::N-Ras
Q61K+/o  control  mice  and  Tyr::N-
Ras
Q61K+/o Rac1 f/f Tyr::Cre
+/o mice. This suggest that expression of Tyr::N-
Ras
Q61K+/o promotes melanocyte proliferation in hair follicles and Rac1 has a 
very little role during this process.  
It has been shown that the transition from anagen to telogen is an apoptosis- 
driven process that leads to shortening of the hair follicle length by about 70% 
due to the well-coordinated apoptotic death of the vast majority of follicular 
keratinocytes,  and  during  this  process,  most  of  the  follicular  melancytes 
undergo apoptosis (Sharov et al., 2005). Consistent with this, we found that in 
the telogen phase of the first hair follicle cycle (day 21), only the permanent 
part  of  the  hair  follicles  remained  in  dorsal  skin  taken  from  control  mice 
(Figure 5.11A). Although, the lower part of hair follicles in Tyr::N-Ras
Q61K+/o 
control mouse have already degenerated, most of follicular melanocytes can 
still be found in the place corresponding to earlier hair bulbs, together with 
continuous accumulation of melanocytes in epidermis/dermis (Figure 5.11B). 
Interestingly, these follicular melanocytes can no longer be maintained if Rac1 
is deleted (Figure 5.12). Together, these data suggest that active N-Ras  	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Figure 5.11. Expression of N-RasQ61K promote survival of dermal melanocytes 
in mice. Immunohistochemical analysis of dorsal skin from Ctr (A) and Ctr N-Ras (B)  
mice at P0.5, P3, P5, P14 and p21 with anti-DCT to detect melanocytes. Example of 
dermal melanocytes are black arrowed. Scale bars 100µm.
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Figure 5.12. Deletion of Rac in meanocytes results gradually loss of 
dermal melanocytes in  N-RasQ61K background. Immunohistochemical 
analysis of dorsal skin from Ctr and Ctr N-Ras  mice at P0.5, P3, P5, P14 and 
p21 with anti-DCT to detect melanocytes. Example of dermal melanocytes are 
black arrowed. Scale bars 100µm.
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protects follicular melanocytes from undergoing apoptosis during hair follicle 
degeneration, which is dependent on Rac1. 
 
5.4 Discussion 
5.4.1 Activated N-Ras doesn’t compensate for loss of Rac1 in 
either migration or proliferation during embryogenesis 
Since around 20% of human melanomas acquire N-Ras
Q61K, we wondered 
whether expression of activated N-Ras would compensate for loss of Rac1 for 
growth, motility defects.  Knockdown of Rac1 in melanoma cells caused a 
block in NFkB activity that resulted in defective proliferation in vitro and in 
tumour  xenografts  (Bauer  et  al.,  2007),  suggesting  that  Rac1  might  be 
important  downstream  of  Ras  in  tumorigenesis.    Additionally,  in  a  K-Ras 
induced lung cancer model, loss of Rac1 prevented tumor formation (Kissil et 
al., 2007), indicating also the importance of Rac in mediating the downstream 
effects  of  Ras  on  proliferation.    We  were  surprised  that  expression  of 
activated N-Ras in melanoblasts didn’t increase the number of melanoblasts 
and motility parameters during embryogenesis, indicating that these pathways 
are  already  running  at  a  high  level  during  embryogensis  and  Ras  is  likely 
already  active  during  embryogenesis,  so  adding  more  active  Ras  doesn’t 
greatly change proliferation rates.  
 
5.4.2 Rac1 is required for activated N-Ras induced survival of 
dermal melanocytes 
Animals  expressing  activated  N-Ras  under  control  of  tyrosinase  promoter 
accumulate more melanocytes in their dermis and in the hair follicles than 
normal  mice.  Interestingly,  Rac1  deletion  in  melanocytes  results  in  loss  of 
dermal melanocytes in a similar fashion as normal mice, suggesting that Rac1 
plays a very important role downstream of N-Ras in regulating melanocyte 
survival. However, it is still unclear how the epidermal/dermal melanocytes 
disappeared from skin during the first a few days after the mouse was born, 	 ﾠ 222	 ﾠ
as  we  failed  to  detect  any  apoptotic  melanocyte  in  dermis  with  cleaved 
caspase-3 antibody in both P0.5 and P3 skin sections (data not shown). It 
could be possible that the removal of epidermal/dermal melanocytes is due to 
infiltration of macrophages.  
Kit signaling via KitL is known to trigger proliferation and survival via activation 
of  Ras  via  MAPK/ERK  signaling  (Mackenzie  et  al.,  1997)  and  PI3  kinase 
signaling. It has also been shown that KitL accumulated in the hair bulbs of 
anagen hair follicles with very little or no expression in the epidermis (Peters 
et  al.,  2003).  This  may  explain  why  in  normal  mice,  melanocytes  cannot 
survive in the epidermis, which is probably due to the low concentration of 
KitL  in  epidermis.  However,  expression  of  activated  N-Ras
Q61K  in  the 
melanocyte may overcome the requirement of KitL, thus promote melanocyte 
survival  and  proliferation  by  activating  the  downstream  targets  in  a  Kit 
independent manner, which is dependent on Rac1 (Figure 5.13 and 5.14). It 
will be of interest to see if the Rac1 function can be compensated by ectopic 
expression of KitL in epidermis (Kunisada et al., 1998).  
Similar  to  Tyr::N-Ras
Q61K  control  mice,  we  observed  more  melanocyte 
accumulation  in  hair  bulbs  during  anagen  in  Tyr::N-Ras
Q61K+/o  Rac1  f/f 
Tyr::Cre
+/o mice. We think this is probably due to the fact that the transgenic 
mouse  line  we  used  has  both  ectopic  expression  of  N-Ras
Q61K  and 
endogenous expression of wildtype N-Ras. Therefore, in the presence of KitL 
in  hair  bulbs,  the  endogenous  N-Ras  and  activated  N-Ras
Q61K  may  work 
synergistically to promote the proliferation and survival of melanocytes (Figure 
5.13 and 5.14). Rac1 deletion does seem to affect melanocytes in the hair 
bulbs,  although  it  is  unclear  whether  Rac1  is  required  for  melanocyte 
proliferation  in  hair  bulbs  as  it  is  impossible  to  determine  the  number  of 
melanocytes in each hair bulb by skin sections. However, during the telogen 
of hair cycle, KitL concentration dropped and hair bulb degenerated (Peters et 
al., 2002; Sharov et al., 2005), which leads to turning off endogenous N-Ras 
pathway in melanocytes. Therefore, hair follicle melanocyte in Tyr::N-Ras
Q61K 
control mice would survived as they do in dermis and deletion of Rac1 in 
these hair follicle melanocyte may disrupt activated N-Ras
Q61K induced  	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Figure 5.13. A predicted model for how Tyr::N-RasQ61K induces melanocyte survival in the 
Kit independent pathway. Left: Expression of KitL is concentrated in hair bulbs during anagen of 
hair cycle, which activate endogenous N-Ras signling pathway via Kit receptor.  expression of 
activated N-RasQ61K work synergistically with endogenous N-Ras to promoter melanocyte 
hyperporliferation. Right: In epidermis/dermis or telogen of hair cycle,  expression of KitL is very low 
or absent. The endogenous Kit pathway is off. The melanocytes are protected by expression of 
atcive N-RasQ61K.
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Figure 5.14. A predicted model for how Rac1 affects Tyr::N-RasQ61K induced melanocyte 
survival. Left: Expression of KitL is concentrated in hair bulbs during anagen of hair cycle, which 
activate endogenous N-Ras signling pathway via Kit receptor.  Expression of activated N-RasQ61K 
work synergistically with endogenous N-Ras to promoter melanocyte hyperporliferation. Rac1 is 
dispensable for this process probably because another survival pathway can be activated by Kit 
signaling thus bypass the requirement for Rac1.  Right: In epidermis/dermis or telogen of hair 
cycle,  expression of KitL is very low or absent. The endogenous Kit pathway is off. The 
melanocytes are protected only by atcive N-RasQ61K induced survival pathway, which is probably 
through Rac1. Thus, deletion of Rac1 cause loss of melanocyte in dermis. 	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survival  pathway,  thus  result  loss  of  melanocytes  in  a  similar  fashion  as 
wildtype mice (Figure 5.13 and 5.14).  
In conclusion, Rac1 is important downstream target of activated N-Ras
Q61K for 
melanocyte survival in skin, but that N-Ras doesn’t contribute detectably to 
migration or cytokinesis independently of Rac1 during embrogensis. 
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Chapter VI 
Summary and future directions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 	 ﾠ 227	 ﾠ
 
6.1 Summary 
One of the key aims of this thesis was to investigate the potential molecular 
mechanism for how fascin increases the invasiveness of cancer cells, which is 
mainly described in Chapter 3.  
In order to address this question, I used immunofluorescence or expression of 
GFP-tagged  fasicn  to  show  for  the  first  time  that  fascin  is  an  integral 
component of invadopodia in multiple cancer cell types.  
In addition, I have used siRNA or shRNA to successfully knockdown fascin in 
several different cancer cell lines. Consistent with previous studies, I showed 
that fascin is required for filopodia formation. Remarkably, I demonstrated that 
fascin  is  also  required  for  the  assembly  of  the  actin  cytoskeleton  in 
invadopodia  as  well  as  for  the  degradation  of  matrix  on  different  types  of 
matrix.    
I  also  confirmed  the  effect  of  phosphorylation  of  fascin  S39  on  filopodia 
formation and further demonstrated that phosphorylation of fascin at S39 also 
contributes to regulation at invadopodia.  
Furthermore,  I  observed  invadopodia  similar  to  a  comet-like  organization 
resembling bacteria-propelling actin tails. I used immunofluorescence and 3D 
reconstruction to show that Arp2/3 complex, cortactin, and fascin localized 
throughout comet heads and tails, whereas N-WASP concentrated mostly in 
the head. In addition to these, I also found several other filopodia proteins 
(IRSP53, IRTKS and mDia2) at invadopodia. This implies the first time that 
invadopodia might be a hybrid structure containing both actin branches and 
bundles. 
Next, I demonstrated that fascin is a very stable component of invadopodia 
and its presence enhance the stability of actin structures at invadopodia both 
in molecular level using FRAP or in cell level using live time imaging.  
Finally,  I  implicate  the  important  role  of  fascin  in  invasive  migration  into 
collagen I-Matrigel gels and 3D collagen degradation particularly in cell types 	 ﾠ 228	 ﾠ
that use a degradation dependent, elongated mesenchymal type of motility 
(Figure  6.1).  I  demonstrated  that  fascin  but  not  N-WASP  or  MT1-MMP  is 
required for formation filopod-like protrusions in 3D. However, knockdown N-
WASP or MT1-MMP which is required for invaopodia formation significantly 
reduce  cell  invasion  and  collagen  degradation  in  3D  but  not  filopod-like 
protrusions, which implicate existence of two types of protrusion in 3D: the 
stable  actin-based  proteolytic  structures  similar  to  invadopodia  in  2D  and 
filopod-like  protrusions.  Therefore  I  have  elucidated  for  the  first  time  that 
fascin promotes long protrusions in 3D and stabilizes actin in invadopodia and 
that this enhanced stability allows for more efficient invasion by mesenchymal 
cells, both in 2D and in 3D.  
Secondly,  another  aim  of  this  thesis  was  to  examine  the  role  of  Rac1  in 
melanoblast  migration  during  mouse  embryogenesis,  which  is  mainly 
described in Chapter 4.  
To assess the functions of Rac1 in the melanocyte lineage in vivo, I generated 
conditional Rac1 knockout mice by crossed mice carrying a floxed allele of 
Rac1 with mice expressing Cre recombinase under control of the tyrosinase 
promoter.  I  showed  in  the  first  time  that  Rac1  is  required  for  normal 
pigmentation  and  melanocyte  distribution  in  mice.  Which  is  due  to  both 
migration and proliferation defect during embryogensis.  In order to study the 
function of Rac1 in melanoblast migration in real time. I crossed mice carrying 
a Z/EG or GFP-Lifeact flox transgene onto the Tyr::Cre Rac1 f/f background. I 
showed that melanoblasts extend long dynamic pseudopodia containing both 
actin and microtubules and they squeeze between epidermal keratinocytes. In 
addition,  I  demonstrated  that  Rac1  is  required  for  the  formation  of  long 
pseudopodia  in  melanoblast,  which  also  dependent  on  microtubules  and 
Arp2/3 complex driven actin assembly.  
In addition, I demonstrated here that Rac1 is not essential for melanoblast 
migration, which is different to previously published model with cells undergo 
collective migration (Murphy and Montell, 1996; Migeotte et al., 2010).	 ﾠ
I also implicated that melanoblasts can initiate short  	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a common pathway. Further characteriza-
tion of cytoskeletal changes accompanying 
upregulation  of  fascin  at  tumor  invasion 
fronts will be informative. It is tempting 
to  speculate  that  fascin  may  have  other 
key cellular roles besides organising actin 
bundles. While fascin is becoming estab-
lished as a marker for tumor progression, 
its role in promoting cancer aggressiveness 
is much less well established or understood. 
Further testing of fascin’s role in invasion 
and  metastasis  in  vivo  in  physiologically 
relevant models for cancer metastasis are 
needed to determine how active a role fascin 
plays in cancer aggressiveness and whether 
it is a potential clinical target.
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It is becoming clear that upregulation of 
fascin  expression  confers  both  normal 
and cancerous cells with increased motile 
properties and the ability to assemble spiky 
actin-based protrusions that aid in invasion 
and cell motility. Many questions remain as 
to why fascin appears to be relatively unique 
among the actin bundling proteins as hav-
ing an important role in cancer invasive-
ness. It is likely that other actin modulating 
proteins work together with fascin to allow 
cells to increase their motility and change 
their morphology when they undergo epi-
thelial to mesenchymal transition (for can-
cer) or when dendritic cells mature. Some 
studies have suggested that cortactin may 
cooperate  with  fascin  to  promote  cancer 
aggressiveness,1,22,30-33 but this may just be 
a coincident increase in expression and co-
localization  in  similar  cytoskeletal  struc-
tures, rather than a direct cooperation in 
low expression of Ki-67, a marker for pro-
liferation.25,26  Hashimoto  et  al.  pointed 
out that this may indicate fascin expres-
sion selectively in highly metastatic but 
non-proliferative cells, an idea that war-
rants further investigation.
In some cases, high fascin expression 
has been correlated with low E-cadherin 
(epithelial  cadherin)  expression,  indi-
cating that as cells progress through the 
epithelial  to  mesenchymal  transition 
(EMT),  they  gain  fascin  whilst  losing 
E-cadherin.27,28 There is evidence that fas-
cin expression is regulated by the wnt acti-
vated LEF-TCF transcriptional signalling 
pathway that promotes EMT.11 However, 
fascin  expression  is  also  regulated  by 
cyclic-AMP  response  element  binding 
protein (CREB) and the aryl hydrocarbon 
receptor (AhR).29 How these two systems 
work together to regulate fascin expres-
sion in tissues and in cancer remains to be 
studied further.
Figure 2. A model showing fascin stabilizing actin bundles in an invasive cell migrating in the 3D 
environment of the tumor stroma. Sites of matrix remodeling can occur at protrusions or at other 
sites along the periphery of the cell, wherever the extracellular matrix (ECM) impedes cell migra-
tion and thus needs to be degraded for the cell to pass through. CHL-1 melanoma cells made both 
actin-rich spots and long thin  lopod-like protrusions in matrigel-collagen gels. We have drawn 
fascin-actin bundles here close to the plasma membrane, but it is possible that they could form 
a core inside of the branched actin networks rather than or additional to a shell around them. 
Arp2/3 complex and cortactin contribute to formation of branched actin networks and may also 
assist in membrane tra cking to and from sites of ECM remodeling. Integrins allow the cell to 
grab and pull against the ECM to aid migration.
Figure 6.1. Model of fascin stabilizing actin bundles in an invasive cell migrating in the 3D 
environment of the tumor stroma. Sites of matrix remodeling can occur at protrusions or at other 
sites along the periphery of the cell, wherever the extracellular matrix (ECM) impedes cell migra- 
tion and thus needs to be degraded for the cell to pass through. CHL-1 melanoma cells made both 
actin-rich spots and long thin filopod-like protrusions in matrigel-collagen gels. We have drawn 
fascin-actin bundles here close to the plasma membrane, but it is possible that they could form
a core inside of the branched actin networks rather than or additional to a shell around them. arp2/3 
complex and cortactin contribute to formation of branched actin networks and may also assist in 
membrane trafficking to and from sites of ECM remodeling. Integrins allow the cell to grab and pull 
against the ECM to aid migration.	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actin-based protrusions independently of Rac1, Arp2/3 complex or myosin, 
suggest a novel form of actin dynamics, which drive melanoblast migration in 
a Rac1 independent manner in vivo.  
Furthermore,  I  demonstrated  that  Rac1  is  not  absolutely  required  for  long 
protrusion formation or polarized motility when myosin activity is suppressed. 
However,  Rac1  controls  the  rate  of  protrusion  initiation  and  the  balance 
between  myosin-based  retraction  and  Rac-based  pseudopod  initiation 
governs translocation (Figure 6.2).  
I further suggest that melanoblast migration across basement membrane from 
dermis  to  epidermis  is  not  an  invasive  process.  I  demonstrated  here  that 
deletion  of  either  Rac1  or  N-WASP  had  no  effect  on  melanoblast 
dermis/epidermis  distribution,  although  both  Rac1  and  N-WASP  play  an 
important role formation of invadopodia and cell invasion.  
Moreover, I investigated melanoblast growth defect both in vivo. I have shown 
that growth defect in Rac1 depleted melanoblast mainly due to defect in Brdu 
incorporation  and  proliferation,  but  not  cell  cycle  exit  or  apoptosis.  I  also 
confirm this in vitro, and further suggested that the growth defect is mainly 
due defect in G1 to S phase transition.  
Unexpectedly, I found that Rac1 depleted melanoblast undergo cytokinesis 
almost  3  fold  slower  then  control  melanoblast.  However,  in  vitro,  I  did  not 
notice  any  defects  on  Rac1  depleted  melanocyte  undergo  cytokinesis, 
implicated a special requirements for Rac in cytokinesis in vivo than in culture 
dishes.  
Overall my results here revealed a novel mode of in vivo migration controlled 
by Rac1 that is important for normal development and likely in melanoma. 
Lastly, in Chapter 5 I investigated the role of Rac1 downstream of active N-
Ras
Q61K in melanoblast during embryogenesis and melanocytes proliferation 
in  adult  mice.  I  have  shown  that  active  N-Ras
Q61K  did  not  contribute 
significantly to melanoblast migration and proliferation during embryogenesis.  	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Figure 6.2. Model of melanoblast motility in epidermis. 
In wild type melanoblasts, Rac1 positively regulates the frequency of initiation of long pseudopods, 
which promote migration speed and allow cells to change their direction of migration. Scar/WAVE 
and Arp2/3 complex drive actin assembly for long pseudopod extension, which also depends on 
microtubule dynamics. Myosin contractility balances the extension of long pseudopods by effecting 
retraction and allowing force generation for movement through the complex 3D epidermal 
environment. In absence of Rac1, melanoblasts mainly use short stubs for migration. the short 
stubs are distinct from blebs and are driven by actin assembly, but are independent of Rac1, Arp2/3 
complex, myosin or microtubules. when myosin was inhibited in absence of Rac1, Rac1 was no 
longer required for long pseudopod generation; but it still strongly controlled the frequency of 
generation of long pseudopods.
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I also demonstrate here that Rac1 is required for activated N-Ras
 Q61K induced 
dermal melanocytes survival in vivo, which implicated Rac1 as an important 
target downstream of activated N-Ras
Q61K. 
 
6.2 Future directions 
6.2.1 Function of fascin in pancreatic cancer formation and 
metastasis 
Although the work present here clearly demonstrates that fascin is important 
for cancer cell invasion in vitro, it is still unclear whether fascin is required for 
tumour  invasion  and  metastasis  in  vivo,  and  if  it  is,  which  stage  of  the 
metastasis is specially fascin dependent.  
Pancreatic cancer is malignant neoplasm of the pancreas. The prognosis is 
relatively poor; the three-year survival rate is now about thirty percent, but 
less than 5 percent of those diagnosed are still alive five years after diagnosis 
and complete remission is still rather rare (Ghaneh et al., 2007). Pancreatic 
cancer is sometimes called a "silent killer" because early pancreatic cancer 
often does not cause symptoms and because of late diagnosis and frequent 
invading local structures or metastasizing makes the pancreatic cancer very 
difficult  to  be  cured  by  surgery.  Therefore,  preventing  pancreatic  cancer 
metastasis is very important to improve the treatment and survival rate. 
Fascin is upregulated in different types of invasive cancer, and its expression 
level often correlates with patient survival rate (Machesky and Li, 2010). My 
preliminary  data  using  human  pancreatic  PDAC  TMA  revealed  a  strong 
correlation of high expression of fascin with poor survival (Figure 6.3), high 
tumour grade and high vascular invasion (Data not shown).  
It  has  been  shown  that  LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre 
transgenic mice model frequently develop metastatic pancreatic tumors (jen 
PNAS). I noticed that in this model, fascin is not expressed in normal  	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Figure 6.3. Fascin expression in human PDAC.
 IHC analysis of tumour assay in human PDAC. representative images 
are shown for normal duct, PDAC with no, low, moderate and high 
staining (B) Kaplan&endashMeier analyses showing cases with high 
Fascin expression (n = 63) have poorer outcomes compared to those 
with low expression (n = 59; P < 0.003) Histoscore Median=74
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pancreas (Figure. 6.4A) and PanINs (Figure 6.4B), but upregulated in both 
primary PDAC invasive front and metastatic PDAC to the liver (Figure 6.4C-
H).  Recently,  fascin  knockout  mice  have  been  generated,  which  develop 
normally with minor defect in neural development (Yamakita et al., 2009). 
It would be interesting to see whether fascin is important for pancreatic cancer 
formation  and  metastasis  in  vivo  by  crossing  the  LSL-KrasG12D/+;LSL-
Trp53R172H/+;Pdx-1-Cre  transgenic  mice  into  fascin  null  background.  A 
recent  paper  showed  that  macroketone,  the  synthetic  homologue  of 
migrastatin  can  stop  cancer  cell  becoming  localized  to  lung  in  tail  vein 
injection xenografts (Chen et al., 2010). Thus it will be interesting to see if 
macroketone can stop metastasis in this transgenic mice model. 
In  addition,  fascin  null  PDAC  cell  lines  derived  from  such  genetically 
engineered mouse model could be used to significantly strengthen the role of 
fascin  in  tumour  invasion.  For  example,  typical  invasion  assay  (without 
helping by fibroblast for invasion) (Li et al., 2010), organotypic assay (with 
help by fibroblast for invasion) (Gaggioli et al., 2007) with fascin null PDAC 
cell  lines  can  be  compared  with  wildtype,  phospho-mimic  and  dephospho-
mimic  fascin  rescued  cell  line  to  see  if  putting  fascin  back  can  promote 
invasion and if actin bundling activity of fascin is critical for this.  
 
Furthermore, in vivo metastasis experiment by tail vein or intraspleen injection 
of cells into nude mice can be used to compare the metastatic ability of those 
cell line to localize to the lung or liver. Subcutaneous injection can be used to 
determine  whether  fascin  also  promote  cancer  cell  growth  and  if  this  is 
dependent on actin bundling activity of fascin. 
 
6.2.2 Function of Rac1 in melanoma progression and 
metastasis 
 
Previous  study  showed  that  Tyr::N-  Ras
Q61K+/o  INK4a
-/-  transgenic  mice 
develop metastatic melanoma at about 6 months (Figure 6.5) (Ackermann et  	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Figure 6.4. Fascin is upregulated in invasive front and metastasis in mouse PDAC 
All sections from LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre pancreatic cancer 
mouse model. Fascin is not expressed in (A) normal duct and (B) PanIN 1a.  In PDAC, 
fascin expression is strongly upregulated at invasive front (D and F) compared to centre 
of the tumour (D and E). The centre (E) and invasive front (F) of the tumour are 
enlarged. fascin upregulation also found in liver metastasis (G and H). Sections stained 
with H&E  and fascin antibody as indicated.  
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Figure 6.5.Tyr::N- RasQ61K+/o INK4a-/- transgenic mice frequently develop 
metastatic melanoma. 
Primary melanoma formed near mouth (A) and on the back (B) of the mouse. Lung 
metastasis (C) and brain metastasis (D) were detected frequently in these mice. 
melanoma cells are black arrowed.   
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al., 2005). In addition, Rac1 is required for initiation of lung cancer formation 
in a K-Ras
G12D activated lung cancer model (Kissil et al., 2007). However, 
whether Rac1 is required for cancer metastasis is still unknown.  We would 
like  to  first  confirm  whether  Rac1  would  affect  melanoma  formation  in  our 
melanoma  model,  Two  cohorts  can  be  compared  on  melanoma  formation:  
Tyr::N-  Ras
Q61K+/o  INK4a
-/-  Tyr::CreER
+/o  Rac1  f/f  and  Tyr::N-  Ras
Q61K+/o 
INK4a
-/- Tyr::CreER
o/o Rac1 f/f treated with tamoxifen. In addition, we would 
like to further address whether Rac1 is required for melanoma progression 
and metastasis in vivo. In this case, tomoxifen or vehicle will be applied to 
Tyr::N-  Ras
Q61K+/o  INK4a
-/-  Tyr::CreER
+/o  Rac1  f/f  mice  when  melanoma  is 
formed. Furthermore, in vitro or in vivo invasion and metastasis experiments 
(as discuss above) using melanoma cells derived from these tumours will be 
used to further confirm the role of Rac1 in tumour progression and metastasis.   
 
6.3 Conclusion 
The  work  presented  here  has  further  characterized  the  regulation  of  actin 
bundling protein fascin and has identified novel functional roles for this protein 
in regulation of invadopodia stability and matrix degradation during cancer cell 
invasion.  Furthermore,  this  study  has  revealed  a  novel  mode  of  in  vivo 
migration by mouse melanoblast during embryogenesis, and identified a novel 
role  of  Rac1  as  regulator  of  dynamics  of  protrusions  that  is  important  for 
normal melanoblast migration. Moreover, this study also shed some light on a 
novel mode of actin dynamics that drive melanoblast migration independent of 
Rac1 and implicated that melanoblast migration through basement membrane 
is not invasive. Finally, I provided evidence to show that Rac1 is important for 
melanoblast  proliferation  and  cytokinesis,  and  Rac1  play  a  role  in 
constitutively active N-Ras
Q61K induced melanocyte hyperproliferation in mice, 
which together suggested a important role of Rac1 in normal development 
and likely in melanoma. Together, these results add to the convincing body of 
evidence implying a significant role for Fascin and Rac1 in the regulation of 
cell  morphology,  motility  and  tumour  cell  invasion,  embryogensis  and 
tumourigenesis.   	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Appendix 
 
Movie  1. Part 1 (Frame 1 to 45): Time-lapse confocal images of A375MM 
cells expressing GFP-actin show actin comets in invadopodia. Images were 
acquired every 4 sec. Elapsed time is indicated. Part 2 (Frame 46 to 95): 
Time-lapse confocal images of A375MM cells expressing GFP-fascin show 
localization throughout the entire actin comets at sites of gelatin degradation. 
Images  were  acquired  every  0.428  sec.  Elapsed  time  is  indicated.  Part  3 
(Frame 96 to 199): 3D reconstruction of immunofluorescence of actin comets 
stained  with  anti-actin  (red)  and  anti-fascin  (green)  antibody,  which  shows 
fascin localized throughout the actin comets. Part 4 (Frame 200 to 249): Time-
lapse confocal images of A375MM cells expressing GFP-N-WASP and RFP-
actin show N-WASP concentrated only at the head of the actin comet. Images 
were acquired every 10 sec. Elapsed time is indicated. Part 5 (Frame 250 to 
354):  3D  reconstruction  of  actin  comets  of  invadopodia  in  A375MM  cells 
expressing  GFP-N-WASP  (green)  and  stained  with  rhodamine  phalloidin 
(red), which showed GFP-N-WASP localized only at the head of the comets.  
 
Movie  2. Left: Photo-bleaching of GFP-fascin at invadopodia. Images were 
acquired  every  0.428  seconds.  Elapsed  time  is  indicated.  Right:  Photo-
bleaching of GFP-actin at invadopodia. Images were acquired every 4.28 sec. 
Elapsed time is indicated. 
 
Movie  3.  Control  (Top)  or  Fascin  (Bottom)  siRNA-treated  A375MM  cells 
stably  expressing  RFP-Lifeact  cultured  on  gelatin  matrix  onvernight  in 
presence  of  5µM  GM6001.  The  timelapse  was  started  within  1  hour  after 
medium was replaced to remve GM6001. Formation of invadopodia, in which 
most of invadopodia had a lifetime exceeding 10 h. Images were acquired 
every  5  min.  Elapsed  time  is  indicated.  Gelatin  is  shown  to  indicate 
degradation. 
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Movie 4. Time-lapse confocal images of NT, Fascin siRNA or 5µM GM6001-
treated CHL-1 cells stably expressing GFP-Lifeact invading into collagen I-
matrigel  matrix  displayed  numerous  filopodia-like  protrusions.  Images  were 
acquired every 10 min. At each time point, a Z-stack images were taken with 
0.5 µm Z-spacing and showed as a combined Z-stack. Elapsed time is also 
indicated. 
Movie  5.  Melanoblasts  show  long  protrusions  in  E15.5  epidermis  explants 
and 3D reconstruction of melanoblasts in control and Rac1 knockout explants. 
This movie shows the motility of melanoblasts in epidermal explants as well 
as a confocal z-stack through the epidermis showing melanoblast shape and 
position. 
 
Movie  6.  Melanoblasts  in  Rac1  depleted  explants  migrate  slower  and  are 
more rounded than controls. This Movie shows a 3D reconstruction of the 
melanoblasts in the skin to demonstrate the shape differences between wt 
and Rac1 KO.  
 
Movie 7. Melanoblasts migrating in epidermis show bright flashes of F-actin 
near the tips of protrusions, which are distinct from blebs. This movieshows 
Lifeact expressing melanoblasts migrating in skin explants.  
 
Movie  8. Inhibtion of actin, tubulin or Arp2/3 complex, ablates long cellular 
protrusion formation of melanoblast in skin explants. This movie shows the 
cell motility data for Chapter 4, where we have shown quantification and still 
photos. 
 
Movie  9.  Deletion  of  Rac1,  Arp2/3  or  WAVE  complex  in  primary  mouse 
melanocytes reduces the formation of long protrusions. This movie shows the 
motility data for cells depleted of Rac1 or components of the WAVE complex 
in vitro. 
 
Movie  10. Rac1 is required for lamellipodia formation and cell migration of 
melanocytes  on  fibronectin  coated  2D  surfaces.  This  movie  shows  the 	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dynamics of melanocytes depleted of Rac1.  
 
Movie  11.  Deletion  of  Rac1  in  melanoblasts  delays  cytokinesis  in  skin 
explants but not in culture dishes. This movie shows that Rac1 deleted cells 
have delayed cytoskinesis in skin explants but not in a culture dish. 
 